Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019835-95301475	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 41.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 51.3;granulocytes: 53.9;Microglial cells: 203.3"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 245.7;HMC-1: 256.3;RPTEC TERT1: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002476	Enhanced		Supported	"Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoli, Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favorable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	2.2	1.3	2.5	6.1	2.3	4.1	6.9	2.5	2.5	4.9	7.2	9.2	4.9	3.4	18.8	2.0	10.2	6.1	2.0	2.3	5.4	18.0	1.3	7.6	3.9	4.3	3.7	3.7	3.3	22.5	1.4	2.1	4.6	41.1	8.5	0.9	1.5	5.5	5.3	2.9	5.4	6.3	4.9	4.1	5.2	4.7	3.2	3.9	7.7	1.7	6.3	15.4	1.8	5.1	18.5	31.7	5.3	9.4	9.5	12.3	1.3	14.4	14.3	12.6	10.9	43.8	13.2	10.2	9.3	19.5	9.0	24.0	7.9	7.1	15.8	30.7	12.1	245.7	8.8	8.8	19.2	28.6	256.3	9.4	3.2	9.1	18.5	17.9	16.4	11.3	25.8	0.4	17.1	5.9	5.4	4.6	6.2	22.3	7.9	7.7	14.3	26.9	69.3	40.4	12.5	9.3	4.8	1.2	10.1	5.9	0.0	15.1	27.0	13.3	8.6	11.2	17.3	0.1	0.0	4.0	25.4	16.0	6.6	0.2	0.5	0.2	1.3	0.6	1.1	1.4	1.0	1.5	1.8	1.6	0.6	1.5	0.3	1.9	2.3	0.3	1.5	1.3	2.5	2.3	2.5	2.5	2.3	5.4	4.3	3.7	4.6	4.9	3.2	5.1	4.6	9.6	32.7	28.4	5.8	4.2	7.0	7.3	4.0	0.1	0.6	0.6	4.5	8.6	9.1	23.9	22.9	0.1	2.0	2.7	0.0	6.9	3.8	4.2	11.3	19.8	0.0	51.3	13.6	3.1	0.4	5.7	6.1	6.0	53.9	9.5	2.9	0.6	4.5	0.0	10.3	4.0	0.0	2.5	8.1	2.0	6.8	10.7	1.8	203.3	13.5	0.5	4.1	16.1	2.5	2.9	8.3	1.9	8.3	27.1	0.5	26.4	4.7	0.8	0.0	8.2	3.1	0.9	8.3	3.4	7.5	0.3	6.4	17.3	9.2	4.5
ACSM1	"BUCS1, MACS1"	ENSG00000166743	"Acyl-CoA synthetase medium chain family member 1"	Q08AH1	16	20623237-20698890	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"breast: 225.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 13.2;Late spermatids: 23.2;Theca cells: 8.4"	"Group enriched"	"Detected in many"	8	"liver cancer: 14.7;prostate cancer: 36.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.3;memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"NTERA-2: 15.6"	"Not detected"	"Not detected"							HPA046291	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 5: Breast - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA046291: AB_10960704"	"unprognostic (1.08e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.50e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	0.4	0.5	0.3	0.0	0.4	3.6	225.3	0.4	0.4	2.0	0.2	1.0	0.5	2.1	0.4	0.4	2.2	0.4	0.5	0.3	0.4	1.1	10.7	0.5	0.3	0.4	0.3	2.5	1.6	0.9	0.1	0.0	0.5	3.7	0.6	0.1	1.8	0.6	0.3	2.0	0.7	0.8	0.3	0.5	2.2	4.4	0.4	0.4	0.5	0.2	0.2	1.0	1.4	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.1	15.6	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.5	0.0	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.4	0.3	0.4	0.4	0.3	0.5	0.3	0.4	0.4	0.1	0.0	0.0	0.3	1.0	0.6	2.6	1.2	1.2	0.0	2.5	2.4	1.0	5.7	1.4	0.0	0.0	0.2	0.2	1.6	1.9	4.2	13.2	1.4	0.2	1.5	1.2	1.3	0.8	2.3	0.1	0.7	2.0	0.8	0.0	2.8	3.6	1.3	0.2	0.0	0.7	2.9	0.0	0.3	2.8	23.2	4.4	0.6	0.0	0.0	1.7	0.0	0.0	1.0	1.3	1.2	3.7	7.2	0.0	2.5	0.6	1.4	3.7	0.0	0.0	0.1	0.2	0.8	0.2	1.1	1.6	0.1	0.3	8.4	2.5	1.4
AGTRAP	ATRAP	ENSG00000177674	"Angiotensin II receptor associated protein"	Q6RW13	1	11736084-11754802	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044120	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Golgi apparatus"	"HPA044120: AB_10960748"	"unprognostic (1.08e-3)"	"unprognostic (2.98e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (6.57e-7)"	"unprognostic (4.44e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.89e-2)"	44.1	50.3	26.6	30.2	28.5	132.3	44.3	27.1	32.4	34.6	44.0	29.3	11.2	24.7	47.7	53.6	48.3	25.2	37.0	24.5	30.5	65.8	29.5	62.3	23.4	37.3	28.8	26.9	67.3	25.7	31.2	22.0	31.3	79.1	9.3	3.4	39.0	21.0	54.3	38.8	25.7	20.3	28.4	83.4	33.7	24.7	31.8	11.3	40.8	12.4	13.3	43.9	43.3	31.1	55.9	66.7	16.7	36.9	27.5	34.9	30.5	28.6	49.0	34.8	30.2	42.0	129.7	5.4	126.7	35.4	87.3	45.8	27.9	135.3	10.7	3.1	61.5	1.6	38.4	51.8	84.9	27.6	64.3	34.6	105.4	112.9	59.2	42.4	46.9	17.3	73.8	52.8	19.8	44.6	13.7	80.9	29.7	24.0	67.3	4.6	15.0	27.5	56.7	5.2	14.6	22.0	52.5	26.4	48.4	22.3	59.8	57.4	26.0	44.1	30.8	70.3	30.9	19.6	24.2	33.3	111.7	196.1	20.7	483.4	844.2	694.6	185.7	442.7	90.4	47.0	66.9	109.8	312.2	38.2	72.0	93.5	756.8	73.0	385.2	25.5	90.8	577.4	26.6	28.5	27.1	32.4	24.5	30.5	37.3	28.8	31.3	28.4	31.8	31.1	46.2	22.4	27.4	3.9	12.1	11.6	30.7	112.4	16.5	1.0	54.8	56.0	12.0	32.9	41.6	36.8	6.2	15.7	60.1	6.9	9.8	95.5	20.6	75.3	30.8	36.1	7.2	21.0	0.2	446.7	92.4	45.3	11.2	41.1	88.0	19.1	42.1	7.7	118.3	3.3	0.2	12.3	20.3	143.5	18.9	23.4	37.9	97.8	28.4	1.9	107.4	19.4	122.6	0.5	7.0	96.9	22.5	27.1	8.6	66.5	8.6	55.3	78.5	5.6	13.1	13.0	23.8	3.5	36.1	34.4	13.5	13.1	45.0	50.4	18.2	25.2
ALOX12B	12R-LOX	ENSG00000179477	"Arachidonate 12-lipoxygenase, 12R type"	O75342	17	8072636-8087716	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 90.2"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 1.7;Rod photoreceptor cells: 1.2;Spermatogonia: 1.2;Suprabasal keratinocytes: 1.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 11.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"A549: 1.1;HEK 293: 1.3;hTCEpi: 1.6;JURKAT: 2.7;OE19: 1.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024002	Supported		Supported	Vesicles,Cytosol		NA	NA		7000	"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	Vesicles	"HPA024002: AB_1844757"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.18e-2)"		"unprognostic (1.26e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.46e-2)"	0.0	0.0	0.4	0.1	0.5	0.1	2.1	0.4	0.6	5.7	0.0	0.1	0.3	0.0	0.0	5.6	0.2	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.5	0.4	0.2	0.0	0.2	1.2	0.1	0.0	0.5	0.4	0.1	0.6	0.8	0.0	0.4	90.2	0.2	0.0	0.1	0.2	0.2	0.2	0.4	0.6	0.0	0.0	19.1	0.0	15.0	0.1	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.3	0.0	0.0	0.0	1.3	0.0	0.4	0.1	0.0	0.2	0.0	0.0	1.6	0.1	0.5	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.8	0.0	0.9	0.0	0.4	0.4	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.0	0.4	0.6	0.1	0.2	0.0	0.1	0.5	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.5	0.4	0.6	0.4	0.2	0.4	0.2	0.5	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.5	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.8	1.2	0.0	1.8	0.0	0.0	0.0	0.1	0.1
AMD1	SAMDC	ENSG00000123505	"Adenosylmethionine decarboxylase 1"	P17707	6	110874770-110898879	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 202.9"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 70.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029281, HPA029282"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA029281: AB_10600101, HPA029282: AB_10599965"	"prognostic unfavorable (3.87e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.71e-2)"	31.8	28.3	35.0	34.7	44.9	89.9	33.9	39.6	56.1	32.8	32.0	36.9	29.2	35.5	25.7	56.0	25.6	33.3	40.2	37.5	38.2	48.6	33.6	33.4	39.9	45.6	38.5	30.0	39.7	40.3	26.0	59.9	42.2	202.9	36.5	35.9	37.4	34.5	26.7	26.9	26.5	35.4	45.5	27.3	31.2	31.9	37.6	40.5	46.2	50.2	50.3	37.4	25.8	67.1	85.8	57.4	68.6	130.6	101.1	63.9	89.8	119.9	131.8	91.4	106.7	92.2	52.3	149.7	56.7	76.7	97.0	57.4	163.9	108.6	125.1	88.5	94.6	155.4	47.5	96.5	60.2	135.7	88.9	43.4	98.0	63.4	126.4	31.8	81.0	75.4	118.2	126.8	156.3	51.8	181.9	103.3	84.7	84.1	51.9	98.5	68.9	89.3	103.9	112.9	87.4	62.2	73.2	91.7	110.7	55.5	59.5	114.9	53.8	60.5	45.7	325.0	131.5	34.4	59.7	152.8	69.6	106.7	79.4	42.9	23.9	37.7	17.4	28.9	20.2	14.5	17.4	20.3	31.5	14.8	20.4	20.8	102.6	15.5	37.3	13.9	22.5	17.0	35.0	44.9	39.6	56.1	37.5	38.2	45.6	38.5	42.2	45.5	37.6	67.1	169.5	38.5	92.5	23.2	164.8	315.3	241.5	49.5	262.4	101.4	178.5	151.1	95.7	125.8	82.7	55.2	60.5	44.5	208.7	144.1	146.8	67.2	31.8	145.0	106.2	104.4	124.4	184.1	39.2	70.0	152.0	132.1	96.4	214.8	93.9	36.9	53.6	59.3	77.0	77.4	37.9	108.2	28.5	109.1	244.2	53.6	43.8	176.7	131.6	23.4	92.0	303.7	60.8	36.7	111.6	87.6	95.9	50.0	118.9	379.4	66.2	89.9	29.3	105.6	19.7	170.5	124.9	93.0	76.7	246.4	288.1	54.6	184.6	45.7	128.8	147.7
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 subunit beta 1"	Q10567	22	29327680-29388583	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		660000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	30.7	46.7	38.0	47.2	38.3	45.8	26.4	37.3	45.2	22.8	35.6	34.9	43.3	22.7	12.1	63.0	23.5	30.4	23.9	36.1	40.8	34.8	34.8	30.1	57.8	44.2	44.6	17.5	38.3	67.0	39.2	44.8	43.7	38.3	30.1	35.3	40.3	25.9	24.5	47.2	45.6	27.1	41.4	52.6	40.9	24.7	52.7	34.2	29.6	20.5	54.4	39.4	32.2	48.8	84.6	47.5	49.3	50.2	37.0	27.0	60.0	59.8	65.5	71.2	68.2	74.4	33.2	46.1	37.2	68.4	33.0	74.6	71.5	97.6	45.2	58.2	102.0	79.1	60.8	42.0	38.9	114.1	99.9	38.6	36.0	67.5	55.0	33.0	98.7	17.2	54.6	54.9	48.3	93.7	45.5	36.8	37.3	124.8	53.3	89.0	54.3	119.9	50.2	194.5	75.9	52.2	74.0	82.5	36.4	33.5	66.7	49.5	84.6	79.1	48.8	46.0	62.1	60.4	32.5	84.6	56.1	48.1	46.7	0.0	29.3	5.7	9.2	29.2	9.1	16.2	6.3	7.9	28.7	18.2	4.9	5.2	3.0	7.2	31.7	9.0	8.8	24.2	38.0	38.3	37.3	45.2	36.1	40.8	44.2	44.6	43.7	41.4	52.7	48.8	17.8	12.8	16.4	27.7	53.0	7.1	9.3	16.7	16.5	26.3	26.2	20.8	16.1	21.5	16.4	22.0	39.6	52.3	15.1	69.6	23.5	41.2	7.5	16.4	11.6	19.8	21.6	40.0	24.1	40.7	30.1	12.1	33.6	30.1	5.1	13.2	35.3	34.3	138.9	45.4	25.6	24.9	18.3	95.5	24.2	13.1	11.8	65.7	12.4	51.5	29.8	28.4	9.2	16.1	14.0	65.9	33.2	12.4	28.5	17.5	51.2	30.1	14.5	42.1	6.6	17.8	12.7	23.5	17.6	33.0	9.1	68.3	17.0	39.6	36.2	18.1
AP1M2	"AP1-mu2, HSMU1B, mu2"	ENSG00000129354	"Adaptor related protein complex 1 subunit mu 2"	Q9Y6Q5	19	10572671-10587315	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 162.0;Proximal tubular cells: 373.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.3;neutrophil: 7.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 172.8;Hep G2: 313.8;MCF7: 268.3;OE19: 156.7;RT4: 164.9;U-2 OS: 166.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA054999			Supported	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA054999: AB_2682666"	"unprognostic (8.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.23e-2)"	"prognostic favorable (3.73e-6)"	"unprognostic (1.80e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.06e-1)"	3.4	0.1	0.8	6.4	0.3	0.9	32.9	0.6	0.8	27.1	0.3	67.1	64.0	6.6	61.8	51.9	46.6	22.7	0.4	0.5	0.4	76.3	1.5	19.2	0.4	0.7	0.6	0.3	55.9	62.4	34.8	16.2	0.4	30.8	63.4	0.1	41.5	24.0	0.3	42.1	54.8	3.0	0.3	0.6	59.1	9.6	0.7	4.2	58.8	0.3	9.5	23.4	19.1	0.6	144.2	71.1	0.4	10.4	0.0	0.0	65.0	0.2	0.0	2.3	1.6	172.8	82.1	0.4	64.7	1.2	43.4	97.6	0.1	109.0	3.2	0.6	1.0	6.7	48.5	313.8	1.3	0.3	0.8	0.2	81.6	3.9	0.1	5.0	0.0	0.4	0.3	0.6	1.2	268.3	0.6	1.8	31.4	156.7	0.0	2.4	9.3	0.7	2.7	164.9	67.3	0.2	0.0	120.0	0.6	34.6	123.3	0.4	0.0	0.4	166.7	0.9	2.2	0.4	0.9	1.4	0.2	0.4	0.2	4.3	0.4	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.6	0.0	1.4	0.2	0.0	2.7	0.8	0.3	0.6	0.8	0.5	0.4	0.7	0.6	0.4	0.3	0.7	0.6	0.4	28.9	34.8	0.0	1.9	6.9	19.2	68.9	13.1	0.0	49.3	30.0	0.5	47.1	64.2	86.5	0.0	123.0	0.5	112.2	137.0	141.3	43.4	52.4	5.4	1.7	74.4	0.0	0.3	115.8	101.0	1.5	73.4	57.7	2.5	0.0	0.7	0.0	9.8	0.0	0.2	95.5	97.6	0.8	0.0	19.9	1.5	2.6	3.6	0.0	1.7	0.0	0.0	0.0	0.2	130.2	125.6	0.7	0.0	37.6	162.0	373.6	61.5	0.0	0.0	0.0	6.2	16.9	4.1	39.1	13.1	66.1	2.8	0.0	131.4	48.3
ARFGEF3	"BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33"	ENSG00000112379	"ARFGEF family member 3"	Q5TH69	6	138161939-138344663	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4;salivary gland: 18.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 114.6;Excitatory neurons: 200.9;Inhibitory neurons: 207.8;Oligodendrocyte precursor cells: 173.9;Oligodendrocytes: 378.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 14.8;RH-30: 13.4;RT4: 19.4;SK-BR-3: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036350	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA036350: AB_10672084"	"prognostic unfavorable (8.20e-4)"	"unprognostic (4.31e-2)"	"unprognostic (9.91e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.69e-2)"	1.2	3.8	13.4	0.7	16.4	0.4	7.9	20.1	17.7	5.0	0.0	4.2	2.2	0.7	0.9	0.4	2.2	1.7	1.0	16.7	13.0	2.1	0.1	6.4	0.2	11.1	17.7	0.1	8.7	15.8	7.0	1.4	14.4	12.0	4.8	2.8	18.0	1.0	0.2	1.2	1.9	0.7	7.5	0.4	10.0	0.6	15.2	0.1	1.9	0.7	0.2	3.4	0.4	28.4	8.0	3.1	0.0	0.6	0.0	0.0	4.7	0.3	0.2	0.2	0.0	0.1	0.4	0.0	3.1	0.3	2.7	2.6	3.8	2.0	0.0	0.0	4.9	0.0	1.5	0.9	0.0	3.0	0.0	0.0	0.9	0.0	0.9	3.5	4.1	2.7	0.0	4.9	0.0	14.8	0.0	0.0	2.7	8.5	3.4	0.6	13.4	2.6	2.6	19.4	6.9	0.0	7.8	22.2	0.9	0.3	4.4	0.0	0.4	0.2	2.2	0.0	7.9	1.7	6.7	0.0	3.2	1.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	16.4	20.1	17.7	16.7	13.0	11.1	17.7	14.4	7.5	15.2	28.4	9.4	16.0	114.6	34.3	0.5	0.0	18.8	0.0	6.2	19.0	39.9	12.6	6.4	14.3	44.6	3.7	0.0	16.5	0.8	2.5	3.9	11.4	83.0	8.6	1.4	11.9	66.7	2.7	200.9	24.7	2.4	4.1	41.3	17.7	2.5	0.1	8.2	0.3	1.4	11.8	207.8	44.2	0.0	0.0	0.0	22.0	0.0	0.5	0.0	36.5	2.0	0.9	0.0	173.9	378.1	14.2	8.4	0.0	0.9	67.6	2.5	0.3	37.2	3.3	0.0	3.5	0.9	4.1	1.1	3.0	0.0	6.2	0.8	0.1	13.2	42.7
ARFIP2	POR1	ENSG00000132254	"ADP ribosylation factor interacting protein 2"	P53365	11	6474683-6481479	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB032985, HPA038156"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus"		"CAB032985: AB_2058811, HPA038156: AB_10697243"	"unprognostic (2.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (2.00e-5)"	"unprognostic (8.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.48e-3)"	19.8	29.3	31.7	18.6	32.3	22.8	50.7	32.5	35.2	36.3	36.2	36.8	32.9	27.2	34.0	31.4	39.3	23.9	17.9	32.1	31.4	27.0	34.6	24.4	22.4	31.2	31.4	29.4	49.4	46.4	40.7	29.7	31.9	46.6	48.1	28.3	57.7	28.2	15.2	32.8	30.7	27.4	30.9	20.7	50.4	18.3	31.8	25.7	36.9	16.1	32.0	29.2	24.4	33.1	50.4	64.8	38.9	38.5	59.1	53.9	56.1	40.3	107.0	86.2	101.8	62.1	80.3	39.9	16.5	79.3	49.8	68.0	49.4	84.1	70.0	30.9	86.5	22.3	87.7	60.4	71.3	36.2	42.8	60.0	65.7	43.0	98.3	64.2	55.9	38.3	35.3	45.0	55.8	98.9	41.9	41.6	67.2	119.0	71.9	31.7	22.6	37.1	61.9	50.4	50.8	63.2	48.7	204.9	25.9	36.3	86.9	33.0	36.8	35.4	35.7	39.1	30.3	67.3	32.5	24.3	65.4	22.0	43.9	13.0	15.6	9.9	17.9	10.9	17.8	12.1	16.7	14.5	21.3	13.8	16.7	17.1	6.1	21.1	6.7	16.6	18.9	13.9	31.7	32.3	32.5	35.2	32.1	31.4	31.2	31.4	31.9	30.9	31.8	33.1	14.8	6.4	6.4	4.6	20.7	28.0	49.3	48.9	16.5	32.6	59.8	45.1	4.3	40.0	30.5	12.9	29.2	80.1	24.3	56.0	58.7	62.7	31.7	28.1	20.1	19.6	63.0	21.8	8.4	85.4	65.8	23.1	62.2	37.2	31.8	30.3	20.3	21.1	28.1	21.9	7.8	126.6	32.6	10.1	16.4	43.3	20.5	14.4	24.9	5.6	25.2	35.4	18.6	6.6	7.6	59.9	63.4	24.5	28.0	73.3	65.2	34.4	34.7	32.3	26.3	21.6	23.3	41.0	26.2	26.2	32.1	112.5	16.9	40.9	52.6	64.7
ARSD		ENSG00000006756	"Arylsulfatase D"	P51689	X	2903972-2929349	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.2;EFO-21: 24.5"									"HPA004694, HPA063835"	Approved		Approved	"Vesicles,Lipid droplets"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Lipid droplets"		"HPA004694: AB_1078221, HPA063835: AB_2685132"	"unprognostic (3.92e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (5.90e-3)"	"unprognostic (6.32e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.18e-2)"	"unprognostic (3.93e-1)"	"prognostic favorable (1.97e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.11e-3)"	8.4	7.8	4.3	6.1	4.1	4.9	23.6	4.2	4.5	23.9	10.7	20.5	21.0	11.2	15.9	10.0	28.0	11.4	4.8	4.1	5.1	38.9	40.0	16.8	3.6	6.3	5.7	18.7	32.4	12.7	4.2	8.6	5.4	19.3	14.8	1.7	17.5	13.3	1.7	7.3	15.4	7.6	5.6	7.2	30.4	3.8	4.6	2.8	21.1	3.2	4.2	11.7	8.4	5.0	6.9	12.0	3.2	15.4	13.6	7.7	0.1	3.9	7.1	1.7	1.1	0.7	23.2	0.0	24.5	7.9	18.1	0.0	0.6	2.0	1.6	0.2	0.0	0.0	0.0	4.0	7.5	0.0	9.1	12.3	6.3	3.4	3.6	11.1	11.5	0.0	0.0	0.1	7.6	16.9	0.1	1.7	2.7	21.3	5.0	2.9	0.0	0.2	12.3	0.1	0.0	8.5	5.4	6.3	4.1	8.5	17.1	13.1	10.6	0.0	0.5	1.2	1.8	0.1	0.0	0.0	11.1	8.2	8.8	1.5	5.8	4.1	1.7	5.0	0.6	1.3	0.8	1.4	4.4	0.8	0.2	0.9	1.0	2.0	2.0	3.0	0.3	2.5	4.3	4.1	4.2	4.5	4.1	5.1	6.3	5.7	5.4	5.6	4.6	5.0	13.4	19.2	36.4	9.8	4.5	5.0	13.9	11.3	10.8	4.9	45.0	30.9	5.6	74.4	23.1	44.1	0.0	19.1	8.6	44.3	19.6	35.1	0.7	68.6	19.6	13.8	67.9	3.4	0.9	53.9	25.0	7.9	31.6	67.8	16.5	66.8	11.7	109.9	18.5	0.0	1.7	56.2	10.2	17.8	6.4	1.4	6.2	16.1	14.2	6.5	23.1	5.8	11.3	3.5	1.5	47.4	47.9	6.8	1.6	18.1	53.1	23.4	25.8	0.9	6.6	15.1	10.7	1.3	3.9	16.2	7.2	26.0	4.3	38.3	60.9	16.4
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587706-114598915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		96000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	79.5	140.2	70.5	80.5	71.1	131.4	108.4	74.0	101.1	85.0	85.0	70.5	59.4	92.4	177.3	132.5	71.3	64.6	93.0	72.1	79.4	138.1	125.9	84.9	115.4	75.4	79.1	106.2	72.5	172.9	135.1	91.2	80.2	132.7	65.5	91.2	111.9	55.1	124.0	98.1	69.2	60.6	71.5	93.9	121.1	75.4	75.6	104.2	99.2	113.0	100.8	106.8	94.0	75.4	83.6	71.0	153.2	38.8	111.0	84.5	148.3	125.2	86.6	88.5	63.4	92.3	94.8	74.2	106.8	80.0	183.2	179.0	105.6	84.6	79.3	63.2	73.8	72.3	84.4	143.4	156.8	173.1	135.1	105.2	227.9	72.7	87.3	104.1	91.0	123.1	136.0	164.4	131.6	159.0	164.6	113.6	187.0	222.2	126.8	159.0	95.0	126.7	195.2	128.4	113.8	156.3	159.7	284.0	487.6	143.9	235.0	202.5	118.9	80.1	68.9	132.3	142.0	213.6	474.5	139.6	106.8	97.2	112.0	490.1	327.8	495.0	212.6	331.2	264.9	549.6	288.8	255.8	255.0	501.7	374.7	305.5	405.4	255.4	348.4	401.5	398.9	756.7	70.5	71.1	74.0	101.1	72.1	79.4	75.4	79.1	80.2	71.5	75.6	75.4	230.6	160.3	176.6	19.6	353.9	519.0	492.9	1068.9	277.7	170.5	470.4	494.1	151.6	163.0	629.7	331.1	41.7	346.1	268.2	198.5	970.5	374.1	85.7	381.6	223.8	227.7	360.7	157.6	35.0	263.6	336.5	247.0	231.4	594.9	267.4	156.8	219.2	337.1	548.1	164.9	37.4	346.8	1133.2	350.1	517.8	60.3	306.0	382.4	494.5	20.6	699.7	360.9	261.6	20.1	22.9	430.5	218.1	250.9	255.0	686.5	176.7	1021.5	426.3	158.6	236.7	155.6	393.0	400.6	326.7	361.4	576.7	757.4	304.0	280.3	201.6	852.2
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976042	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 2809.6;salivary gland: 3847.3"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	74000000000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	128.6	3.9	17.1	2.7	28.8	0.4	1061.4	23.1	18.8	3.4	16.0	6.7	30.9	1.5	2.5	22.0	3.0	38.7	114.7	14.9	22.2	326.8	2809.6	14.8	0.4	20.2	23.3	6.0	752.1	0.1	1.3	0.5	27.1	1051.4	4.2	3.6	3847.3	40.2	1.7	206.8	28.6	0.3	14.0	1.4	315.2	25.9	21.4	0.8	1.9	2.3	1.5	5.8	7.5	24.5	0.2	0.0	0.0	0.0	11.3	0.0	5.5	0.0	0.0	0.0	0.0	0.1	4.0	14.2	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.3	0.1	56.6	4.9	1.5	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.3	29.9	0.0	0.0	0.0	5.1	0.2	158.9	0.0	0.0	1.7	130.4	0.0	0.0	0.0	2.0	1.0	25.4	13.0	0.0	41.8	0.0	0.0	0.5	0.1	1.8	0.9	1.9	0.8	0.4	0.0	0.5	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	28.8	23.1	18.8	14.9	22.2	20.2	23.3	27.1	14.0	21.4	24.5	9.9	22.4	276.8	0.0	14.7	4.2	422.1	25.3	0.0	0.0	1315.5	704.8	115.9	451.8	63.0	5.5	2.1	0.0	10.4	5.5	46.9	11.7	1.9	1.4	1.2	14.2	12.4	85.5	0.1	254.2	0.0	7.7	94.8	5.5	3.8	1.2	65.3	4270.8	0.0	0.0	0.1	13.1	901.3	93.1	0.7	4.2	0.9	14.8	62.2	1.0	2.0	23.7	0.0	7.5	7.3	221.5	6.4	0.0	0.3	1691.9	15.3	596.1	6.3	0.3	0.0	0.0	11.9	7.4	0.4	9.9	9.7	0.0	12.3	0.1	12.6	674.2
BASP1	"CAP-23, CAP23, NAP-22, NAP22"	ENSG00000176788	"Brain abundant membrane attached signal protein 1"	P80723	5	17065598-17276843	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 486.3;epididymis: 303.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 345.6;Extravillous trophoblasts: 362.9;Langerhans cells: 489.4;Muller glia cells: 796.9;Syncytiotrophoblasts: 738.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 128.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 128.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 467.0;HeLa: 800.8;SiHa: 830.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045218, HPA050333"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		63000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA045218: AB_2679263, HPA050333: AB_2681090"	"unprognostic (3.35e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.25e-11)"	"unprognostic (1.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.70e-1)"	35.3	13.8	235.9	73.6	257.0	87.6	14.0	103.0	486.3	56.9	79.9	12.5	7.3	37.3	303.3	10.9	11.4	29.2	13.9	247.3	210.9	15.1	17.2	36.5	80.9	134.7	153.1	36.6	3.7	3.4	21.2	92.1	184.3	79.7	10.8	74.3	13.2	21.6	2.3	22.0	22.2	33.4	107.7	76.5	22.7	2.9	157.1	24.1	11.3	6.8	91.5	57.9	27.3	281.8	0.1	125.6	152.7	0.2	71.7	76.1	227.1	161.7	50.9	127.9	135.0	6.1	0.1	51.3	22.4	112.0	467.0	10.6	98.2	109.2	164.8	21.3	57.9	0.4	800.8	0.3	158.9	101.3	1.4	131.2	132.7	145.6	121.0	163.9	140.1	0.2	0.4	0.5	138.2	183.7	0.3	92.5	115.7	0.3	39.6	0.1	0.5	28.0	46.5	31.3	99.3	21.3	830.7	72.3	0.2	336.5	0.3	101.9	187.7	169.3	0.6	14.2	26.1	1.7	0.2	27.1	171.2	123.0	23.1	25.0	3.1	25.3	0.0	1.5	0.0	5.4	0.0	0.0	4.9	7.9	0.0	0.0	128.5	1.8	2.1	0.5	0.3	0.8	235.9	257.0	103.0	486.3	247.3	210.9	134.7	153.1	184.3	107.7	157.1	281.8	8.0	9.6	4.8	22.2	158.7	215.9	88.0	21.3	58.1	54.8	9.8	10.2	1.6	0.0	15.8	9.2	12.5	155.0	3.8	0.6	0.0	0.6	0.9	98.4	345.6	30.2	0.0	18.1	254.0	3.4	362.9	102.6	23.4	156.4	27.3	18.1	35.7	2.5	53.8	244.0	125.3	0.7	12.2	227.9	489.4	0.0	0.6	298.5	28.4	53.4	275.1	796.9	1.0	115.1	23.7	1.0	0.2	0.0	173.0	121.0	0.0	0.3	93.5	58.4	0.0	2.0	66.2	0.4	3.4	21.0	58.8	738.5	11.9	8.3	1.8	13.2
BIK	NBK	ENSG00000100290	"BCL2 interacting killer"	Q13323	22	43110750-43129712	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 17.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 329.3;Club cells: 215.6;Ionocytes: 443.5;Paneth cells: 140.5;Respiratory ciliated cells: 204.1;Urothelial cells: 175.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 72.9;plasmacytoid DC: 58.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 89.9;CAPAN-2: 44.3;Daudi: 44.2;U-698: 172.1"	"Not detected"	"Not detected"							HPA051360	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA051360: AB_2681453"	"unprognostic (1.18e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.86e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.45e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.04e-1)"	0.2	2.3	0.2	4.1	0.4	4.1	4.9	0.7	0.3	2.8	0.0	8.5	3.6	0.2	1.2	11.3	3.0	3.1	0.3	0.5	0.0	3.8	0.5	1.4	11.6	0.0	0.0	0.3	2.5	1.6	1.0	0.1	0.1	11.4	5.2	0.2	17.5	0.5	0.0	3.5	5.3	0.2	0.0	2.9	13.4	2.0	0.1	1.4	1.8	0.1	11.2	2.6	6.5	0.0	89.9	0.7	0.2	0.1	0.0	0.0	1.1	0.0	0.2	0.0	0.0	28.8	44.3	44.2	4.2	0.0	0.9	19.5	4.8	1.9	0.0	0.7	6.7	0.1	0.6	4.9	0.7	21.2	4.1	0.0	8.8	0.0	0.0	0.3	0.2	9.5	0.3	2.0	0.0	22.9	16.9	28.9	6.7	24.2	7.3	0.2	0.1	20.6	0.9	2.6	1.7	0.0	3.1	8.2	6.5	3.1	1.6	28.9	0.8	0.1	2.4	0.2	1.0	10.4	17.1	172.1	0.0	2.2	0.2	1.8	2.9	72.9	2.7	0.7	4.3	17.1	9.5	4.2	10.4	11.7	6.4	3.5	11.3	0.9	0.8	58.6	7.1	6.3	0.2	0.4	0.7	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	4.2	0.0	9.3	12.6	32.7	329.3	3.4	0.0	39.7	24.1	0.7	17.2	215.6	7.3	0.0	1.4	7.9	43.0	7.9	62.2	0.3	17.7	0.8	2.3	50.6	5.7	0.3	16.2	1.2	0.9	90.7	9.1	0.0	0.1	5.3	0.7	0.9	0.0	0.2	52.9	443.5	1.4	4.8	0.4	0.0	4.0	35.6	0.0	6.4	0.0	1.0	0.0	0.1	105.2	140.5	0.7	79.7	53.1	10.2	15.7	204.1	0.0	0.0	0.0	14.9	0.2	11.0	16.1	11.8	1.0	12.9	0.3	53.9	175.3
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.6;salivary gland: 25.4;stomach 1: 32.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.4;Intestinal goblet cells: 139.7;Ionocytes: 40.7;Paneth cells: 40.0;Undifferentiated cells: 79.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 27.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 149.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA050769	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Nucleoli	"HPA050769: AB_2681230"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.1	0.0	0.5	2.1	0.4	0.0	12.4	0.2	0.4	10.4	0.1	32.8	19.0	2.3	0.0	3.0	3.7	5.5	0.0	0.4	0.1	0.2	0.8	5.8	0.0	0.6	0.4	0.0	5.1	0.0	0.1	0.0	0.6	17.0	41.6	0.0	25.4	1.4	0.0	5.4	15.1	1.2	0.2	0.1	32.9	0.0	0.5	0.1	0.1	0.0	0.2	1.2	0.4	0.6	0.0	1.3	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	149.2	0.2	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.0	9.3	0.0	0.0	18.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.4	0.1	0.6	0.4	0.6	0.2	0.5	0.6	0.4	9.6	16.3	0.3	0.2	0.3	3.4	5.9	6.2	0.0	20.5	10.8	0.1	20.0	14.5	0.0	0.0	0.0	0.1	35.4	0.0	6.0	0.0	4.0	2.0	0.5	25.9	0.0	0.1	11.1	0.0	0.2	25.0	13.9	0.0	0.0	0.0	3.3	0.1	0.0	0.1	139.7	40.7	0.0	1.0	0.0	0.0	0.6	10.6	0.0	0.0	0.0	0.0	0.0	0.1	3.9	40.0	0.0	0.0	12.4	4.4	0.0	5.2	0.0	0.0	0.4	0.9	0.0	0.0	10.9	0.4	0.0	0.4	0.0	79.8	5.5
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 71.3;Muller glia cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 55.1;NB-4: 99.8;U-937: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	13.6	13.0	31.8	10.0	38.9	3.4	31.1	26.6	37.1	35.9	18.7	17.7	6.3	21.5	61.5	64.3	21.3	11.2	14.8	35.3	25.2	27.8	57.7	19.4	19.9	36.9	30.5	22.0	89.1	29.0	22.2	1.9	30.8	32.9	3.9	36.9	55.0	17.6	3.1	47.7	15.2	12.0	26.8	17.7	26.8	11.5	30.7	13.1	51.9	5.3	20.4	18.4	32.7	44.0	0.4	2.1	2.1	25.0	0.8	0.2	1.7	3.1	8.4	3.7	1.7	19.5	1.7	40.0	27.4	0.0	9.6	13.6	16.4	0.4	1.7	35.5	12.4	7.6	0.1	55.1	31.6	0.0	21.3	12.3	20.7	8.8	18.9	10.5	0.3	17.7	5.9	1.2	0.0	0.8	2.6	99.8	25.4	0.2	8.7	49.1	0.8	3.0	6.3	0.0	9.3	12.2	4.3	0.7	14.5	16.7	18.8	8.8	0.2	2.9	7.8	18.6	0.1	24.5	21.1	32.0	0.1	61.9	2.8	12.3	7.1	27.4	7.5	3.9	5.7	19.8	4.3	4.6	4.1	17.7	3.9	3.8	22.4	22.4	2.4	3.9	5.5	5.8	31.8	38.9	26.6	37.1	35.3	25.2	36.9	30.5	30.8	26.8	30.7	44.0	3.2	6.4	10.7	27.1	31.2	18.0	13.2	12.0	15.4	24.5	47.0	28.8	4.1	22.8	22.2	1.8	18.8	3.4	17.2	0.2	7.9	20.0	1.7	7.9	11.2	8.6	23.9	4.0	38.3	30.5	0.9	15.7	3.1	7.6	12.7	14.4	8.2	71.3	16.4	11.8	24.4	1.3	8.2	7.1	7.2	7.3	14.3	6.7	26.6	16.9	19.6	150.3	27.8	47.7	48.1	9.4	2.5	16.1	12.4	40.6	0.4	44.6	27.8	29.5	6.6	6.9	13.8	1.0	1.6	20.6	25.9	2.9	15.7	2.7	2.5	11.9
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 263.1;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1839.9;Endometrial ciliated cells: 1221.7;Glandular and luminal cells: 1555.7;Intestinal goblet cells: 1471.3;Paneth cells: 2326.0;Proximal enterocytes: 3162.1;Undifferentiated cells: 1266.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 529.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 230.7;PC-3: 47.6;RPMI-8226: 40.5;SCLC-21H: 58.0;T-47d: 105.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"	"Region enhanced"	"Detected in many"		"midbrain: 9.7"	HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.7	0.2	0.2	7.8	0.3	0.2	26.7	4.2	0.3	12.3	37.6	263.1	54.4	7.5	1.4	1.3	29.6	2.2	0.1	1.1	1.2	46.5	40.4	10.7	0.2	1.3	1.9	0.5	96.6	1.5	27.7	1.0	0.6	58.3	17.5	0.4	72.9	8.3	0.1	9.6	169.5	0.8	0.5	0.2	1.4	0.7	0.9	1.0	116.3	0.0	1.2	1.5	0.2	0.2	2.5	3.6	0.0	0.4	0.0	0.0	17.8	0.0	0.0	0.0	0.0	4.2	35.7	0.0	9.9	0.0	0.0	1.0	0.4	0.0	0.0	0.1	4.9	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	230.7	0.4	1.2	2.1	9.1	47.6	0.1	0.0	40.5	2.1	0.2	58.0	0.7	0.0	33.6	0.0	0.2	105.4	0.0	0.2	0.2	0.6	0.9	0.1	0.2	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.3	1.1	1.2	1.3	1.9	0.6	0.5	0.9	0.2	1.6	38.5	37.8	0.0	13.2	0.1	60.3	43.7	0.0	0.7	289.9	182.5	0.6	287.4	86.3	126.9	4.2	63.9	5.1	1839.9	9.8	297.5	0.0	1221.7	130.5	10.3	606.1	5.3	0.0	19.1	17.7	4.1	16.8	1555.7	28.0	1.5	0.4	40.5	5.1	0.0	0.0	1471.3	116.0	0.3	0.0	0.3	2.5	9.9	10.6	0.0	2.0	11.8	0.0	0.0	0.0	36.7	2326.0	0.0	4.4	433.2	3162.1	58.6	498.4	10.6	0.0	0.0	20.3	0.1	0.3	2.7	0.0	72.4	17.5	0.0	1266.0	607.3
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 334.7;Proximal enterocytes: 629.1;Proximal tubular cells: 487.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 458.7;RPMI-8226: 616.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	54.8	40.7	125.3	75.0	147.0	25.1	60.4	139.4	156.9	136.8	113.0	83.6	190.1	44.2	122.8	78.4	140.8	94.4	63.7	123.7	133.2	327.3	261.1	82.3	86.3	143.1	137.4	34.4	100.7	58.5	48.0	75.4	144.7	122.5	79.5	42.1	57.4	101.7	26.6	47.0	255.0	37.9	140.4	137.0	103.5	20.9	143.9	52.5	159.1	22.4	82.2	94.5	47.4	157.6	64.6	85.0	60.5	57.4	72.2	42.5	252.3	66.0	61.7	88.3	87.4	49.6	67.1	80.3	81.4	72.1	69.0	95.0	92.7	124.9	62.7	121.3	36.7	80.2	42.1	79.6	104.6	158.7	119.3	64.5	93.9	76.4	136.6	50.1	78.3	94.6	86.3	458.7	59.1	71.6	84.9	75.6	91.0	42.4	50.3	91.3	69.4	616.6	346.1	264.1	65.3	34.2	51.6	360.2	91.6	143.0	151.5	64.0	82.5	93.9	79.5	21.2	45.2	85.5	380.6	108.1	63.6	113.8	80.2	37.1	115.4	49.0	77.6	166.3	84.4	102.4	61.6	72.2	185.1	110.5	65.5	72.4	15.9	124.6	174.1	161.3	94.5	135.7	125.3	147.0	139.4	156.9	123.7	133.2	143.1	137.4	144.7	140.4	143.9	157.6	39.2	73.7	62.7	16.6	55.7	9.2	40.3	48.6	12.5	33.6	76.5	36.4	26.9	77.2	56.8	119.5	16.7	157.9	47.8	99.0	187.9	168.1	3.3	187.7	49.7	49.6	65.3	23.3	8.8	154.7	130.9	23.5	63.7	334.7	12.0	34.0	40.0	119.8	216.3	43.7	10.8	82.9	75.3	122.9	24.9	4.1	18.6	79.0	17.8	13.1	90.8	86.6	55.6	15.6	51.7	108.9	103.5	16.6	44.4	65.2	629.1	487.6	73.3	31.6	13.1	15.2	22.3	8.3	7.2	27.1	9.7	109.0	38.2	32.8	99.8	53.8
COPG1	COPG	ENSG00000181789	"COPI coat complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		57000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428"	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	84.7	111.0	66.6	59.0	68.2	59.4	79.8	69.5	80.7	100.4	93.0	107.6	86.7	75.5	157.4	86.8	70.0	53.8	95.5	70.3	73.7	82.7	149.5	84.4	54.8	74.3	71.5	77.9	162.4	96.3	139.0	81.9	77.4	107.7	109.8	33.4	130.7	72.7	75.7	74.4	86.7	72.2	66.4	81.9	114.0	46.5	73.2	53.5	83.3	43.2	67.1	67.2	72.2	73.2	167.8	83.2	119.1	104.0	272.8	219.0	126.9	266.3	251.8	179.5	225.2	153.9	101.2	91.1	150.8	380.7	145.6	98.4	99.5	157.2	193.6	112.0	41.4	151.9	103.2	252.6	247.9	116.4	156.4	230.9	135.6	143.8	235.0	196.1	164.3	68.9	54.2	213.6	219.2	253.4	68.7	117.7	71.3	243.6	100.9	73.3	111.8	178.3	227.3	136.7	74.1	86.1	204.2	150.3	255.9	129.8	167.1	167.6	223.9	96.9	91.7	207.2	104.2	165.7	86.1	158.9	236.4	86.9	190.0	79.1	49.9	37.2	44.1	59.2	53.6	24.9	39.8	43.9	57.0	26.9	30.0	36.2	37.2	57.0	57.3	52.2	43.8	56.2	66.6	68.2	69.5	80.7	70.3	73.7	74.3	71.5	77.4	66.4	73.2	73.2	16.6	16.0	31.5	7.8	19.2	8.8	16.9	35.4	12.0	9.2	18.9	8.6	23.3	17.2	34.6	27.6	4.2	55.6	19.7	77.0	43.0	44.5	10.4	26.2	27.7	22.8	38.6	22.9	14.1	46.5	63.1	32.5	53.0	36.9	15.2	28.6	28.9	56.5	39.0	5.0	14.8	75.1	22.4	31.2	14.8	4.7	41.0	21.6	23.2	7.5	36.5	12.7	18.6	4.5	11.8	40.8	44.6	31.2	68.4	24.4	64.5	39.5	32.6	7.1	19.7	20.2	33.3	24.3	17.0	16.4	10.2	72.2	19.4	27.7	44.6	20.6
COPZ1	"CGI-120, COPZ"	ENSG00000111481	"COPI coat complex subunit zeta 1"	P61923	12	54301202-54351846	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		70000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic unfavorable (7.84e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.51e-1)"	"unprognostic (7.54e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (6.40e-5)"	"unprognostic (1.02e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (7.45e-5)"	"unprognostic (2.16e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.41e-2)"	75.1	101.1	70.7	51.0	71.9	58.2	95.3	70.8	86.4	85.8	84.6	83.7	74.1	73.1	125.3	107.0	90.2	55.8	104.0	70.8	71.9	105.1	115.4	74.0	68.4	69.6	70.8	73.0	151.3	106.5	105.7	83.5	69.9	76.1	102.6	104.2	104.9	68.7	104.4	76.0	68.5	79.2	70.9	74.9	89.4	35.9	72.0	96.2	115.3	90.3	93.8	73.2	68.7	73.8	135.4	212.1	149.8	133.2	179.8	234.7	96.5	109.3	166.9	149.9	110.6	122.9	185.5	103.1	180.6	165.9	96.3	102.0	265.0	183.7	181.1	137.0	153.5	99.8	181.8	190.6	183.9	133.3	89.9	172.8	250.0	183.2	294.8	257.5	206.8	103.2	221.7	202.1	199.7	177.3	158.7	141.5	109.2	204.2	160.0	121.8	96.4	145.8	225.7	123.5	140.3	112.5	113.2	197.7	147.2	139.6	274.7	210.0	131.7	92.0	96.8	90.7	108.0	82.6	112.1	100.7	172.5	110.4	164.9	97.5	127.3	95.0	93.6	117.7	100.3	86.4	86.2	84.8	128.0	86.2	69.9	75.2	42.9	114.7	134.6	151.6	116.7	134.7	70.7	71.9	70.8	86.4	70.8	71.9	69.6	70.8	69.9	70.9	72.0	73.8	54.3	57.7	73.3	15.3	64.4	28.7	71.9	137.9	47.8	51.0	91.6	72.0	77.2	68.6	105.7	68.0	22.9	175.3	73.3	62.5	273.9	152.2	19.8	66.8	73.6	58.1	66.9	58.5	13.5	115.6	273.9	73.8	63.7	74.5	87.5	100.9	50.7	95.1	173.1	48.8	15.4	141.4	85.5	64.3	42.6	25.4	62.7	78.8	53.4	7.5	150.5	86.3	76.2	14.6	13.7	113.9	74.0	57.2	132.5	100.9	118.0	208.0	92.8	75.4	19.7	35.8	57.1	64.2	60.2	66.6	35.9	202.2	62.0	99.8	87.5	95.3
CORO1B	coronin-2	ENSG00000172725	"Coronin 1B"	Q9BR76	11	67435510-67443821	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 301.4;Paneth cells: 324.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 221.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017616, HPA040113, HPA070456"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		960000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB017616: AB_2087018, HPA040113: AB_2676850, HPA070456: AB_2686268"	"unprognostic (1.94e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.02e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.64e-3)"	54.4	56.4	20.2	29.7	23.8	20.3	53.4	23.4	27.0	55.7	21.1	70.2	62.9	72.8	14.6	80.2	54.2	44.1	26.1	19.4	22.7	48.2	47.2	53.7	41.9	28.0	23.6	42.7	52.5	24.6	35.1	31.2	25.1	71.0	34.5	6.6	73.2	39.6	13.0	42.4	62.3	36.7	24.2	66.0	77.1	13.9	25.1	21.1	55.8	9.9	18.4	58.3	53.5	26.3	80.9	81.4	37.5	76.0	94.1	81.3	56.6	58.5	118.0	94.2	70.8	134.1	116.0	6.4	111.3	80.8	95.8	67.9	41.9	74.9	16.8	19.4	40.7	54.9	47.3	57.9	148.1	2.3	120.8	110.6	66.3	80.1	37.2	59.7	120.7	49.4	42.7	9.2	54.2	238.4	14.4	11.2	47.7	198.2	73.4	11.2	41.0	14.9	62.6	104.3	40.7	50.8	52.4	139.6	181.6	26.0	178.5	63.0	92.2	63.4	47.4	87.4	35.2	1.6	3.3	14.6	103.4	8.2	66.4	57.3	102.8	8.0	10.9	212.9	8.3	20.0	37.6	14.6	79.0	11.0	21.2	11.4	47.8	11.9	221.8	60.8	55.2	57.8	20.2	23.8	23.4	27.0	19.4	22.7	28.0	23.6	25.1	24.2	25.1	26.3	58.7	3.2	2.2	4.6	53.4	27.9	60.1	90.8	40.9	13.0	53.8	39.0	1.6	50.1	66.4	47.8	8.4	87.8	39.2	301.4	60.7	111.4	8.9	43.6	32.9	52.0	99.0	19.8	1.8	105.0	229.8	35.8	111.1	64.8	28.0	46.7	47.8	22.4	251.8	15.2	2.4	188.6	81.4	138.6	66.4	5.0	39.4	96.3	71.2	10.3	195.3	30.0	41.2	4.5	6.8	136.9	324.9	34.6	64.3	55.6	263.5	84.0	41.2	14.6	52.6	22.1	55.1	8.1	6.6	47.6	31.0	150.5	100.3	54.8	128.0	74.5
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"		6	106360717-106572017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"esophagus: 61.9;placenta: 72.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 219.4;dendritic cells: 153.6;Plasma cells: 89.9;Syncytiotrophoblasts: 600.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.7;HBEC3-KT: 124.1;hTERT-HME1: 95.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.2"	"Low region specificity"	"Detected in many"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	17.0	1.2	0.6	21.9	0.5	24.1	17.3	0.7	0.8	6.8	40.3	25.0	25.4	2.4	6.2	61.9	6.7	8.1	1.0	1.9	0.4	15.3	11.8	9.8	20.4	0.8	0.7	2.3	4.9	5.8	0.4	72.0	0.6	25.2	19.2	0.8	9.3	5.4	1.1	42.1	23.7	4.8	0.5	12.6	10.3	5.1	1.5	9.7	2.6	1.2	33.5	19.0	14.0	0.4	34.7	0.2	0.0	0.1	25.5	93.7	9.9	4.9	33.5	10.8	10.0	2.4	11.5	54.0	2.3	21.7	14.6	54.5	0.2	124.1	5.3	74.0	2.3	0.0	1.5	16.9	12.1	33.4	0.2	44.9	66.7	19.7	95.8	0.1	46.5	41.9	1.7	7.3	28.5	3.5	9.7	10.7	0.4	0.2	21.2	16.4	0.4	0.4	14.9	80.0	2.2	0.2	20.3	31.9	0.3	3.0	16.4	24.3	13.5	11.6	1.5	0.2	34.4	5.7	4.7	57.7	56.0	39.3	26.3	0.3	3.4	0.4	7.4	3.6	10.1	6.6	9.8	8.5	8.6	2.9	5.8	5.7	2.4	4.8	4.1	1.0	9.9	4.0	0.6	0.5	0.7	0.8	1.9	0.4	0.8	0.7	0.6	0.5	1.5	0.4	13.4	12.8	11.9	0.0	24.2	0.0	0.0	0.0	0.0	0.0	31.2	14.1	0.0	0.0	13.0	33.1	0.0	219.4	153.6	0.0	3.9	10.9	0.0	20.2	2.7	4.4	0.0	0.0	0.0	12.5	15.3	2.5	0.0	31.6	1.3	0.1	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	26.4	0.0	0.0	89.9	0.0	0.0	15.0	8.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	600.1	76.7	0.1	0.0	0.0
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 177.7;skin 1: 434.9"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 185.7;Suprabasal keratinocytes: 291.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 13.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067089	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA		35000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"	"Nucleoli, Vesicles"	"HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	34.4	11.1	29.7	11.2	28.2	22.4	35.2	37.3	31.2	59.2	13.1	15.0	18.8	11.8	77.4	177.7	12.5	10.3	43.8	29.5	30.0	17.6	15.7	26.4	8.7	33.8	29.0	14.6	35.9	10.9	19.7	28.2	36.4	24.5	10.2	27.5	53.1	14.1	39.0	434.9	14.9	10.9	27.1	9.3	22.8	27.0	37.5	19.6	21.0	22.3	25.1	13.3	85.1	27.3	74.8	10.9	65.9	50.4	9.8	16.2	21.1	14.4	25.2	20.9	13.3	5.4	92.6	22.9	41.0	18.7	21.6	37.3	7.7	85.9	9.6	58.0	11.9	14.9	3.4	69.3	20.3	11.3	8.4	18.2	83.5	26.7	27.0	17.7	57.2	42.4	26.8	10.5	13.0	45.6	25.3	41.6	35.0	60.0	18.7	28.4	19.3	14.7	10.7	25.2	72.1	45.4	32.9	29.4	44.4	22.3	36.3	27.2	37.7	13.4	16.4	20.4	32.2	22.9	32.5	27.0	5.0	56.6	54.5	2.6	5.2	13.8	2.6	1.8	1.6	1.7	1.3	2.1	6.4	1.5	1.3	1.2	3.7	8.6	1.2	2.0	1.3	2.6	29.7	28.2	37.3	31.2	29.5	30.0	33.8	29.0	36.4	27.1	37.5	27.3	150.6	28.9	13.9	30.0	9.6	103.1	42.3	16.1	40.5	9.0	39.9	33.3	14.0	24.3	17.0	18.4	8.4	71.3	23.5	20.5	33.2	20.9	116.3	20.0	17.9	42.7	49.1	20.0	18.0	18.7	43.2	15.7	30.1	38.5	0.0	27.2	20.0	25.6	58.0	16.8	14.1	37.5	12.2	43.0	97.4	34.8	14.9	38.3	48.0	12.2	33.6	185.7	71.1	17.1	24.1	37.6	28.3	23.0	13.3	53.5	28.6	30.5	5.2	12.8	46.0	15.0	24.5	72.1	43.6	154.0	291.5	48.4	17.2	14.3	28.6	60.5
CTNND2	"GT24, NPRAP"	ENSG00000169862	"Catenin delta 2"	Q9UQB3	5	10971836-11904446	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein"	"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 93.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2382.9;Excitatory neurons: 1253.9;Inhibitory neurons: 1124.0;Oligodendrocyte precursor cells: 1418.0;Oligodendrocytes: 433.8"	"Cancer enriched"	"Detected in many"	16	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.1;MCF7: 9.0;SK-BR-3: 5.3;U-266/84: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015077, CAB037339, HPA071124"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"CAB037339: , HPA015077: AB_2669150, HPA071124: "	"unprognostic (7.32e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.23e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.55e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.76e-2)"	0.2	0.7	79.2	0.2	79.3	0.0	0.9	49.7	75.7	0.1	15.2	1.1	0.1	0.1	0.3	0.1	0.2	2.6	3.8	84.6	56.7	0.0	0.5	0.7	0.1	93.8	72.6	0.5	15.8	0.0	9.0	0.3	71.5	0.9	0.3	7.0	0.8	0.2	0.1	0.7	0.5	0.1	77.7	3.9	0.6	2.6	83.7	0.2	0.2	0.1	0.0	0.1	0.2	76.1	0.0	0.2	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	9.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.0	17.5	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.2	79.3	49.7	75.7	84.6	56.7	93.8	72.6	71.5	77.7	83.7	76.1	0.1	0.0	0.0	2382.9	0.1	0.0	0.1	0.0	0.0	24.0	7.9	4.1	12.7	28.6	0.0	1.8	0.0	0.0	0.0	0.1	3.9	6.5	25.6	0.8	0.1	0.8	4.9	0.0	1253.9	6.1	0.2	0.5	0.0	0.9	0.0	0.0	0.0	0.2	0.1	8.4	1124.0	0.1	0.0	0.0	0.7	31.1	1.5	0.2	0.0	69.3	0.0	33.0	0.0	1418.0	433.8	2.2	0.0	0.0	0.0	2.8	0.0	0.4	0.0	3.6	0.0	3.3	0.3	4.6	5.9	0.0	0.0	0.0	0.1	0.5	0.3	0.1
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 44.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Early spermatids: 7.5;Excitatory neurons: 3.9;granulocytes: 2.5;Hepatocytes: 6.4;Late spermatids: 3.3;Spermatocytes: 2.4"	"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA066463, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Vesicles	"HPA066463: AB_2685670, HPA072245: , HPA075539: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	44.7	0.1	0.1	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.2	0.1	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.8	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.0	0.3	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.2	0.0	0.0	3.9	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	6.4	0.1	1.7	1.9	0.0	0.0	0.6	1.9	3.3	0.0	0.2	0.0	1.0	0.0	0.2	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.7	0.1	2.4	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.2
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898077	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 80.2;kidney: 40.9;liver: 166.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 139.7;Proximal enterocytes: 204.6"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	19	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 3.8"					"Low region specificity"	"Detected in all"			"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.0	0.0	0.1	0.1	0.1	1.1	0.2	0.1	0.3	0.1	0.5	2.2	79.9	0.0	25.8	0.2	0.0	3.3	0.0	0.2	0.1	40.9	166.7	0.0	0.1	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.1	6.6	0.9	0.0	0.0	0.1	0.0	0.8	80.2	0.0	0.3	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	12.3	1.9	0.1	5.8	0.0	0.0	0.1	1.8	5.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.4	139.7	0.0	0.0	0.0	8.9	0.0	3.8	0.0	18.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	204.6	37.7	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.2	0.1	5.6	0.2
DACT2	"bA503C24.7, C6orf116, DAPPER2"	ENSG00000164488	"Dishevelled binding antagonist of beta catenin 2"	Q5SW24	6	168292830-168319777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;placenta: 12.9"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 58.2;Syncytiotrophoblasts: 216.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;CACO-2: 2.7;hTCEpi: 1.8;NTERA-2: 2.2;OE19: 11.2;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"basal ganglia: 16.9;cerebral cortex: 21.4;hippocampal formation: 16.8"	HPA030251	Enhanced	Supported				NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA030251: AB_10611108"	"unprognostic (5.22e-6)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.07e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.05e-3)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-4)"	"unprognostic (4.23e-2)"	2.3	3.3	3.7	0.4	19.4	0.0	0.6	2.9	6.2	1.7	1.4	1.0	0.8	2.7	0.1	1.5	1.7	0.4	5.2	2.7	2.7	3.6	5.8	1.6	0.4	4.1	3.5	0.1	2.9	0.0	0.6	12.9	4.6	7.3	0.3	5.8	6.5	0.4	0.2	5.7	0.6	0.2	2.8	0.0	0.7	1.0	4.1	1.9	0.3	0.0	0.6	1.1	1.2	3.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	11.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	19.4	2.9	6.2	2.7	2.7	4.1	3.5	4.6	2.8	4.1	3.0	0.0	0.0	2.0	0.0	0.0	3.1	1.9	0.8	0.0	10.7	0.1	3.0	0.6	1.5	1.3	1.8	0.0	58.2	0.0	0.1	0.0	1.3	0.0	11.8	0.5	0.7	5.3	0.0	0.1	0.2	6.1	3.4	0.0	11.0	0.0	3.3	0.0	0.3	5.3	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.1	3.6	6.5	0.0	26.3	0.0	0.0	0.1	0.3	1.2	0.0	0.0	1.1	0.0	5.7	0.0	0.9	0.0	0.5	0.1	0.0	0.3	0.0	1.4	216.3	0.2	0.0	1.9	0.1
DHCR24	"DCE, KIAA0018, seladin-1"	ENSG00000116133	"24-dehydrocholesterol reductase"	Q15392	1	54849627-54887195	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 1129.5;liver: 623.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 298.1;Alveolar cells type 2: 682.3;Hepatocytes: 1091.4;Theca cells: 442.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1031.9"	"Low region specificity"	"Detected in all"							"HPA017981, CAB037247, HPA063005"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919"	"unprognostic (2.88e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.82e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.97e-2)"	58.3	1129.5	35.7	19.8	58.5	1.6	104.8	125.3	73.0	54.9	30.4	55.6	62.2	13.1	1.6	296.1	60.4	42.2	18.0	55.9	63.9	48.6	623.5	215.9	9.4	216.2	91.3	28.5	30.5	157.9	17.0	21.6	158.9	128.6	40.5	15.8	136.2	8.3	197.7	247.6	29.6	12.6	129.3	134.1	98.9	74.2	87.9	10.1	15.4	11.1	33.9	13.5	103.9	280.7	342.1	58.5	210.6	257.1	1031.9	219.0	50.5	94.8	160.3	130.7	268.6	341.6	210.2	55.3	191.5	82.4	427.4	319.2	250.5	501.3	118.3	8.3	159.6	303.3	131.8	421.7	168.9	126.7	68.2	161.0	429.0	397.6	74.7	66.7	67.2	124.5	224.7	0.2	50.2	143.5	25.8	111.4	592.0	90.7	164.2	0.3	54.2	166.3	735.3	257.1	144.5	53.2	185.0	337.5	123.1	221.6	441.5	143.3	62.2	45.3	130.0	66.1	183.9	22.7	55.0	91.2	32.8	215.3	60.4	5.1	1.5	0.7	6.0	1.8	0.3	3.7	2.5	2.6	5.2	1.3	2.2	2.9	0.0	2.7	0.7	3.0	0.4	4.4	35.7	58.5	125.3	73.0	55.9	63.9	216.2	91.3	158.9	129.3	87.9	280.7	6.2	298.1	682.3	12.4	13.3	31.5	17.3	150.6	79.1	9.7	87.9	33.1	15.3	145.8	205.2	68.0	0.0	35.2	6.4	133.3	3.9	55.3	22.9	14.5	5.8	13.5	24.0	71.6	14.5	76.5	34.4	17.5	38.7	44.7	32.2	26.4	111.0	1091.4	28.0	5.0	8.7	39.2	69.2	68.9	8.2	77.2	14.0	9.4	14.2	1.9	6.8	3.6	2.1	5.5	62.6	48.6	27.7	7.9	1.8	52.4	22.6	14.4	136.3	6.4	0.0	1.5	23.2	5.4	14.7	145.4	80.4	30.6	10.6	442.4	35.2	45.2
DHDH	HUM2DD	ENSG00000104808	"Dihydrodiol dehydrogenase"	Q9UQ10	19	48933699-48944969	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 17.3;kidney: 18.0"	"Group enriched"	"Detected in many"	11	"Proximal enterocytes: 213.7;Proximal tubular cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.2"	"Group enriched"	"Detected in many"	33	"granulocytes: 4.2;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2;U-266/70: 3.2;U-266/84: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044131	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Actin filaments"		"HPA044131: AB_10966968"	"unprognostic (1.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (3.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.81e-6)"	"unprognostic (1.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.54e-1)"	0.2	0.4	1.6	0.0	1.6	0.1	0.2	1.9	3.3	0.3	1.0	0.3	10.5	0.1	0.0	0.8	0.3	0.2	0.1	1.7	1.7	18.0	0.4	1.1	0.2	1.2	1.3	0.6	0.4	0.5	1.8	1.3	1.2	3.2	0.0	1.7	0.4	0.1	0.2	0.2	17.3	0.0	1.3	1.7	0.7	1.9	2.7	0.1	0.1	0.0	0.2	0.3	0.4	1.6	1.4	0.0	0.1	0.7	0.4	0.3	0.5	0.0	0.2	0.2	0.7	1.4	1.1	0.0	0.2	0.0	0.9	0.4	0.5	1.0	0.4	0.5	1.1	2.0	0.5	0.5	0.0	0.0	0.4	0.2	0.1	0.5	0.0	0.3	0.0	3.2	0.7	0.2	0.0	0.3	0.0	0.1	0.3	2.1	0.9	0.7	0.1	1.0	0.1	0.4	2.1	1.1	0.2	0.1	0.5	0.1	1.0	0.0	0.0	0.0	0.8	0.3	0.0	3.2	2.8	0.8	0.7	0.0	0.2	4.2	0.0	0.5	0.7	0.0	0.4	0.0	0.8	0.3	0.0	0.0	2.3	1.5	0.0	0.0	0.0	0.0	0.6	0.2	1.6	1.6	1.9	3.3	1.7	1.7	1.2	1.3	1.2	1.3	2.7	1.6	0.5	3.2	6.4	1.0	1.0	0.8	2.4	3.3	2.2	2.4	1.0	3.4	0.7	1.5	4.6	3.7	0.0	0.2	0.4	1.5	9.8	2.2	0.7	0.3	0.5	0.8	0.0	0.4	1.0	0.4	0.2	0.5	4.1	0.8	1.3	0.1	0.0	0.0	12.9	0.0	1.2	5.0	2.0	0.8	0.0	2.4	0.0	1.7	0.0	0.0	0.0	1.6	0.0	0.0	0.5	1.5	3.6	0.0	0.0	3.5	213.7	77.8	0.5	4.5	0.0	1.2	0.4	0.0	0.8	3.1	0.1	0.1	0.6	0.4	2.7	3.2
DOP1B	"C21orf5, DOPEY2, KIAA0933"	ENSG00000142197	"DOP1 leucine zipper like protein B"	Q9Y3R5	21	36156782-36294274	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.2;dendritic cells: 3.8;Extravillous trophoblasts: 11.4;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 19.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072065	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Mitochondria	"HPA072065: AB_2686486"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	3.5	1.7	2.9	5.6	4.8	24.2	5.8	19.8	8.0	4.6	0.0	15.4	12.6	2.3	3.0	11.8	4.2	4.1	4.5	3.6	1.0	3.2	9.1	4.9	4.7	3.6	1.1	1.6	4.6	30.4	2.3	3.1	4.5	12.1	15.1	1.6	19.3	3.4	15.9	7.1	11.7	3.8	0.1	5.5	20.5	3.5	2.1	6.5	4.0	13.5	6.3	4.0	5.9	3.4	25.9	5.4	4.0	6.8	4.4	8.4	38.2	12.0	14.2	16.7	10.4	3.8	2.0	4.8	1.8	9.0	12.7	5.2	7.8	2.8	13.5	8.8	7.0	11.0	1.2	1.4	3.9	10.8	5.5	2.9	5.5	10.9	2.9	10.0	7.1	11.2	3.5	7.6	5.0	29.0	8.7	11.1	3.3	30.4	5.6	15.4	2.3	23.7	8.8	10.2	10.7	6.1	8.0	35.9	10.1	5.5	13.1	13.2	12.2	6.4	1.7	8.4	9.8	5.7	15.0	2.2	9.2	23.0	3.7	1.0	3.0	6.1	2.6	2.7	1.4	7.3	1.7	1.5	1.9	10.5	1.1	0.9	4.8	1.0	2.4	5.9	1.4	1.4	2.9	4.8	19.8	8.0	3.6	1.0	3.6	1.1	4.5	0.1	2.1	3.4	2.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	11.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	0.0
DSC2	"CDHF2, DSC3"	ENSG00000134755	"Desmocollin 2"	Q02487	18	31058840-31102522	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 164.0;vagina: 97.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 384.0;Paneth cells: 324.8;Squamous epithelial cells: 705.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 48.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"eosinophil: 28.9;neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 37.6;CAPAN-2: 48.3;HaCaT: 71.1;hTCEpi: 76.0;OE19: 60.7;SK-BR-3: 44.4;SuSa: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011911, HPA012615"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		24000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"	Cytosol	"HPA011911: AB_1847618, HPA012615: AB_1847619"	"unprognostic (3.28e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (7.66e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (3.01e-4)"	5.5	1.8	1.3	12.7	1.4	0.7	22.2	1.3	1.6	59.2	1.9	50.5	41.6	1.5	5.9	164.0	6.1	3.7	10.6	1.2	2.0	5.9	7.3	7.9	3.7	2.6	1.5	0.6	10.5	27.0	0.5	21.3	2.2	15.8	44.5	1.0	46.8	1.0	0.3	11.9	42.9	4.0	1.8	3.0	43.2	0.8	1.6	6.6	4.0	3.1	62.2	3.6	97.4	2.3	18.1	1.9	2.9	0.0	0.0	0.0	37.6	0.0	0.0	0.0	0.0	9.8	48.3	0.0	0.7	0.0	0.9	71.1	11.8	4.9	0.0	0.0	6.9	27.1	8.4	16.9	0.3	0.2	0.5	0.4	76.0	0.0	7.3	6.1	0.0	0.0	13.4	0.0	0.0	14.7	0.0	1.1	11.3	60.7	17.4	13.2	0.0	0.2	0.1	0.7	0.0	0.1	0.0	44.4	0.0	43.4	12.2	18.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	28.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.4	1.3	1.4	1.3	1.6	1.2	2.0	2.6	1.5	2.2	1.8	1.6	2.3	25.1	28.9	5.6	3.3	1.0	83.7	44.5	16.4	67.7	0.8	75.3	65.7	33.8	32.9	11.1	7.3	0.0	100.8	1.0	384.0	0.0	83.5	0.1	19.1	4.0	6.7	69.4	0.4	3.3	33.2	186.6	5.9	47.4	43.8	0.0	2.7	8.2	16.0	24.8	0.0	1.5	83.1	20.3	48.8	29.3	0.2	0.3	35.3	14.2	4.7	25.2	11.2	0.0	2.0	0.2	155.7	324.8	0.7	0.3	140.6	118.2	9.7	3.8	0.7	0.0	1.2	3.0	0.1	1.3	705.6	55.0	83.9	2.0	0.3	114.0	76.1
DUSP16	"KIAA1700, MKP-7, MKP7"	ENSG00000111266	"Dual specificity phosphatase 16"	Q9BY84	12	12473282-12562863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 114.9;Oligodendrocytes: 196.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 37.7;RT4: 34.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020326	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA020326: AB_1847890"	"unprognostic (8.05e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.49e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.76e-2)"	9.3	47.8	4.9	7.8	8.3	3.6	15.0	7.7	5.3	12.2	6.3	11.3	13.6	11.3	6.2	12.7	10.5	8.0	7.2	4.8	6.0	7.6	33.3	12.0	6.4	7.3	8.1	10.7	18.8	8.0	12.9	5.5	6.2	19.7	10.9	7.5	14.6	3.4	11.3	11.1	13.1	4.9	5.4	6.8	13.2	7.1	6.7	15.2	8.8	4.7	9.0	10.7	17.0	11.8	4.5	6.5	7.6	4.2	2.8	3.3	13.6	2.6	5.8	6.4	9.1	18.1	8.6	0.4	1.4	2.9	11.3	2.9	14.1	2.4	8.6	14.4	7.0	0.7	6.8	19.2	5.4	1.3	3.0	2.8	6.7	5.1	16.3	6.8	5.0	7.3	4.0	11.8	0.4	8.6	1.7	0.9	37.7	11.1	1.9	2.0	2.6	8.6	3.6	34.3	12.3	11.5	10.6	13.6	6.7	28.2	5.5	2.2	4.5	2.9	8.3	1.8	2.9	8.3	10.6	1.5	3.8	2.9	4.0	0.0	0.0	0.0	0.5	0.0	2.3	0.0	1.6	0.7	0.1	0.0	0.5	0.3	0.8	0.0	0.0	0.0	3.9	0.3	4.9	8.3	7.7	5.3	4.8	6.0	7.3	8.1	6.2	5.4	6.7	11.8	9.6	28.9	55.5	30.3	3.3	2.8	14.9	1.5	3.4	4.8	23.8	13.1	11.5	20.0	9.7	3.7	2.1	10.5	5.6	35.7	0.0	14.3	1.3	15.1	10.2	9.2	49.6	0.0	19.5	24.6	4.1	9.9	11.7	19.9	23.5	114.9	7.5	34.2	5.3	6.7	24.8	10.0	2.0	9.4	1.9	2.3	5.9	5.7	5.4	38.4	2.9	36.8	0.0	56.3	196.3	20.9	25.3	6.8	4.3	34.3	25.4	5.2	10.4	4.8	0.0	11.1	10.3	3.0	5.8	6.2	1.8	30.1	27.9	9.9	18.7	24.5
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"EBP cholestenol delta-isomerase"	Q15125	X	48521799-48528716	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease variant, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 328.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 674.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003130	Approved		Supported	"Endoplasmic reticulum"		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	10.2	73.3	16.7	17.1	17.2	48.3	17.4	18.5	17.8	19.4	22.0	50.6	85.5	11.0	17.3	41.3	14.3	10.5	32.5	16.8	18.7	44.0	328.5	24.4	18.8	24.4	16.6	12.7	26.0	44.0	7.2	8.2	24.2	40.6	57.5	10.7	25.0	11.7	9.5	27.8	54.2	14.9	15.8	16.9	31.6	14.2	15.9	28.2	14.4	10.6	32.7	14.1	23.3	16.0	224.5	96.4	107.4	77.0	74.5	39.2	50.5	48.2	43.6	64.3	93.9	169.9	382.7	115.9	35.2	41.3	83.5	230.3	217.5	293.8	49.8	85.8	149.7	50.1	115.2	139.3	57.8	179.2	138.2	51.3	108.6	112.9	86.4	22.5	46.5	98.1	77.6	119.5	50.7	163.7	119.1	199.9	118.2	88.3	199.1	93.8	10.3	363.7	175.6	68.8	110.0	59.6	175.4	122.6	31.2	91.5	122.9	71.1	46.6	33.1	56.2	132.9	63.1	47.5	72.1	107.7	78.7	239.7	40.6	96.1	37.7	97.1	129.4	53.4	104.5	71.5	90.5	116.7	53.5	57.2	76.5	99.7	7.3	63.9	57.2	105.4	103.1	93.6	16.7	17.2	18.5	17.8	16.8	18.7	24.4	16.6	24.2	15.8	15.9	16.0	15.2	32.1	49.8	2.9	38.9	37.1	58.2	245.6	23.3	23.8	57.8	26.2	49.9	77.2	116.6	53.3	8.4	55.9	74.5	140.3	39.2	91.7	10.5	30.5	14.7	26.1	30.0	48.8	7.4	239.1	113.0	21.4	36.2	56.5	40.6	41.2	27.1	674.6	65.0	8.4	10.3	96.8	93.6	30.2	36.0	11.8	13.4	31.9	37.4	4.7	34.8	19.3	101.0	5.0	5.1	156.7	137.3	14.7	54.4	46.4	171.9	99.7	34.8	23.3	13.1	12.5	23.6	8.7	22.7	47.6	45.5	37.5	57.1	128.7	149.1	71.1
ELAPOR1	"EIG121, KIAA1324, maba1"	ENSG00000116299	"Endosome-lysosome associated apoptosis and autophagy regulator 1"	Q6UXG2	1	109113679-109206781	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 156.7;salivary gland: 166.1;stomach 1: 88.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;dendritic cells: 1.2;Hofbauer cells: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 65.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 65.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 20.8;SCLC-21H: 16.8;SK-BR-3: 17.6;T-47d: 59.1;U-87 MG: 12.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029869, HPA070749"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"		"HPA029869: AB_10794320, HPA070749: AB_2686304"	"unprognostic (2.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.14e-7)"	"unprognostic (4.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-3)"	"prognostic favorable (5.69e-5)"	"unprognostic (2.79e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (3.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.02e-2)"	0.8	3.2	3.6	4.1	4.4	0.5	56.7	0.0	4.9	70.1	0.0	28.3	45.5	12.8	9.7	1.6	23.9	5.6	0.2	4.4	13.2	0.1	0.2	5.1	2.5	0.2	0.1	0.1	156.7	9.2	32.9	0.2	0.7	48.6	27.8	0.4	166.1	0.3	0.0	3.9	35.3	1.1	0.0	0.8	88.2	18.3	10.0	0.8	9.0	0.1	1.9	0.4	0.1	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.5	0.2	0.1	0.2	0.0	0.0	0.5	0.6	0.7	1.3	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.1	1.0	0.0	0.0	0.5	20.8	0.2	0.3	0.5	0.0	0.1	0.1	0.3	1.1	0.1	0.0	16.8	0.4	0.1	17.6	0.0	0.1	59.1	0.0	0.4	0.0	2.1	0.2	0.2	1.3	3.6	0.0	12.4	0.0	0.1	0.0	0.1	0.0	4.6	0.0	7.6	0.4	7.5	3.2	0.0	0.1	3.3	1.5	65.2	0.5	0.0	0.0	9.8	2.2	3.6	4.4	0.0	4.9	4.4	13.2	0.2	0.1	0.7	0.0	10.0	1.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0
EPN1		ENSG00000063245	"Epsin 1"	Q9Y6I3	19	55675226-55709858	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 387.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 263.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009729, HPA061136, HPA071503"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB009729: AB_2277865, HPA061136: AB_2684436, HPA071503: "	"unprognostic (6.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.94e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.92e-3)"	57.1	75.3	63.1	27.3	61.2	22.1	53.0	30.3	82.2	51.1	14.8	73.1	88.7	47.8	9.2	80.5	48.7	14.3	148.6	65.2	31.5	85.2	137.1	50.5	19.3	37.8	38.5	76.2	104.3	22.3	51.1	17.4	31.1	64.8	16.2	8.9	50.9	20.0	156.1	71.0	80.4	11.0	27.9	72.8	152.6	80.8	40.0	11.6	49.0	35.3	11.2	50.1	54.5	47.1	95.5	128.8	31.5	64.8	35.6	33.8	64.6	69.3	39.0	48.2	48.0	54.1	58.7	58.1	46.1	55.6	42.5	71.5	27.7	52.9	17.4	20.4	263.2	42.8	67.4	65.3	48.9	27.8	39.3	43.9	45.6	41.7	30.1	34.7	46.4	40.7	64.7	48.0	32.2	53.6	44.4	45.2	72.3	71.4	179.6	29.5	42.8	103.2	36.8	55.3	45.2	109.9	64.1	68.8	48.0	21.7	51.6	95.7	78.4	133.0	63.8	48.4	101.3	52.2	50.9	41.7	97.9	55.0	67.5	1.4	1.8	2.3	0.6	2.2	0.4	1.0	0.6	0.6	1.1	0.8	0.6	0.6	2.1	0.3	3.6	1.7	0.9	1.5	63.1	61.2	30.3	82.2	65.2	31.5	37.8	38.5	31.1	27.9	40.0	47.1	62.6	3.2	20.4	9.8	44.2	31.4	29.0	25.9	44.3	33.3	32.7	25.8	15.5	55.8	17.9	44.1	66.7	46.1	28.1	227.7	119.3	57.1	63.2	39.5	37.5	46.1	45.0	35.3	7.8	88.5	80.8	37.2	145.2	45.9	10.8	87.0	83.9	106.1	62.9	28.6	7.8	115.6	22.4	136.5	21.4	169.4	47.5	55.4	23.2	6.5	40.8	33.6	28.8	4.5	8.9	106.5	167.7	53.0	57.7	37.6	387.2	81.8	20.9	41.3	13.1	41.2	34.6	50.2	62.7	46.6	27.4	52.3	26.3	48.2	132.5	39.2
ERVH48-1	"C21orf105, NDUFV3-AS1, SUPYN"	ENSG00000233056	"Endogenous retrovirus group 48 member 1"	M5A8F1	21	42916803-42925646	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	65	"placenta: 152.2"	"Group enriched"	"Detected in some"	8	"Cytotrophoblasts: 130.7;Extravillous trophoblasts: 258.3;Syncytiotrophoblasts: 88.8"	"Cancer enriched"	"Detected in some"	18	"testis cancer: 74.5"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 7.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.7"	"Cell line enriched"	"Detected in some"	7	"BEWO: 296.4"														"Secreted in female reproductive system"	NA	NA		57000	"Cluster 1: Neutrophils - Mixed function"		"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-2)"	0.1	0.4	0.5	0.2	0.8	0.7	0.1	2.3	1.3	0.0	0.7	0.1	0.3	0.2	0.2	0.1	0.1	0.3	0.1	0.6	0.0	0.1	0.1	0.4	0.4	0.6	0.0	0.2	0.7	0.0		152.2	0.7	0.7	0.0	1.5	0.4	0.0	0.4	0.8	0.5	0.0	0.0	0.4	0.3	1.4	0.4	1.3	0.4	0.0	0.0	0.0		0.5	0.0	0.3	0.7	0.1	0.0	0.0	296.4	0.1	0.0	0.0	0.0	11.9	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	2.8	1.4	0.4	0.1	1.2	0.2	0.0	0.0	0.2	0.0	0.1	11.1	1.0	0.7	0.6	0.0	0.2	8.2	5.0	0.9	0.0	0.3	6.4	0.3	0.1	0.0	0.2	0.4	0.3	0.1	0.0	0.0	44.6	0.3	0.2	0.3	0.2	0.6	0.4	0.1	0.9	2.9	0.5	0.4	3.0	0.2	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.6	7.7	0.0	0.0	0.0	0.0	0.0	0.5	0.8	2.3	1.3	0.6	0.0	0.6	0.0	0.7	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	130.7	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.4	0.0	0.0	0.0	0.0	258.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	19.2	3.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.0	88.8	0.0	0.0	0.0	0.0
FAAH	FAAH-1	ENSG00000117480	"Fatty acid amide hydrolase"	O00519	1	46394317-46413848	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 128.5;Proximal enterocytes: 87.4;Spermatocytes: 89.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 29.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 37.5;OE19: 18.8;RT4: 42.4;SK-BR-3: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007425	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA007425: AB_1078820"	"unprognostic (6.12e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.39e-3)"	"unprognostic (9.86e-2)"	"prognostic favorable (4.25e-5)"	"prognostic favorable (3.63e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.00e-3)"	7.5	14.2	23.5	2.9	28.4	10.4	9.5	25.6	29.6	7.5	29.3	18.9	22.0	3.9	9.1	8.7	12.0	5.2	5.0	24.6	23.3	20.0	32.8	7.8	2.5	32.1	25.4	3.9	22.4	24.6	19.0	3.4	28.7	44.1	15.2	5.5	17.4	7.1	9.5	12.1	22.0	2.3	27.9	3.3	17.1	46.8	26.4	7.1	38.6	5.6	2.7	6.9	8.2	45.8	5.0	1.2	0.8	1.0	1.2	0.8	37.5	1.0	0.5	0.5	0.8	7.3	11.4	0.3	3.9	0.7	0.4	16.2	0.7	2.3	0.2	2.2	5.4	0.1	0.2	3.5	0.8	1.4	2.8	0.6	10.7	0.4	1.3	0.4	0.0	0.9	0.1	0.8	0.0	10.7	0.8	2.2	3.2	18.8	0.4	0.9	0.4	0.2	9.0	42.4	4.8	3.6	5.6	21.2	0.2	0.9	14.6	14.5	0.0	0.1	0.6	1.1	0.7	2.1	1.0	0.6	0.1	13.4	0.4	0.0	6.9	29.1	0.4	1.9	0.2	0.1	0.4	0.2	8.2	0.1	0.6	0.6	0.4	0.5	1.0	8.8	0.2	1.4	23.5	28.4	25.6	29.6	24.6	23.3	32.1	25.4	28.7	27.9	26.4	45.8	1.2	22.4	13.2	6.5	2.4	5.2	29.0	6.8	10.2	15.5	15.4	9.0	2.9	27.1	11.0	22.0	43.8	16.3	7.3	51.6	0.0	12.4	50.7	9.5	1.9	1.8	15.5	6.6	15.7	6.4	8.7	3.7	37.8	6.0	0.0	6.3	0.4	37.1	2.8	1.7	11.4	38.2	10.2	2.5	4.2	128.5	7.5	3.3	5.4	1.9	2.5	7.3	0.0	7.5	45.1	4.2	41.3	4.5	0.7	20.1	87.4	22.6	5.2	14.5	0.0	2.9	3.2	89.0	23.0	6.4	6.0	12.4	1.2	1.3	55.2	18.9
FAM155B	"CXorf63, TED, TMEM28"	ENSG00000130054	"Family with sequence similarity 155 member B"	O75949	X	69504326-69532508	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"heart muscle: 43.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 23.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.4;HAP1: 16.2;Hep G2: 6.1;NTERA-2: 24.3;OE19: 6.5;SCLC-21H: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036093	Uncertain					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA036093: AB_10673613"	"prognostic unfavorable (4.61e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.09e-4)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (1.83e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.21e-2)"	0.1	0.8	2.2	0.0	2.1	0.0	0.2	3.0	2.6	0.2	0.5	0.3	0.1	0.3	0.4	0.1	0.7	0.2	43.5	2.1	2.7	0.9	0.2	0.1	0.1	2.4	3.1	0.1	1.8	3.1	2.4	0.0	3.4	0.9	0.2	0.4	1.1	4.9	0.1	0.0	0.2	0.1	2.0	0.7	1.1	1.5	3.5	0.1	8.0	0.0	0.1	0.2	0.1	2.3	0.0	2.7	0.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.7	0.0	5.2	0.0	0.0	0.0	16.2	0.6	0.0	0.0	5.0	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.2	0.0	0.0	24.3	6.5	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.8	0.1	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.1	3.0	2.6	2.1	2.7	2.4	3.1	3.4	2.0	3.5	2.3	0.2	0.0	0.0	1.3	0.0	0.0	0.3	1.6	0.0	0.4	0.6	0.1	23.7	0.0	0.8	1.8	0.0	0.0	0.0	0.5	0.0	0.5	0.0	2.0	0.5	0.7	1.2	0.0	0.8	1.2	0.0	0.4	0.0	4.4	0.0	0.0	0.4	0.3	0.1	0.0	0.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.8	0.2	0.0	0.0	1.2	0.0	0.5	0.3	0.8	0.0	0.1	0.2	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3
FAM3B	"2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44"	ENSG00000183844	"FAM3 metabolism regulating signaling molecule B"	P58499	21	41304212-41357727	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 142.6;pancreas: 212.3;salivary gland: 119.4;stomach 1: 114.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 304.6;Exocrine glandular cells: 399.9;Proximal enterocytes: 831.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 40.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.4;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 19.5;CAPAN-2: 11.7;Hep G2: 32.1;OE19: 27.3;RPMI-8226: 80.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015885, HPA029777, CAB034131"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2080000	250000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB034131: AB_2231472, HPA015885: AB_1848396, HPA029777: AB_2673194"	"unprognostic (2.88e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.79e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"unprognostic (3.78e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-3)"	1.5	0.1	0.0	2.5	0.1	0.8	17.7	0.1	0.3	4.9	1.3	5.9	142.6	0.3	22.1	56.2	17.2	16.2	0.6	0.1	0.1	17.9	2.6	9.3	1.5	0.1	0.1	0.2	212.3	0.5	5.4	15.2	0.1	37.9	0.1	0.0	119.4	8.7	0.1	2.3	135.0	0.5	0.1	0.6	114.9	6.9	0.1	3.1	8.0	0.0	16.8	34.4	16.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	19.5	11.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.4	0.9	27.3	0.0	0.2	0.0	80.6	0.0	5.8	0.4	0.4	0.0	0.7	0.4	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.3	1.4	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.3	0.7	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	22.4	25.7	0.0	0.8	1.3	17.0	2.9	1.2	0.0	101.3	123.1	0.2	102.9	36.5	66.2	0.0	304.6	1.4	2.7	25.4	172.1	25.2	0.2	0.1	2.5	0.0	0.0	0.1	399.9	11.1	3.4	147.3	0.7	1.3	0.6	0.4	0.3	27.0	0.0	0.1	120.9	42.7	5.0	15.8	11.5	0.6	3.9	5.4	1.9	2.1	0.0	0.0	0.0	0.1	144.6	169.0	0.4	0.2	64.9	831.6	0.7	22.4	0.0	0.0	0.4	1.8	28.0	8.1	29.1	1.3	161.3	0.9	0.0	125.2	130.5
FBXO25	FBX25	ENSG00000147364	"F-box protein 25"	Q8TCJ0	8	406428-477967	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 97.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 625.7;Late spermatids: 312.5;Spermatocytes: 640.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 58.7;SK-MEL-30: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.63e-1)"	"prognostic favorable (5.38e-5)"	"unprognostic (2.74e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.41e-1)"	14.4	20.4	9.3	7.6	9.4	9.1	13.8	13.4	11.8	9.1	8.3	16.6	15.4	8.4	16.8	10.0	8.6	9.3	15.3	8.8	9.2	15.8	30.0	10.4	12.0	8.8	10.2	8.8	28.6	14.2	12.1	6.8	9.1	24.9	18.7	7.2	16.3	10.5	18.3	12.4	11.1	11.0	8.4	8.1	15.1	97.8	8.6	20.7	18.6	19.7	12.1	11.3	9.0	11.4	13.4	10.6	4.5	8.8	6.9	4.4	18.6	12.6	18.5	11.8	18.1	6.0	12.7	0.3	3.4	19.4	17.8	8.5	8.7	24.5	16.1	10.0	14.5	7.1	6.3	28.3	20.5	11.4	13.7	12.7	37.6	3.6	18.7	17.9	5.0	58.7	8.4	0.1	13.9	12.8	50.8	13.6	2.1	29.0	4.6	2.4	3.4	18.1	15.4	22.5	13.7	14.4	12.7	4.2	61.5	11.2	9.0	8.1	7.5	4.8	4.1	0.8	10.1	9.2	14.4	13.6	13.0	4.7	14.7	1.6	9.1	6.6	9.0	10.8	11.1	16.2	10.7	8.5	9.1	10.9	9.5	9.4	0.7	9.9	9.9	9.0	12.5	6.9	9.3	9.4	13.4	11.8	8.8	9.2	8.8	10.2	9.1	8.4	8.6	11.4	21.3	19.2	28.5	15.3	24.2	34.8	19.6	28.0	19.9	31.8	35.9	21.7	36.6	42.9	20.4	35.0	10.4	20.0	26.8	30.4	72.4	53.3	625.7	20.0	17.8	25.7	43.3	12.6	20.5	102.6	18.9	18.2	16.3	27.4	20.3	15.4	28.2	77.0	25.4	53.8	20.0	58.2	42.7	32.7	24.2	312.5	38.8	17.4	39.2	11.2	36.2	22.1	38.1	8.5	28.3	51.5	41.2	29.3	21.4	39.1	34.9	58.3	13.2	36.3	26.3	17.8	16.2	640.9	142.1	17.4	40.5	16.1	19.5	14.4	47.2	21.8
GP2	ZAP75	ENSG00000169347	"Glycoprotein 2"	P55259	16	20309574-20327808	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	966	"pancreas: 35381.6"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 504.1"	"Cancer enriched"	"Detected in many"	14	"pancreatic cancer: 320.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015739, HPA016668"	Enhanced				"Secreted to digestive system"	NA	NA		41000	"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"HPA015739: AB_1849905, HPA016668: AB_1849907"	"unprognostic (2.14e-2)"		"unprognostic (1.97e-2)"	"unprognostic (5.68e-2)"			"unprognostic (4.29e-2)"	"unprognostic (1.63e-1)"			"unprognostic (2.84e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"			7.1	1.9	0.2	0.9	0.2	0.7	3.8	0.6	0.4	2.5	0.4	3.9	36.6	2.1	0.2	3.9	1.4	18.7	6.5	0.3	0.2	33.4	5.0	1.5	2.1	0.2	0.6	15.4	35381.6	0.0	2.9	2.4	0.3	33.4	6.2	0.1	7.5	0.0	1.6	1.8	10.1	0.1	0.1	2.5	27.4	1.9	0.2	0.1	1.3	0.0	0.2	1.0	1.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.6	0.4	0.3	0.2	0.2	0.6	0.3	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.2	1.1	0.1	0.1	87.2	0.0	0.0	0.0	0.0	0.0	1.7	9.8	1.3	7.5	0.3	0.5	0.2	0.0	0.0	0.0	504.1	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.1	0.0	0.0	0.3	15.6	0.3	0.4	0.0	0.0	4.2	0.2	0.0	0.0	0.0	20.7	13.9	0.4	0.0	69.7	2.0	0.0	0.0	0.3	0.0	0.5	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.1	19.9	2.1
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492439-101669726	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 28.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Respiratory ciliated cells: 28.8;Squamous epithelial cells: 27.1;Suprabasal keratinocytes: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 39.3;CACO-2: 28.0;HaCaT: 46.3;hTCEpi: 35.5;MCF7: 32.7;OE19: 37.9;RT4: 68.9;T-47d: 79.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004820: AB_1857928, HPA062839: AB_2684878"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.1	0.0	0.0	1.0	0.0	0.0	12.3	0.0	0.3	6.9	0.0	8.0	4.0	1.7	16.1	20.4	8.5	3.3	0.0	0.0	0.0	6.3	0.4	5.6	0.0	0.0	0.0	0.0	11.1	9.3	0.8	6.7	0.0	23.2	9.2	0.0	14.8	7.2	0.0	28.6	4.3	0.4	0.0	0.1	9.8	0.3	0.0	2.9	10.2	0.0	4.6	7.7	10.4	0.0	39.3	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	28.0	18.9	0.0	0.0	0.1	0.0	46.3	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.3	0.2	37.9	0.0	0.0	0.0	0.1	0.0	68.9	1.9	0.0	0.0	15.0	0.0	4.4	79.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.1	13.0	0.3	0.0	24.3	10.5	7.6	20.5	0.0	14.4	6.1	0.7	17.2	20.8	11.0	0.0	14.0	0.2	10.3	5.9	7.5	2.4	20.0	1.5	0.8	1.2	0.0	0.8	5.5	7.1	0.8	15.3	20.7	0.0	0.0	0.0	0.0	1.4	0.0	1.3	9.8	2.0	0.0	1.1	9.3	0.0	0.3	1.8	0.0	0.6	0.0	0.0	2.0	0.5	8.8	8.5	0.0	1.3	9.3	5.7	0.1	28.8	0.0	0.0	0.5	1.0	0.1	0.0	27.1	26.0	19.8	0.3	0.1	11.0	6.3
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137139154-137168756	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 186.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 132.6;Inhibitory neurons: 134.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;prostate cancer: 1.8"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 186.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.4;REH: 1.9;RPMI-8226: 2.5;SCLC-21H: 5.2;SH-SY5Y: 3.1;T-47d: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA067773: "	"unprognostic (3.58e-2)"	"unprognostic (4.51e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.48e-4)"	"unprognostic (5.20e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.72e-2)"	0.0	0.1	15.7	0.2	46.4	0.0	0.2	0.0	186.7	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	35.9	0.0	0.0	0.0	0.1	0.1	1.3	19.5	0.0	0.1	0.2	0.7	0.0	3.8	0.7	0.0	3.7	1.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.4	0.0	1.9	0.0	2.5	0.0	0.0	5.2	3.1	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	46.4	0.0	186.7	35.9	0.0	1.3	19.5	3.8	0.0	0.0	35.6	0.0	0.0	0.0	8.5	0.0	0.0	0.3	0.1	0.0	28.0	1.2	0.9	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	1.9	0.2	0.1	0.2	1.8	0.0	132.6	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.7	134.4	1.8	0.0	0.0	0.0	0.6	0.0	0.2	0.0	9.4	2.0	1.7	0.0	10.1	7.6	0.2	0.1	0.0	0.0	0.7	0.5	0.1	0.3	7.8	0.0	0.0	0.1	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564675-25729294	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 30.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.2;Club cells: 16.7;Extravillous trophoblasts: 29.2;granulocytes: 18.9;Hofbauer cells: 29.3;Macrophages: 26.4;monocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.1;eosinophil: 5.2;intermediate monocyte: 7.2;memory B-cell: 4.1;myeloid DC: 3.2;naive B-cell: 5.0;non-classical monocyte: 6.8;plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 43.6;JURKAT: 69.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.29e-4)"	30.2	5.4	6.5	12.9	8.9	7.8	9.4	2.3	14.7	4.0	0.0	3.1	2.8	5.3	1.3	2.4	8.7	4.7	4.3	18.9	2.6	2.4	3.2	9.4	15.1	5.4	6.2	2.9	7.1	4.2	3.2	4.4	2.5	7.5	3.9	4.8	3.2	1.6	0.9	3.3	4.7	5.9	2.9	18.8	3.8	15.7	7.6	10.2	4.1	1.2	15.6	6.2	1.5	6.0	0.1	3.9	11.9	3.9	8.1	1.0	17.3	1.3	3.8	3.8	6.5	6.4	6.8	22.5	0.3	0.3	10.5	0.2	11.9	9.1	11.1	43.6	7.6	10.3	1.3	14.3	0.3	33.8	16.8	2.0	6.2	2.6	4.6	0.6	0.7	69.4	1.1	0.1	4.4	5.6	24.4	2.4	8.5	12.1	0.0	10.8	18.9	3.8	0.0	6.6	27.6	37.5	2.2	0.1	9.0	10.9	3.3	13.4	0.3	0.1	23.6	0.2	4.9	2.6	9.1	17.4	15.8	11.8	3.7	0.5	4.1	5.2	0.0	7.2	0.2	4.1	0.0	0.2	3.2	5.0	0.1	0.1	0.2	0.0	6.8	2.7	0.3	1.5	6.5	8.9	2.3	14.7	18.9	2.6	5.4	6.2	2.5	2.9	7.6	6.0	3.9	16.0	32.2	0.0	10.2	0.0	0.0	0.0	0.0	0.0	11.7	9.5	0.0	0.0	16.7	0.0	0.0	2.0	1.1	0.0	1.9	9.4	0.0	12.7	5.8	2.4	0.0	0.0	0.0	1.8	29.2	4.1	0.0	2.2	18.9	3.7	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	27.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	2.1	0.0	0.0	1.8	6.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	3.3	1.1	5.0	0.0	0.0
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320996-77331597	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 263.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 373.2;Late spermatids: 398.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 182.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		340000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 62: Liver - Hemostasis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	13.9	34.7	11.1	9.7	12.5	9.3	23.2	13.2	16.3	12.7	10.5	21.9	22.5	10.8	22.1	26.9	14.9	11.9	14.3	10.5	12.3	24.5	263.1	7.8	13.5	12.6	11.7	6.5	20.1	26.4	13.3	11.2	12.8	21.1	21.7	5.1	24.1	9.6	47.4	22.1	15.6	7.9	12.3	12.1	18.9	57.8	11.9	14.0	19.5	37.3	17.4	11.9	13.8	14.0	18.8	39.0	27.6	19.9	17.1	23.9	45.8	11.4	11.9	21.6	30.9	13.0	45.2	43.5	14.9	13.6	13.4	24.1	18.9	22.5	20.7	23.2	21.0	20.8	13.3	26.9	26.3	7.8	15.8	22.1	24.0	12.4	20.8	12.0	18.6	24.7	17.5	37.0	14.5	182.1	12.2	16.4	8.2	64.1	30.3	20.2	29.5	34.2	32.5	24.0	30.2	26.2	26.0	49.1	35.6	15.5	81.2	11.1	13.8	17.0	52.5	18.9	8.6	28.2	32.7	35.2	41.9	11.3	20.8	13.4	15.5	9.9	2.6	22.2	2.4	8.2	4.6	3.7	20.7	10.4	3.9	3.1	1.6	5.1	20.1	15.0	7.9	7.4	11.1	12.5	13.2	16.3	10.5	12.3	12.6	11.7	12.8	12.3	11.9	14.0	6.1	6.4	9.6	6.5	13.5	13.4	19.8	26.2	15.9	7.3	36.1	34.2	13.0	47.1	19.0	9.2	4.2	91.4	7.5	34.9	46.9	45.0	125.8	19.4	15.6	11.1	28.8	30.3	2.9	68.0	62.5	15.0	33.1	27.0	3.8	25.7	15.4	373.2	44.6	16.8	3.3	45.7	20.3	38.1	10.9	398.1	11.8	19.0	17.8	3.7	30.4	26.4	4.1	2.0	9.2	41.8	37.4	6.0	13.2	19.8	72.9	77.8	15.0	11.9	0.0	12.3	13.2	51.3	29.4	38.0	14.1	76.2	6.7	55.8	50.3	30.3
H3C6	"H3.1, H3/d, H3FD, HIST1H3E"	ENSG00000274750	"H3 clustered histone 6"	P68431	6	26224199-26227473	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 1.0;Syncytiotrophoblasts: 1.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 10.5;hTERT-RPE1: 7.5;SCLC-21H: 11.9;T-47d: 7.3"					"Low region specificity"	"Detected in all"			HPA042570	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"	"unprognostic (2.42e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-2)"	0.6	3.5	1.0	1.0	1.5	0.4	1.8	3.9	3.2	1.2	2.7	2.9	4.7	0.8	4.9	2.8	1.5	1.0	6.0	1.1	1.5	1.6	2.9	0.5	1.3	2.0	1.7	1.0	0.7	1.5	0.6	0.9	2.4	3.4	1.9	0.2	1.9	0.7	5.1	1.2	4.7	0.4	1.9	2.2	2.6	1.4	1.4	1.2	2.6	3.7	0.9	1.2	1.2	3.4	1.9	2.0	2.8	1.3	3.3	1.6	0.2	1.3	1.5	0.7	0.5	0.6	1.1	0.0	10.5	0.5	1.0	2.3	0.0	0.3	0.6	2.9	2.5	0.4	1.0	0.6	1.0	0.1	1.7	2.3	2.4	0.3	0.7	7.5	1.1	0.2	0.3	2.2	1.9	1.8	0.4	0.1	0.2	1.4	1.9	1.4	0.6	0.3	5.7	1.1	11.9	1.4	1.9	3.0	3.4	0.4	7.3	1.2	0.6	1.3	0.4	0.4	0.3	0.8	0.3	0.2	0.6	0.1	0.7	0.2	0.7	0.0	0.5	0.6	0.7	0.5	0.7	0.7	0.5	0.9	0.6	0.7	2.7	0.2	0.6	1.7	1.3	0.5	1.0	1.5	3.9	3.2	1.1	1.5	2.0	1.7	2.4	1.9	1.4	3.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0
H4C8	"H4/h, H4FH, HIST1H4H"	ENSG00000158406	"H4 clustered histone 8"	P62805	6	26277609-26285638	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"brain: 51.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.8;dendritic cells: 3.4;Extravillous trophoblasts: 1.5;Hofbauer cells: 1.8;Plasma cells: 1.3;Syncytiotrophoblasts: 10.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 51.4"	"Group enriched"	"Detected in some"	7	"eosinophil: 4.2;neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 17.5;U-266/84: 29.8"	"Low region specificity"	"Detected in single"							HPA042201	Supported					NA	NA		25000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (4.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.08e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (7.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.55e-2)"	"unprognostic (6.36e-2)"	0.5	0.2	5.7	0.1	5.2	0.9	0.3	51.4	8.6	1.3	1.9	0.9	0.6	0.2	0.0	1.2	0.2	0.7	0.6	4.5	7.3	0.2	0.6	0.5	0.0	5.3	4.9	0.4	0.3	0.0	0.1	0.2	4.6	0.4	0.0	0.0	0.3	0.0	2.5	0.8	0.2	0.0	9.5	0.1	0.2	0.4	5.5	1.1	0.3	0.0	0.7	0.2	0.6	18.4	3.1	3.6	0.4	0.4	1.0	0.0	2.4	4.7	0.0	0.0	0.0	3.5	0.9	2.1	5.8	0.3	0.1	1.9	0.0	0.7	0.3	3.6	1.5	3.8	8.3	4.2	2.2	1.4	2.7	2.7	0.0	1.7	1.5	0.0	3.5	0.9	4.2	0.0	1.9	3.5	17.5	10.9	1.6	0.2	3.6	11.5	2.3	1.4	0.0	3.1	2.8	1.2	4.9	4.9	2.4	0.0	6.0	5.7	0.8	2.5	6.3	1.7	7.7	2.9	29.8	3.1	1.1	7.4	2.6	0.0	0.2	4.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	8.9	0.0	0.0	0.5	0.0	1.1	5.7	5.2	51.4	8.6	4.5	7.3	5.3	4.9	4.6	9.5	5.5	18.4	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.4	0.3	0.0	0.0	0.0
HOMER2	"CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2"	ENSG00000103942	"Homer scaffold protein 2"	Q9NSB8	15	82836946-82986153	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 226.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 215.9;Endometrial ciliated cells: 184.4;Glandular and luminal cells: 151.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 15.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 52.7;Karpas-707: 92.6;SCLC-21H: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040134, CAB079014"	Uncertain	Supported	Supported	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB079014: , HPA040134: AB_10795272"	"unprognostic (7.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.75e-4)"	"unprognostic (3.31e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.16e-4)"	"unprognostic (2.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.45e-3)"	1.5	6.3	6.5	1.1	7.6	4.6	26.9	8.2	12.8	23.1	69.8	3.2	8.5	8.4	33.7	21.2	25.9	12.8	21.9	16.2	7.8	7.2	46.4	5.3	1.3	5.7	4.6	2.6	226.2	5.1	7.7	0.6	5.7	57.7	1.0	6.4	71.2	4.6	108.7	45.0	1.3	1.4	4.1	4.8	55.4	6.1	6.0	3.0	28.9	55.9	3.6	1.3	11.7	8.0	16.6	6.9	7.2	18.9	0.2	0.1	1.1	1.1	0.0	1.7	0.6	1.2	11.5	0.1	8.8	8.4	8.3	9.1	52.7	24.9	1.2	45.1	33.5	10.6	0.4	8.3	0.7	0.4	32.6	1.8	37.4	0.6	2.1	1.9	0.0	20.6	0.4	92.6	7.0	48.4	3.2	1.1	11.4	1.4	5.1	2.2	11.5	5.5	25.3	20.1	50.8	13.1	18.6	14.1	17.6	5.2	17.1	3.5	0.2	17.2	31.7	1.3	15.3	11.8	5.9	1.8	29.0	0.4	6.4	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.3	0.1	0.0	0.4	0.0	0.0	0.5	0.2	0.3	6.5	7.6	8.2	12.8	16.2	7.8	5.7	4.6	5.7	4.1	6.0	8.0	1.9	16.0	10.1	24.8	3.8	4.6	56.1	7.2	10.2	15.0	39.7	20.4	23.0	215.9	14.6	11.0	18.8	1.1	4.4	0.3	7.9	29.6	1.9	184.4	15.4	12.4	3.0	8.2	24.8	76.5	0.4	3.6	14.3	151.9	0.0	11.9	1.4	59.6	13.3	20.2	35.1	0.4	0.0	3.2	73.9	4.0	1.8	9.2	37.4	7.5	7.9	18.5	1.0	6.6	11.8	25.9	0.1	0.7	4.1	81.5	0.7	12.1	4.0	5.1	0.0	7.8	4.8	5.5	16.6	19.4	6.0	0.7	3.1	4.1	0.4	30.5
HPN	TMPRSS1	ENSG00000105707	Hepsin	P05981	19	35040506-35066573	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 200.5;liver: 866.2;pancreas: 272.1"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 442.2;Proximal tubular cells: 201.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 127.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"EFO-21: 31.5;Hep G2: 47.8;T-47d: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006804	Approved					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA006804: AB_1079046"	"unprognostic (6.74e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.96e-2)"	1.8	0.9	5.6	0.2	8.8	0.0	11.6	7.0	7.2	1.6	4.2	1.1	1.4	4.0	3.9	0.3	7.4	4.0	5.1	5.7	6.5	200.5	866.2	11.8	0.4	7.5	8.1	1.3	272.1	24.2	14.8	0.5	7.5	20.1	0.3	0.3	15.6	4.7	22.1	0.9	1.1	0.2	6.5	2.6	58.2	1.3	7.6	0.2	19.9	5.4	0.1	0.6	0.4	11.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.5	0.0	0.1	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.3	0.1	0.0	0.0	3.2	0.2	0.1	0.0	0.2	0.5	22.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.8	7.0	7.2	5.7	6.5	7.5	8.1	7.5	6.5	7.6	11.7	0.5	9.6	32.4	8.8	3.0	0.1	5.1	0.0	0.0	7.2	12.0	8.9	3.4	51.5	1.3	33.1	0.0	0.1	0.0	0.1	52.8	7.5	8.9	4.9	1.0	1.1	2.4	10.7	2.3	26.5	0.3	1.9	18.3	12.5	2.5	0.1	8.6	442.2	1.1	0.0	1.7	2.4	0.0	9.7	0.3	26.0	0.0	1.8	0.0	2.8	0.6	1.6	0.0	0.0	41.6	14.4	0.0	0.4	0.0	7.5	0.0	201.0	0.0	0.6	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.8	1.8	0.1	0.1	0.5
ICA1	"ICA69, ICAp69"	ENSG00000003147	"Islet cell autoantigen 1"	Q05084	7	8113184-8262687	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 594.7;Late spermatids: 867.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"T-reg: 29.9"	"Lineage enriched"	"Detected in many"	9	"T-cells: 29.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.1;MCF7: 42.5;OE19: 48.4;RT4: 49.4;SCLC-21H: 66.1;SH-SY5Y: 105.8;SK-BR-3: 52.1;T-47d: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017646, HPA061452"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 25: Pancreas - Digestion"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Vesicles, Cytosol"		"HPA017646: AB_1851382, HPA061452: AB_2684525"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.83e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.23e-8)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.08e-2)"	15.8	10.4	11.3	5.7	16.2	23.8	21.1	21.5	21.8	16.4	1.2	22.8	13.6	6.8	13.6	9.5	13.7	11.1	44.3	13.4	9.3	16.0	8.8	11.2	13.5	8.0	9.5	1.7	62.7	20.9	19.8	8.2	9.3	22.1	23.5	2.9	37.1	4.9	2.8	12.8	17.8	5.6	5.1	12.4	30.5	24.2	13.3	5.0	14.1	3.3	9.6	13.8	7.4	15.3	0.0	1.5	1.7	0.2	0.2	0.0	4.2	0.0	0.0	0.6	0.2	1.0	47.1	0.3	5.2	0.1	0.9	0.0	0.8	1.9	0.0	0.0	6.8	9.1	0.9	0.0	0.4	9.1	1.8	0.0	3.0	0.0	0.0	0.5	31.5	8.2	26.4	0.0	0.0	42.5	0.4	0.0	9.9	48.4	0.4	0.0	0.0	19.5	19.0	49.4	66.1	105.8	0.0	52.1	0.7	11.6	43.4	14.3	19.8	0.0	0.9	0.2	1.0	14.1	7.5	0.0	0.0	6.9	10.3	1.0	2.4	0.2	0.3	0.8	0.6	0.4	5.4	0.4	2.4	0.7	0.3	0.2	3.4	0.9	0.4	0.6	29.9	1.3	11.3	16.2	21.5	21.8	13.4	9.3	8.0	9.5	9.3	5.1	13.3	15.3	73.4	28.9	24.4	6.5	1.6	20.5	16.2	7.1	9.1	10.4	42.8	28.7	43.2	22.8	20.1	22.0	6.2	2.7	2.1	28.2	43.0	38.4	594.7	34.2	5.8	44.1	77.2	16.4	132.1	74.8	0.8	4.5	56.1	65.4	8.2	11.2	42.1	1.3	23.9	0.0	138.0	80.5	44.7	8.1	9.3	867.0	7.5	9.6	14.2	60.0	6.3	0.8	3.1	49.3	3.9	59.8	53.1	3.0	1.7	53.8	23.8	8.3	17.8	1.7	6.6	1.2	5.6	13.9	9.6	18.4	8.9	2.2	9.5	4.7	41.8	42.7
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1"	O75874	2	208236229-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 536.3"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 320.2;Granulosa cells: 257.5;Hepatocytes: 328.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 768.1;RT4: 524.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		16000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559"	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	150.8	230.8	24.0	37.5	23.9	10.7	63.0	24.6	30.9	67.9	40.8	124.9	179.4	22.9	164.9	92.2	36.6	69.5	25.3	23.5	26.1	122.0	536.3	49.8	33.3	26.4	25.7	84.4	39.9	42.0	16.7	82.5	25.9	214.6	131.2	35.0	59.3	79.1	25.7	23.6	117.4	43.8	25.5	40.1	113.6	57.0	30.0	21.8	45.5	28.1	29.8	153.1	39.9	30.6	66.5	109.6	152.5	63.3	275.1	191.4	86.7	26.3	122.3	44.2	107.3	176.1	159.1	13.1	168.8	84.4	181.6	101.4	112.4	130.7	43.0	8.8	41.7	56.7	87.3	768.1	367.3	37.0	54.7	169.5	278.0	102.7	74.2	69.8	126.1	37.2	58.1	44.5	68.9	42.8	26.3	66.2	284.5	479.7	43.9	25.2	54.8	37.8	206.3	524.0	25.9	45.2	100.5	99.7	351.7	161.2	37.9	111.0	81.1	45.2	44.1	65.3	29.6	20.8	34.5	16.9	148.2	226.7	37.0	12.4	70.1	11.0	9.1	32.3	10.6	10.6	8.2	10.9	50.9	10.1	6.7	7.8	13.8	17.2	15.5	18.8	15.1	29.9	24.0	23.9	24.6	30.9	23.5	26.1	26.4	25.7	25.9	25.5	30.0	30.6	13.9	12.8	49.5	39.2	20.2	12.4	18.8	60.5	52.3	19.5	61.8	31.5	21.8	45.8	69.1	29.5	25.0	320.2	23.7	106.8	21.5	31.1	13.8	31.0	23.4	22.0	58.4	30.3	16.6	86.5	178.8	29.6	76.0	108.8	14.0	257.5	39.7	328.2	175.3	11.8	16.2	98.4	57.0	130.2	23.8	11.2	24.5	71.7	26.6	19.7	47.8	25.4	18.6	66.4	20.0	44.8	55.5	29.3	13.7	53.2	181.2	108.5	21.9	56.6	13.1	7.8	23.6	8.0	26.2	82.4	14.9	95.6	19.8	127.1	129.3	46.7
ITIH6	"ITIH5L, UNQ6369"	ENSG00000102313	"Inter-alpha-trypsin inhibitor heavy chain family member 6"	Q6UXX5	X	54748918-54798255	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	7	"melanoma: 10.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"WM-115: 50.7"									HPA000506	Uncertain				"Secreted to blood"	NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"			"HPA000506: AB_2666007"	"unprognostic (3.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.73e-3)"	"unprognostic (7.24e-2)"		"unprognostic (2.83e-1)"		"unprognostic (5.38e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"		"unprognostic (2.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLK1	Klk6	ENSG00000167748	"Kallikrein 1"	P06870	19	50819146-50823787	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	84	"pancreas: 9557.9;salivary gland: 5487.3"	"Group enriched"	"Detected in many"	7	"Exocrine glandular cells: 788.4;Intestinal goblet cells: 1317.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 50.9;renal cancer: 84.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"memory B-cell: 9.5;naive B-cell: 4.0"	"Lineage enriched"	"Detected in single"	13	"B-cells: 9.5"	"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 43.8"									HPA059690	Approved				"Secreted to digestive system"	NA	NA		10000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA059690: "	"unprognostic (1.51e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.23e-2)"	1.4	2.4	0.1	4.0	0.0	0.4	1.8	0.0	0.4	1.9	0.0	68.8	9.6	2.0	0.0	1.3	0.6	0.1	3.0	0.3	0.0	89.4	0.6	0.5	0.5	0.0	0.0	4.7	9557.9	0.4	0.2	1.1	0.0	2.7	53.0	0.0	5487.3	0.1	0.2	26.3	9.7	2.8	0.0	3.3	1.4	0.1	0.0	0.2	2.9	0.2	1.5	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.4	0.2	0.3	0.5	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.1	0.1	0.4	0.2	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	0.0	9.7	0.0	0.1	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	9.5	0.0	0.0	0.1	4.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	18.9	19.5	1.2	2.9	1.2	0.0	1.0	1.1	0.3	0.0	2.5	0.0	0.0	0.0	0.2	62.2	45.0	3.3	0.6	0.1	1.4	0.4	117.1	0.0	0.0	788.4	0.0	7.7	1.5	0.0	8.9	8.8	0.4	0.0	0.6	0.0	0.0	1317.5	14.2	1.6	5.3	0.3	6.2	1.5	5.4	0.0	6.2	0.0	0.0	0.0	0.0	125.8	134.4	0.0	10.9	9.8	57.1	0.3	0.3	0.0	0.0	0.0	1.1	0.3	0.9	1.7	54.0	0.0	2.1	2.5	148.5	3.8
LRTOMT	"CFAP111, COMT2, DFNB63, LRRC51, LRTOMT1, LRTOMT2"	ENSG00000184154	"Leucine rich transmembrane and O-methyltransferase domain containing"	Q96E66	11	72080337-72096895	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 67.1;testis: 49.3"	"Group enriched"	"Detected in many"	12	"Early spermatids: 574.9;Late spermatids: 2222.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039949	Approved		Uncertain	Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules		"HPA039949: AB_10960708"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (8.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (6.12e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	5.0	4.5	21.1	2.5	21.8	2.1	8.7	19.5	24.2	8.7	25.1	5.4	3.7	7.2	17.1	3.8	67.1	3.4	3.7	19.1	19.2	11.7	7.9	7.7	3.2	23.0	25.7	8.1	8.9	10.3	8.9	5.4	21.4	9.3	7.7	19.7	4.4	5.4	7.5	5.8	3.4	5.7	23.4	4.0	5.5	49.3	21.0	4.5	11.0	4.6	3.6	4.1	3.8	22.0	3.9	13.7	8.9	6.9	7.3	6.7	2.1	4.4	3.6	4.0	3.5	6.6	20.4	5.1	6.6	7.8	9.6	7.3	6.3	10.8	4.5	9.4	6.2	3.5	6.3	4.8	1.3	3.0	3.9	2.9	5.4	6.0	4.6	6.4	1.5	10.2	4.0	7.8	6.0	13.6	9.0	6.0	4.4	22.8	3.6	10.8	8.6	7.7	15.9	4.7	8.2	6.2	8.7	19.4	10.4	6.1	39.6	3.3	6.5	4.0	5.7	11.3	3.1	8.0	9.4	5.8	4.0	2.5	4.5	1.8	1.7	3.5	2.0	1.9	1.9	3.2	2.1	1.6	1.0	3.5	1.8	1.8	6.1	6.6	1.3	2.8	4.6	1.4	21.1	21.8	19.5	24.2	19.1	19.2	23.0	25.7	21.4	23.4	21.0	22.0	4.6	0.0	1.5	3.3	2.5	2.3	7.5	10.0	1.8	3.5	8.4	7.5	2.2	5.7	10.7	3.7	12.5	12.7	1.4	4.4	11.7	7.5	574.9	84.3	3.0	6.5	1.2	3.6	2.0	2.5	7.7	5.3	4.1	7.2	0.0	2.2	3.6	6.0	3.1	6.7	1.9	10.8	10.2	1.6	2.8	2222.2	14.9	3.3	1.8	1.9	1.4	21.3	4.1	2.0	3.6	2.0	2.5	10.1	5.1	6.8	4.0	19.9	113.1	16.6	6.6	6.1	7.9	90.3	28.1	2.2	2.4	13.1	1.7	2.9	3.4	6.5
MAPK8IP2	"IB2, JIP2, PRKM8IPL"	ENSG00000008735	"Mitogen-activated protein kinase 8 interacting protein 2"	Q13387	22	50600793-50613981	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 84.0;pituitary gland: 35.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.8;Enteroendocrine cells: 32.3;Horizontal cells: 99.3;Rod photoreceptor cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 19.3;HEK 293: 11.0;SCLC-21H: 15.7;SH-SY5Y: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034780	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA034780: AB_10670283"	"unprognostic (7.82e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.80e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.78e-3)"	"unprognostic (6.33e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.75e-2)"	1.4	9.2	54.7	0.3	50.2	0.0	1.4	27.5	67.8	1.4	0.0	2.1	0.2	2.1	0.3	1.2	1.5	0.0	0.4	53.7	35.1	0.7	0.5	0.5	0.0	78.0	27.0	7.0	1.8	2.0	35.2	0.3	84.0	1.9	0.1	9.6	2.8	0.2	0.3	1.5	1.0	0.2	18.6	0.8	1.5	7.1	39.4	0.2	1.0	0.1	0.0	0.3	1.0	49.2	0.3	1.1	4.7	4.1	0.4	0.0	3.7	0.0	0.0	1.0	0.6	2.4	0.8	0.6	1.0	0.0	19.3	0.0	6.6	0.0	0.0	0.3	11.0	0.0	0.4	1.2	0.5	0.0	0.8	0.3	5.5	0.0	0.1	0.0	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	3.4	0.8	1.8	1.1	0.7	0.0	0.0	0.1	15.7	19.8	3.7	4.6	0.2	0.9	0.9	0.0	0.0	0.1	0.1	0.6	0.0	1.1	3.1	0.5	0.5	0.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	50.2	27.5	67.8	53.7	35.1	78.0	27.0	84.0	18.6	39.4	49.2	0.6	3.2	2.0	6.5	0.1	0.4	1.6	0.5	0.6	57.8	2.3	3.9	2.3	2.8	2.7	0.0	16.7	0.2	0.0	0.5	0.0	3.0	0.6	0.7	1.7	0.7	32.3	0.0	15.6	2.5	1.1	0.7	0.0	1.5	0.0	0.5	0.0	0.3	0.1	99.3	13.1	0.5	4.1	0.0	0.4	1.8	5.9	0.3	7.2	3.7	0.2	11.2	0.0	6.0	3.2	0.7	0.1	0.7	0.1	1.2	0.3	0.7	0.3	26.7	0.0	1.3	1.0	3.4	2.7	0.6	0.6	1.1	0.3	0.5	0.6	0.5
MFSD3		ENSG00000167700	"Major facilitator superfamily domain containing 3"	Q96ES6	8	144509070-144511213	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056013	Uncertain		Approved	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA056013: AB_2683009"	"unprognostic (7.92e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (2.00e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.44e-7)"	"unprognostic (4.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	8.4	22.6	9.2	3.4	8.0	1.8	10.7	7.2	12.0	8.0	6.4	22.6	13.5	8.3	4.1	16.1	8.4	2.5	21.8	8.8	6.7	27.5	44.6	7.6	2.8	10.8	7.1	6.7	18.8	12.3	17.8	1.5	9.4	19.2	3.3	1.5	19.6	5.4	23.5	17.8	15.4	1.2	5.4	10.8	15.6	6.3	9.5	2.3	23.9	6.1	1.7	9.7	9.2	7.0	16.2	21.7	5.4	4.6	5.9	4.4	17.6	5.1	5.3	2.8	4.2	7.3	11.2	23.3	17.3	4.8	5.6	15.5	2.5	12.1	0.5	11.0	44.0	7.5	19.9	18.3	11.0	3.6	9.9	6.5	22.3	1.8	7.7	12.1	7.3	16.0	14.2	6.2	6.8	53.7	9.0	18.9	14.3	22.9	36.9	9.9	2.8	41.7	13.2	9.5	39.1	19.7	13.0	31.6	11.3	3.4	33.1	5.2	7.9	3.7	9.9	4.2	7.1	6.0	2.6	8.1	8.0	11.3	6.5	1.8	7.4	3.8	3.9	6.7	3.7	4.9	3.9	4.0	11.0	2.5	3.5	3.6	0.4	3.8	3.6	19.2	4.4	4.1	9.2	8.0	7.2	12.0	8.8	6.7	10.8	7.1	9.4	5.4	9.5	7.0	3.0	3.2	3.7	6.5	8.0	6.0	10.3	17.3	8.6	8.2	18.8	14.5	9.3	30.0	11.8	27.6	10.4	16.5	3.7	31.3	37.2	17.6	0.6	5.1	3.9	3.8	19.8	8.2	6.2	21.0	15.0	4.0	16.3	7.4	0.0	9.7	3.3	27.6	15.5	16.8	6.2	19.6	24.4	7.0	3.2	1.8	4.4	6.4	8.8	1.9	7.5	14.8	6.2	2.5	3.8	15.7	19.1	4.9	14.8	12.8	33.1	63.6	3.2	10.0	0.0	7.0	3.4	3.8	11.7	19.0	7.1	9.3	3.5	16.9	27.1	9.8
MIEN1	"C17orf37, C35, MGC14832, ORB3, Rdx12, XTP4"	ENSG00000141741	"Migration and invasion enhancer 1"	Q9BRT3	17	39728496-39730532	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	14	"OE19: 1667.9;SK-BR-3: 502.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056650, HPA061344"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA056650: , HPA061344: AB_2684484"	"unprognostic (2.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.37e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.22e-3)"	29.1	35.9	33.4	17.5	35.4	27.0	31.5	36.2	44.8	31.1	34.2	42.4	26.3	29.0	14.6	47.3	27.2	12.1	49.5	32.5	35.3	57.2	53.7	29.6	20.2	34.5	34.8	18.5	40.7	21.6	39.6	13.5	34.5	46.3	12.8	4.8	46.2	13.8	47.2	35.0	37.5	9.5	32.9	36.2	48.5	41.3	35.4	13.9	37.0	5.3	13.7	31.0	32.0	37.2	38.8	59.7	13.4	34.5	16.3	12.0	16.2	40.7	21.4	24.2	23.6	12.9	27.2	28.1	55.5	15.1	39.0	47.1	15.6	13.8	8.2	58.2	65.8	26.5	29.8	36.5	28.2	33.9	39.2	10.8	23.3	11.7	12.0	18.8	15.6	52.9	38.2	48.9	14.7	22.5	70.1	38.2	12.5	1667.9	26.4	32.2	23.6	56.8	12.2	21.8	43.6	41.7	40.8	502.3	70.7	12.0	66.1	48.1	41.5	16.4	41.8	78.9	47.1	62.3	62.8	55.1	64.5	41.1	32.4	138.5	76.2	107.3	80.1	100.9	43.4	109.2	56.2	72.3	54.5	88.3	43.9	63.1	132.9	58.7	104.2	79.4	94.6	119.9	33.4	35.4	36.2	44.8	32.5	35.3	34.5	34.8	34.5	32.9	35.4	37.2	59.8	44.8	64.2	7.8	60.9	60.2	138.1	185.1	95.6	25.7	127.0	114.2	59.6	82.9	129.3	99.3	4.2	150.2	69.1	226.6	303.3	137.0	136.2	81.6	48.7	58.9	188.8	72.0	11.0	176.1	74.4	50.9	76.5	77.3	81.8	43.8	54.7	118.9	148.0	35.3	9.6	178.3	254.3	101.3	42.8	76.7	42.3	81.3	138.7	12.2	80.1	90.7	130.7	4.5	20.8	216.8	283.7	49.7	54.0	194.8	188.5	224.9	122.1	17.3	46.0	31.5	61.1	108.5	68.0	131.7	70.3	266.1	65.4	51.7	128.1	204.0
MLPH	"exophilin-3, l(1)-3Rk, l1Rk3, ln, Slac-2a"	ENSG00000115648	Melanophilin	Q9BV36	2	237485428-237555322	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 135.9;salivary gland: 122.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 125.0;Alveolar cells type 2: 389.7;Gastric mucus-secreting cells: 251.8;granulocytes: 187.3;Intestinal goblet cells: 189.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 142.9;MCF7: 255.4;SK-BR-3: 234.5;SK-MEL-30: 182.2;U-87 MG: 236.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA014685	Enhanced					NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA014685: AB_1853997"	"unprognostic (3.32e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.14e-6)"	"unprognostic (2.26e-4)"	"unprognostic (1.36e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.74e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.34e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-3)"	13.2	1.4	0.6	2.4	0.7	0.1	56.9	0.7	1.6	69.3	1.3	20.4	8.8	18.1	8.9	6.4	18.0	31.0	69.2	1.1	0.7	4.3	39.0	62.7	0.6	1.1	1.0	11.8	16.1	9.0	2.1	1.9	0.8	135.9	21.7	0.3	122.0	13.0	6.6	11.6	15.2	2.8	0.6	0.2	98.1	2.5	0.8	0.9	39.9	2.5	1.2	22.1	21.9	0.9	0.3	133.7	0.3	0.3	58.5	39.5	0.4	26.8	31.5	14.7	18.5	1.1	101.1	0.2	0.1	49.6	51.0	0.3	0.1	0.9	13.0	0.1	0.3	0.1	0.1	0.0	23.3	0.1	0.7	48.1	14.7	43.4	56.2	75.6	0.1	0.0	0.1	0.3	142.9	255.4	0.4	0.6	0.4	105.4	77.1	0.5	0.1	0.2	0.5	3.2	1.5	0.2	0.1	234.5	182.2	0.7	61.5	1.7	26.8	80.1	2.3	0.9	38.0	0.2	0.2	0.2	236.0	0.1	63.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	1.6	1.1	0.7	1.1	1.0	0.8	0.6	0.8	0.9	12.3	125.0	389.7	0.0	0.8	4.1	17.3	6.0	0.0	0.0	95.6	59.7	63.2	52.9	64.2	12.9	0.0	0.4	0.7	34.9	1.9	12.0	0.2	9.5	10.1	10.1	14.4	0.0	0.2	41.3	0.3	4.5	251.8	17.5	187.3	0.2	1.4	28.8	1.2	0.0	0.1	189.0	32.6	0.8	2.9	0.7	8.4	7.4	30.2	5.6	0.6	0.0	0.0	0.0	0.0	58.1	22.4	3.0	0.8	54.4	9.1	0.6	48.5	0.0	0.0	3.1	3.7	0.3	0.6	1.2	2.4	0.7	6.1	0.4	30.5	38.6
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183704	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 333.5;kidney: 302.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 273.3;Proximal enterocytes: 372.4;Proximal tubular cells: 125.7;Syncytiotrophoblasts: 126.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 17.3;medulla oblongata: 9.3;pons: 10.9;thalamus: 4.6"	"Immune cell enriched"	"Detected in some"	122	"neutrophil: 139.4"	"Lineage enriched"	"Detected in many"	122	"granulocytes: 139.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 684.4;BJ hTERT+: 1116.9;HSkMC: 651.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 28.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 32.3;olfactory bulb: 8.5;spinal cord: 15.9"	"CAB000013, HPA052583, HPA056072"	Enhanced					NA	NA		320000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	103.9	1.0	0.7	4.5	17.3	11.5	38.5	1.5	1.9	22.7	0.3	1.9	333.5	13.3	22.5	2.3	1.9	13.4	4.3	0.1	0.6	302.5	56.1	27.6	10.3	9.3	2.3	0.9	1.2	0.5	0.6	73.0	10.9	79.6	3.4	0.1	6.1	44.5	20.3	1.9	289.7	1.5	0.9	7.9	1.6	1.3	4.6	16.6	1.2	23.5	12.3	6.0	7.6	0.4	0.1	0.0	0.9	0.3	280.1	684.4	1.6	160.3	1116.9	82.2	209.8	0.0	0.3	172.9	0.1	130.1	107.4	0.5	5.2	6.1	201.3	0.0	0.8	0.0	0.1	0.2	229.6	0.0	0.0	651.1	1.0	40.4	308.1	89.4	59.5	0.4	0.2	0.3	135.1	0.7	0.4	1.0	6.1	0.5	1.1	303.3	139.9	1.6	5.2	1.9	0.5	1.5	0.1	0.5	31.9	68.3	0.2	0.2	165.8	356.4	0.8	115.7	27.9	0.1	0.0	217.3	42.5	0.1	7.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	139.4	0.0	0.0	1.1	0.0	0.0	0.7	17.3	1.5	1.9	0.1	0.6	9.3	2.3	10.9	0.9	4.6	0.4	5.9	9.6	13.0	0.3	2.3	0.8	74.1	2.5	0.0	0.0	1.5	64.1	1.6	21.5	11.2	22.0	0.0	82.1	6.9	0.0	9.8	0.2	0.5	6.2	273.3	6.6	0.0	0.0	2.2	0.0	57.8	40.6	0.0	5.7	2.5	0.0	2.9	53.2	8.9	0.0	8.1	9.9	2.0	3.1	1.2	0.5	4.1	10.7	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.6	13.8	1.2	0.1	40.0	372.4	125.7	1.6	0.0	0.0	17.4	11.1	0.2	0.5	0.1	0.3	126.0	2.5	0.1	12.6	33.6
MOGAT2	"DGAT2L5, FLJ22644, MGAT2"	ENSG00000166391	"Monoacylglycerol O-acyltransferase 2"	Q3SYC2	11	75717838-75732958	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 48.2;liver: 25.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 73.8;Hepatocytes: 79.6;Intestinal goblet cells: 36.2;Proximal enterocytes: 159.6;Undifferentiated cells: 32.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 4.5;RPMI-8226: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028834	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA028834: AB_10601865"	"unprognostic (5.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.15e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.24e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-3)"	0.0	0.0	0.0	1.9	0.2	0.0	1.4	0.0	0.1	0.1	0.0	13.9	44.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	25.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	12.6	0.0	0.2	0.2	0.0	0.6	48.2	0.7	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.3	1.5	0.2	0.0	0.0	0.0	0.0	73.8	0.0	0.0	0.0	0.1	0.0	0.0	2.4	2.7	0.0	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.4	79.6	0.0	0.0	0.0	36.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.3	0.0	0.0	0.6	159.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.4	0.1
MON1B	"HSRG1, KIAA0872, SAND2"	ENSG00000103111	"MON1 homolog B, secretory trafficking associated"	Q7L1V2	16	77190835-77202398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046285	Approved		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA046285: AB_10959467"	"unprognostic (1.73e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.97e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (1.94e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (9.42e-5)"	"unprognostic (2.21e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.75e-1)"	12.9	9.6	19.3	17.2	25.5	15.7	9.0	20.8	18.9	11.1	9.4	15.6	16.3	10.6	12.0	13.2	10.8	13.2	10.5	18.1	19.1	10.6	12.4	12.6	18.3	24.9	24.0	8.8	13.7	17.5	8.3	8.1	21.2	19.7	13.1	21.0	13.9	10.2	11.4	13.6	16.0	9.7	20.6	15.2	13.7	5.6	22.6	15.3	19.7	7.7	15.5	11.8	7.1	23.0	14.8	35.7	15.0	15.5	16.0	15.9	20.5	14.6	17.4	13.0	13.9	20.9	22.4	26.9	24.1	11.9	23.3	29.8	15.7	14.5	11.5	19.6	17.9	19.0	12.7	20.5	22.4	20.9	52.5	15.7	28.5	19.3	17.2	14.0	24.5	24.7	25.6	9.0	11.3	29.9	26.3	24.6	15.5	19.9	9.6	34.0	10.3	30.4	14.9	11.9	22.4	18.8	25.5	10.2	17.6	10.7	23.3	30.6	26.2	16.2	18.5	18.4	13.0	30.0	21.4	72.9	28.7	21.4	20.3	17.8	9.7	16.6	9.5	16.3	9.8	6.0	7.6	8.8	8.3	7.0	5.6	7.2	21.7	10.3	11.1	4.7	9.9	9.0	19.3	25.5	20.8	18.9	18.1	19.1	24.9	24.0	21.2	20.6	22.6	23.0	19.4	38.5	34.8	1.6	17.3	7.5	10.0	12.7	8.0	15.0	16.6	14.4	12.6	12.8	19.8	14.7	18.8	10.5	16.9	42.3	3.9	14.0	17.8	13.1	15.6	20.7	24.0	16.2	1.9	19.5	12.4	12.6	21.9	20.0	12.7	17.4	19.6	28.4	13.2	8.4	3.0	27.9	10.2	32.0	7.8	14.1	9.0	18.7	8.8	4.7	26.1	21.5	26.8	3.0	5.0	20.0	18.7	10.1	13.8	21.0	23.8	11.7	14.6	23.5	19.7	21.6	11.0	10.4	5.3	14.6	9.5	16.8	17.2	10.9	23.5	18.8
NAT1	AAC1	ENSG00000171428	"N-acetyltransferase 1"	P18440	8	18170477-18223689	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 24.2;Paneth cells: 32.7;Respiratory ciliated cells: 32.0"	"Cancer enriched"	"Detected in all"	14	"breast cancer: 47.9"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB017782, HPA043704"	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB017782: , HPA043704: AB_2678625"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.15e-2)"	3.6	1.5	0.5	5.4	0.7	3.2	5.9	0.8	0.9	6.5	0.8	14.2	11.7	2.4	15.2	2.5	4.4	3.6	1.8	0.5	0.7	5.7	10.4	3.5	6.0	1.2	0.7	2.9	1.8	1.1	1.0	4.1	0.8	7.3	12.8	0.3	1.9	2.9	0.4	2.4	8.9	3.6	0.8	4.1	4.9	1.8	0.8	4.6	2.1	1.5	6.7	4.5	1.3	1.0	22.6	2.7	2.5	3.3	6.3	6.3	5.3	8.0	8.5	8.8	10.2	4.0	4.7	11.0	6.2	5.2	8.1	3.6	4.5	5.4	8.9	10.3	2.3	7.6	3.0	3.0	6.0	3.3	9.7	5.2	6.5	6.0	0.5	2.2	7.9	9.3	6.6	2.9	10.0	4.0	9.8	10.3	2.4	17.8	3.4	4.9	2.5	4.3	9.3	12.6	1.3	1.7	0.3	9.5	5.5	5.2	7.7	9.7	8.5	5.3	3.1	8.0	1.3	2.0	4.0	9.3	4.6	7.5	2.4	5.4	4.6	9.4	3.3	5.3	2.4	4.4	3.4	3.4	6.1	3.9	3.2	3.9	8.2	6.3	5.4	3.5	6.3	2.7	0.5	0.7	0.8	0.9	0.5	0.7	1.2	0.7	0.8	0.8	0.8	1.0	4.6	0.0	3.6	0.7	4.7	0.4	0.8	9.1	1.2	0.0	3.5	1.9	1.6	0.0	11.3	5.5	0.0	5.9	2.3	24.2	1.9	5.7	10.8	3.9	3.2	3.0	3.6	0.8	0.8	6.9	7.7	2.1	3.6	2.8	2.5	1.1	2.2	12.7	7.2	0.0	0.2	10.7	8.2	6.3	2.6	2.2	4.1	5.3	3.6	1.9	4.9	2.5	4.1	0.0	0.5	5.8	32.7	5.7	2.6	2.3	12.7	16.6	32.0	0.0	0.0	0.7	3.4	4.2	0.6	2.2	0.6	10.9	4.1	3.2	8.4	2.5
NEDD4L	"KIAA0439, NEDD4-2, RSP5"	ENSG00000049759	"NEDD4 like E3 ubiquitin protein ligase"	Q96PU5	18	58044226-58401540	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 253.2;Excitatory neurons: 280.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 29.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 5.1"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 146.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024618	Approved				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA024618: AB_1854362"	"unprognostic (2.56e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.24e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.55e-15)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (4.75e-2)"	11.2	16.8	20.9	6.7	34.4	27.0	25.8	25.1	31.3	7.6	0.7	38.8	18.7	5.3	10.0	12.0	9.1	9.5	26.9	32.3	16.2	53.4	36.5	47.9	4.1	10.9	18.4	6.4	60.5	13.6	28.4	12.0	10.4	64.2	42.8	20.5	27.5	20.4	34.0	11.2	33.8	6.2	8.6	7.9	51.5	7.8	16.7	4.5	17.4	13.1	7.9	19.4	5.9	16.3	70.7	24.5	14.6	20.9	5.1	2.1	49.8	19.2	88.2	48.6	74.6	28.6	37.1	15.1	57.7	7.4	51.3	50.3	19.5	86.1	100.8	34.9	15.5	10.6	14.3	111.3	2.4	0.5	6.0	13.0	54.6	66.4	78.8	39.1	4.0	13.2	18.7	6.3	20.0	16.2	1.0	1.0	12.2	26.7	33.3	14.3	20.1	17.6	47.0	88.7	17.5	5.0	16.1	5.1	146.1	28.3	29.4	5.6	28.8	131.5	38.5	7.5	83.4	8.3	15.3	9.5	27.6	10.8	10.8	0.7	0.3	1.2	0.2	0.3	0.5	0.8	0.6	0.1	0.1	0.3	0.3	0.2	0.2	0.3	0.1	0.1	5.1	0.3	20.9	34.4	25.1	31.3	32.3	16.2	10.9	18.4	10.4	8.6	16.7	16.3	6.0	253.2	144.8	110.4	5.1	112.8	161.2	34.0	86.6	18.1	99.5	65.9	47.8	64.3	112.8	62.5	173.0	13.0	3.6	144.5	49.0	35.7	22.6	64.0	7.3	14.7	45.2	57.9	280.9	49.2	4.7	9.5	114.7	75.0	3.8	4.7	17.5	41.3	7.3	62.2	173.3	201.5	101.7	8.4	8.2	6.6	3.4	13.3	14.2	88.1	7.3	45.2	2.1	11.1	105.0	49.9	145.3	17.7	12.7	126.9	127.3	91.6	72.7	10.0	0.0	34.3	6.0	1.1	12.5	62.3	53.0	80.0	6.6	8.2	72.9	155.5
NLRP8	"CLR19.2, NALP8, NOD16, PAN4"	ENSG00000179709	"NLR family pyrin domain containing 8"	Q86W28	19	55947832-55988629	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 15.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA056989	Uncertain					NA	NA						"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA056989: AB_2683301"	"unprognostic (2.43e-2)"											"unprognostic (3.35e-1)"		"unprognostic (3.13e-1)"	"unprognostic (6.96e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1
NSUN7	FLJ14001	ENSG00000179299	"NOP2/Sun RNA methyltransferase family member 7"	Q8NE18	4	40749925-40811184	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.5;Late spermatids: 75.6;Respiratory ciliated cells: 36.4;Spermatocytes: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.6;CAPAN-2: 5.5;Karpas-707: 4.0;MCF7: 2.6;SuSa: 3.0;T-47d: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA020653	Uncertain		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA020653: AB_1848710"	"unprognostic (2.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.76e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-2)"	0.6	0.9	0.6	1.0	0.6	0.6	3.8	0.4	0.4	2.5	7.2	2.8	1.7	2.2	2.7	1.8	6.8	1.2	2.1	0.5	1.5	4.7	0.4	3.3	0.3	1.8	2.4	2.3	7.2	3.3	3.6	1.3	1.5	4.5	2.4	0.7	4.8	1.5	0.0	1.5	2.1	1.2	1.2	2.7	3.2	16.5	2.0	0.3	4.7	0.2	0.3	1.3	1.2	0.8	2.6	0.1	1.2	0.0	0.0	0.0	1.7	0.0	0.2	0.1	0.1	1.0	5.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	2.6	0.1	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.4	0.7	0.6	1.5	0.3	1.7	0.0	3.0	3.9	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.4	0.4	0.5	1.5	1.8	2.4	1.5	1.2	2.0	0.8	0.1	9.6	7.8	3.6	4.3	1.1	3.1	1.5	2.2	0.1	8.6	7.1	3.5	0.0	10.5	9.2	0.0	9.2	0.1	2.7	9.8	5.8	47.5	20.7	0.9	0.6	8.3	0.4	0.7	5.4	3.6	1.2	4.6	5.4	0.0	8.5	0.7	0.2	3.8	0.0	0.9	7.1	4.1	0.8	0.4	75.6	1.5	2.2	0.0	8.4	1.0	2.1	0.0	18.1	1.3	4.7	2.7	0.0	0.3	4.5	2.2	5.5	36.4	0.1	0.0	0.4	0.8	38.9	11.4	8.2	1.0	4.5	0.7	3.4	7.7	5.7
NUPR2	NUPR1L	ENSG00000185290	"Nuclear protein 2, transcriptional regulator"	A6NF83	7	56114681-56116417	"Predicted intracellular proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"testis: 354.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 15101.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 13.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.0;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 11.9"	"Not detected"	"Not detected"													NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (5.81e-2)"	"unprognostic (2.01e-1)"		"unprognostic (1.10e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.25e-2)"		"unprognostic (2.46e-1)"		"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.53e-5)"	"unprognostic (1.66e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.44e-2)"	2.2	3.3	7.3	0.3	7.4	1.0	2.6	8.4	9.2	1.8	5.3	0.9	1.2	0.7	3.0	0.7	1.6	0.4	1.2	7.3	8.1	18.2	2.3	1.0	0.6	6.6	6.7	1.3	4.0	3.3	12.7	0.7	7.1	6.5	0.7	2.6	7.7	5.7	1.5	1.4	0.7	0.6	6.5	0.7	6.0	354.9	8.7	1.3	15.4	1.0	0.6	0.6	0.8	6.5	1.0	3.1	1.4	4.0	3.6	1.5	0.5	0.2	1.4	0.7	0.4	0.4	2.2	0.4	4.7	0.1	1.5	0.3	1.9	0.5	0.9	0.7	6.0	2.4	1.4	2.7	1.9	0.8	0.3	2.8	2.0	1.0	4.4	1.7	1.3	3.1	3.0	2.5	1.4	3.3	1.3	3.1	1.3	1.2	3.3	1.1	1.6	11.9	2.3	0.5	3.9	3.6	1.9	0.5	5.4	4.6	1.2	0.7	1.0	0.6	1.7	0.9	0.7	3.8	4.8	4.6	2.4	3.0	1.1	2.0	0.3	0.6	0.3	0.0	0.5	0.4	1.8	0.5	0.4	0.5	5.1	1.4	0.1	0.4	0.5	0.8	0.5	0.8	7.3	7.4	8.4	9.2	7.3	8.1	6.6	6.7	7.1	6.5	8.7	6.5	0.2	0.0	1.5	0.0	0.2	0.0	21.3	0.0	2.2	1.4	39.6	41.3	0.0	0.0	1.8	90.1	0.0	9.6	0.5	1.4	422.6	3.6	3765.4	3.9	0.1	6.7	14.6	0.0	0.0	1.8	1.7	0.9	9.7	2.4	1.3	0.1	0.0	0.0	0.6	16.8	0.0	3.0	0.0	0.0	0.0	15101.8	94.1	5.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.5	68.4	0.0	24.8	0.1	3.2	2.9	0.8	85.5	0.0	1.5	112.8	53.3	2.7	0.0	2.9	0.6	0.0	2.0	20.4
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77428256	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 124.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.9;Excitatory neurons: 183.1;Horizontal cells: 69.0;Inhibitory neurons: 276.5;Muller glia cells: 86.5;Oligodendrocyte precursor cells: 190.5"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 13.6;HeLa: 34.8;SK-BR-3: 11.1"									"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	20.9	4.8	24.2	1.0	28.6	0.4	14.0	4.8	24.6	17.4	0.0	5.6	2.0	26.4	6.3	2.0	28.7	4.3	23.7	25.5	32.5	15.6	2.3	5.2	1.2	20.5	15.9	4.2	7.9	0.8	12.5	23.8	18.8	19.0	1.2	22.5	10.5	11.9	0.7	2.0	3.3	17.7	9.9	0.8	5.5	3.0	36.7	0.3	124.7	0.8	1.0	4.0	4.9	17.2	0.1	4.9	0.8	0.3	1.5	0.0	0.5	1.5	13.6	0.2	0.1	1.4	0.1	0.3	0.1	0.1	0.2	0.6	0.2	0.0	0.2	0.2	0.7	0.4	34.8	0.3	0.0	0.4	0.5	0.8	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.2	0.0	0.2	0.5	0.8	0.8	0.2	0.1	0.6	0.9	0.4	0.0	0.2	5.4	1.0	2.3	11.1	0.7	0.7	1.8	0.9	0.5	0.3	0.3	0.2	0.5	0.7	0.5	0.4	1.2	0.5	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	24.2	28.6	4.8	24.6	25.5	32.5	20.5	15.9	18.8	9.9	36.7	17.2	0.8	3.2	2.8	64.9	0.3	0.4	2.0	0.1	0.0	10.8	5.8	3.0	28.0	2.8	1.6	1.8	54.2	0.0	0.2	0.1	0.0	2.3	6.8	15.3	2.1	4.5	4.9	0.0	183.1	0.0	0.1	3.8	0.0	7.9	1.3	1.8	2.9	0.1	0.4	69.0	276.5	1.0	0.0	1.0	1.6	5.1	5.9	0.9	1.8	10.3	0.1	86.5	0.0	190.5	45.5	0.2	0.4	0.0	0.3	29.1	0.2	0.7	0.7	5.8	6.6	1.8	7.7	1.1	2.6	0.5	1.1	0.0	0.1	8.8	1.2	4.2
PDXDC1	KIAA0251	ENSG00000179889	"Pyridoxal dependent decarboxylase domain containing 1"	Q6P996	16	14974591-15139339	"Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 483.6;Late spermatids: 733.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047369, HPA049121, HPA051484"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		9600	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus, Vesicles"		"HPA047369: AB_2680015, HPA049121: AB_2680641, HPA051484: AB_2681502"	"unprognostic (3.67e-2)"	"unprognostic (4.99e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.47e-3)"	"unprognostic (4.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"	33.3	37.9	4.9	20.9	5.0	12.9	33.1	14.7	6.5	35.7	7.9	61.3	52.5	31.9	17.0	43.4	29.2	20.8	39.1	6.0	4.1	47.6	104.5	34.6	13.4	6.2	4.7	31.1	70.4	27.1	63.2	23.5	7.5	55.8	47.8	13.4	80.5	25.2	52.0	27.8	61.1	18.5	1.2	31.8	56.7	113.2	7.2	11.7	42.9	16.5	15.0	39.1	34.7	5.7	21.4	30.9	31.1	26.1	16.9	20.4	51.4	19.6	17.4	14.3	19.7	38.0	45.3	40.7	42.0	26.5	20.5	34.0	22.1	20.1	20.5	25.0	30.2	24.7	51.8	100.2	44.3	19.7	56.4	21.5	20.4	25.0	20.9	28.0	15.3	21.6	18.5	26.0	34.1	52.2	12.9	10.4	15.3	20.8	11.7	19.9	12.9	48.6	22.7	33.9	31.9	22.8	52.6	30.0	50.9	19.7	121.0	30.3	23.8	11.0	10.0	12.3	25.7	24.2	25.1	39.3	22.7	16.4	35.8	2.9	7.8	11.6	9.4	7.7	10.8	8.3	6.8	7.7	11.7	9.0	8.2	8.1	1.0	7.5	6.2	5.4	6.6	8.2	4.9	5.0	14.7	6.5	6.0	4.1	6.2	4.7	7.5	1.2	7.2	5.7	29.6	38.5	64.6	32.7	33.0	38.2	42.2	21.6	18.8	32.1	57.9	27.8	45.7	58.6	52.9	29.5	31.3	51.7	30.6	149.8	27.4	38.2	483.6	48.1	41.7	35.1	161.2	33.2	80.7	58.3	56.5	36.0	71.9	75.3	39.3	42.1	27.5	123.6	30.5	40.4	68.3	216.7	24.4	33.1	16.8	733.8	49.0	30.9	26.6	31.9	27.5	19.7	39.1	55.8	45.0	46.5	114.4	45.5	45.4	58.1	115.6	53.4	48.3	47.4	46.0	24.0	28.0	142.3	72.7	24.6	42.6	80.7	33.9	21.2	127.2	76.5
PHOSPHO2	MGC22679	ENSG00000144362	"Phosphatase, orphan 2"	Q8TCD6	2	169694454-169701708	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 158.7;Spermatocytes: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034726, HPA034727"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA034726: AB_10602191, HPA034727: AB_2674302"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (4.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.53e-2)"	5.0	2.8	1.9	2.4	1.9	2.9	10.6	4.1	1.6	4.7	3.7	5.8	6.4	5.3	4.2	3.2	6.0	4.0	2.7	1.6	2.8	5.6	3.6	3.3	3.0	1.4	1.8	6.0	5.1	7.2	4.6	3.0	1.5	13.0	5.8	7.2	8.5	4.7	3.4	3.5	6.4	3.1	1.7	2.5	4.7	13.7	2.4	3.0	9.8	1.6	3.0	3.8	2.8	1.9	6.6	1.8	4.6	6.2	8.5	2.7	17.8	2.8	1.9	4.3	4.7	6.3	4.9	6.4	6.1	2.1	8.9	5.0	6.2	3.4	3.5	9.5	7.0	6.4	6.1	11.0	5.6	5.3	5.6	4.9	6.3	4.9	6.5	3.6	3.9	8.9	10.8	6.4	2.7	6.0	3.7	6.8	6.0	4.2	2.3	3.6	2.8	5.1	6.8	19.6	19.1	6.5	5.8	3.1	6.8	5.5	8.4	3.2	2.3	4.7	4.3	4.2	3.1	6.2	6.0	5.7	5.5	3.2	5.1	0.1	0.7	1.0	3.3	0.9	4.6	6.5	3.6	3.2	0.9	8.8	4.7	4.6	1.3	9.8	0.9	4.2	4.4	1.4	1.9	1.9	4.1	1.6	1.6	2.8	1.4	1.8	1.5	1.7	2.4	1.9	6.1	3.2	3.6	0.0	6.8	2.5	10.3	5.4	2.8	8.7	15.2	11.0	4.1	5.7	4.7	3.7	6.2	8.8	2.5	7.0	9.8	7.6	158.7	10.6	5.0	4.3	15.0	6.9	0.0	11.1	9.3	6.9	15.3	3.3	0.0	5.7	2.5	3.7	2.8	6.7	0.0	6.6	12.2	0.6	1.6	35.9	4.7	2.0	3.6	0.0	1.0	6.4	1.0	0.0	0.0	6.4	6.8	4.9	3.8	6.5	12.7	12.2	13.4	10.2	0.0	6.7	9.3	68.9	13.9	4.5	4.3	5.5	5.7	8.8	7.5	5.5
PICK1	"dJ1039K5, MGC15204, PRKCABP"	ENSG00000100151	"Protein interacting with PRKCA 1"	Q9NRD5	22	38056311-38075701	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 116.1;Late spermatids: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000819, HPA072674"	Approved		Supported	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA000819: , HPA072674: AB_2686547"	"unprognostic (1.97e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.79e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.56e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.61e-3)"	8.8	14.9	12.4	4.8	15.2	5.4	13.5	12.8	20.3	9.9	12.9	11.9	10.1	11.7	13.8	15.9	16.3	8.9	18.2	14.5	13.5	15.1	17.5	10.8	5.4	14.5	13.6	15.4	18.5	29.3	28.8	6.7	16.7	25.6	12.2	5.9	18.6	12.6	26.3	16.9	11.3	11.3	11.6	10.1	16.2	27.4	15.6	5.9	14.6	16.2	8.2	9.3	12.0	23.0	19.5	13.7	7.6	10.0	5.3	4.1	11.3	10.7	12.8	22.5	22.7	14.6	12.0	8.6	11.6	13.0	17.0	20.8	21.0	43.2	19.3	5.3	33.6	3.1	16.8	17.1	19.3	10.1	20.4	13.3	24.9	14.8	21.9	22.8	8.8	11.1	6.4	6.2	4.7	12.4	6.0	0.9	12.1	44.3	14.9	5.1	0.3	7.8	25.8	31.1	31.5	16.0	12.0	28.8	11.1	11.1	16.8	7.3	2.4	6.4	12.0	8.6	6.4	13.9	3.4	2.7	13.8	3.4	9.4	0.0	0.9	0.0	0.5	0.4	0.2	0.3	0.5	1.0	1.6	1.1	1.0	0.5	0.6	0.4	0.5	0.3	0.7	0.6	12.4	15.2	12.8	20.3	14.5	13.5	14.5	13.6	16.7	11.6	15.6	23.0	8.1	9.6	10.6	11.1	8.1	8.0	14.2	15.6	12.0	12.7	18.7	16.1	10.2	11.5	12.1	7.3	8.4	26.1	6.0	25.4	11.7	18.8	116.1	15.4	3.6	7.8	10.3	1.7	26.8	15.7	14.8	6.8	29.6	17.3	8.9	36.3	5.7	9.7	15.1	20.2	19.4	20.1	18.3	31.5	13.3	85.5	11.1	16.3	7.2	6.5	16.0	13.6	8.2	8.5	29.0	21.4	18.5	17.0	5.8	22.1	18.3	16.0	12.8	12.5	13.1	6.0	9.5	17.2	6.7	12.0	9.7	38.4	6.8	15.5	18.5	14.7
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 78.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 74.5;Distal enterocytes: 21.7;Gastric mucus-secreting cells: 18.3;Glandular and luminal cells: 17.1;Suprabasal keratinocytes: 13.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 11.1;RT4: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.0	0.0	0.1	0.4	0.3	0.3	2.4	0.1	0.1	5.7	0.0	6.4	6.7	0.0	1.6	5.7	0.1	0.1	0.3	0.1	0.0	7.8	0.2	12.2	0.1	0.0	0.0	0.0	0.1	2.9	1.7	0.1	0.0	4.3	3.8	0.2	2.6	0.4	2.9	78.1	4.2	0.1	0.0	0.1	2.4	0.1	0.0	4.4	1.9	0.5	0.3	1.2	11.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.1	0.1	0.0	0.0	0.0	0.0	8.3	0.4	0.0	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	74.5	0.0	0.0	5.5	2.7	1.3	0.6	0.0	1.2	0.3	2.9	0.0	0.5	5.5	0.0	1.7	0.0	21.7	3.9	0.4	0.0	7.3	1.0	0.1	0.0	0.0	0.0	1.3	0.7	0.1	18.3	17.1	2.5	0.0	0.0	0.0	0.1	0.0	0.0	7.7	4.1	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	0.0	0.3	3.1	10.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	5.6	13.8	1.2	0.6	0.0	6.7	2.0
PLEKHB2	"EVT2, FLJ20783"	ENSG00000115762	"Pleckstrin homology domain containing B2"	Q96CS7	2	131104847-131353709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075014	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA075014: AB_2732275"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (9.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.72e-8)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.65e-1)"	27.0	55.5	52.7	38.3	55.4	64.8	26.1	61.4	56.2	25.4	53.4	59.9	46.8	16.6	30.7	30.3	26.7	29.7	33.5	57.8	73.1	111.8	22.4	44.4	37.0	64.8	69.4	11.7	20.8	88.5	26.2	31.0	81.3	34.6	60.9	81.1	26.0	26.3	35.6	23.5	56.2	25.9	56.8	42.5	58.5	36.1	60.0	31.2	48.7	30.6	34.5	38.3	18.2	63.1	85.3	65.4	48.6	38.1	37.4	36.2	79.2	94.4	80.0	88.9	73.8	140.0	83.4	68.2	97.5	92.0	64.4	58.8	89.0	81.5	98.8	40.0	48.6	119.4	31.0	81.4	51.9	115.4	88.8	31.9	67.2	105.2	96.9	54.6	71.1	36.5	57.5	53.0	166.9	46.7	71.4	57.0	73.9	80.8	99.1	52.5	37.7	72.7	138.6	89.7	60.3	39.7	29.6	166.3	107.6	64.9	23.6	89.0	86.6	89.2	60.4	76.7	86.5	51.2	85.6	46.5	130.8	76.6	82.8	27.5	54.9	29.0	24.4	69.2	23.9	15.5	18.2	23.2	52.7	17.1	19.4	23.2	32.3	26.5	78.2	18.7	23.6	48.3	52.7	55.4	61.4	56.2	57.8	73.1	64.8	69.4	81.3	56.8	60.0	63.1	37.8	60.9	53.9	14.4	50.0	114.3	35.6	47.2	64.9	85.6	57.6	26.5	28.6	34.3	59.5	64.4	125.1	44.9	59.5	174.4	158.5	62.4	66.4	108.8	44.2	57.2	56.8	44.2	38.9	43.1	51.0	29.6	62.2	164.1	58.9	25.4	31.4	20.9	106.3	101.0	41.5	67.6	128.1	111.0	169.5	22.1	14.3	117.9	76.5	26.2	86.2	46.0	49.4	15.1	32.0	81.5	68.4	24.0	35.8	58.6	120.2	193.4	52.1	78.8	13.1	26.1	35.9	92.3	65.9	97.6	140.4	92.9	59.1	51.0	76.1	70.7
PLPP6	"FLJ46512, FLJ90191, PDP1, PPAPDC2"	ENSG00000205808	"Phospholipid phosphatase 6"	Q8IY26	9	4662294-4665258	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.2;Late spermatids: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"HDLM-2: 99.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018096	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA018096: AB_1855609"	"unprognostic (2.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.88e-2)"	3.6	6.6	3.8	6.2	4.0	1.5	7.3	7.0	5.0	5.0	8.7	9.3	10.5	4.0	12.7	7.4	3.3	4.6	2.8	4.3	3.3	5.4	18.9	3.4	8.2	3.4	3.6	4.0	17.2	7.7	4.7	7.1	3.6	16.4	9.9	5.1	7.7	4.8	1.9	8.2	11.4	3.4	3.3	6.0	11.3	5.9	3.3	6.1	7.1	1.5	8.4	5.2	5.1	3.5	8.2	8.3	8.8	10.9	6.9	7.7	8.8	5.5	7.1	4.4	5.0	2.2	5.3	7.9	2.2	5.5	10.9	10.0	6.2	7.8	4.6	99.2	5.9	15.7	8.7	11.3	6.3	5.7	11.4	8.5	6.2	3.4	7.5	5.8	6.6	8.8	2.7	8.1	5.6	8.8	5.4	15.0	8.1	8.2	2.9	5.3	0.0	6.1	7.6	9.3	22.0	11.1	6.5	5.8	3.5	10.8	8.2	12.7	7.8	3.9	3.3	5.3	3.6	1.7	6.4	2.0	6.1	4.1	3.7	6.8	4.1	3.5	3.1	3.7	3.6	2.6	5.6	4.8	4.2	3.3	9.6	6.9	1.8	4.2	4.4	3.2	8.6	4.1	3.8	4.0	7.0	5.0	4.3	3.3	3.4	3.6	3.6	3.3	3.3	3.5	2.8	6.4	2.7	0.0	2.6	0.0	2.5	0.0	2.8	7.5	4.2	2.7	0.0	5.7	1.3	1.8	2.1	18.6	2.9	9.7	1.9	11.0	82.2	2.1	3.4	3.0	10.9	2.1	0.0	13.9	2.9	2.3	7.1	5.3	0.0	4.1	4.2	15.3	6.5	3.3	0.0	7.3	0.0	4.7	0.0	46.3	2.8	1.7	0.0	0.0	3.0	4.6	3.1	0.0	0.0	10.8	6.5	4.9	1.5	7.5	13.4	2.8	0.0	4.9	0.0	1.7	1.8	0.5	1.1	4.6	0.0	10.4	3.4	3.5	5.1	3.1
PNKD	"BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, MR-1S, PDC, PKND1, TAHCCP2"	ENSG00000127838	"PNKD metallo-beta-lactamase domain containing"	Q8N490	2	218270392-218346793	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 508.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010134, HPA017068"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA010134: AB_1079645, HPA017068: AB_1855495"	"unprognostic (3.15e-3)"	"unprognostic (1.80e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.29e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (5.13e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.44e-3)"	50.9	88.9	127.6	33.3	134.7	35.4	49.7	131.2	168.4	62.8	129.3	74.7	40.6	45.6	77.3	40.5	60.6	41.6	98.4	127.8	137.5	106.5	191.5	55.5	40.9	133.9	130.9	47.1	46.1	93.4	49.5	46.9	134.1	87.4	54.7	26.7	60.6	55.3	85.1	44.9	51.1	36.4	128.7	58.7	81.6	45.6	137.8	45.8	90.0	93.6	37.6	64.2	45.4	134.7	53.2	68.3	49.1	77.0	72.2	60.6	90.0	32.7	70.3	76.1	85.0	112.9	51.2	61.7	63.7	55.0	83.5	53.6	95.4	61.4	52.9	128.0	119.4	90.0	119.5	169.4	78.7	58.9	38.6	83.0	59.8	51.9	15.0	51.0	83.2	48.0	67.8	78.3	68.4	152.2	77.6	139.5	49.0	121.3	69.3	75.1	49.5	51.8	88.3	79.2	47.4	39.9	23.6	156.9	94.6	52.0	52.4	56.4	51.5	31.4	53.7	37.5	45.5	32.4	35.7	69.0	79.9	95.8	38.8	142.4	111.4	151.9	97.7	114.3	94.2	223.1	105.7	117.7	106.4	187.2	116.4	111.2	31.3	136.2	109.4	99.0	150.0	132.2	127.6	134.7	131.2	168.4	127.8	137.5	133.9	130.9	134.1	128.7	137.8	134.7	84.5	70.5	91.2	30.0	58.2	55.2	91.5	179.2	82.6	54.5	130.1	162.4	154.5	128.7	127.8	196.8	6.2	172.9	48.2	292.0	508.7	70.6	13.5	125.9	116.5	66.9	121.3	56.3	44.9	49.8	105.3	88.5	99.9	114.1	57.1	97.0	83.2	250.4	136.7	35.3	47.4	186.3	187.2	85.3	59.6	16.5	103.2	66.2	136.9	20.6	79.6	168.8	51.5	19.6	32.8	37.7	143.6	124.1	74.6	93.4	162.7	326.7	148.5	41.6	92.1	60.0	128.6	42.5	50.6	113.9	62.4	77.3	52.5	97.2	228.1	117.5
PNPLA7	"C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2"	ENSG00000130653	"Patatin like phospholipase domain containing 7"	Q6ZV29	9	137459952-137550402	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 56.2;Excitatory neurons: 23.6;Inhibitory neurons: 21.5;Oligodendrocytes: 21.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.0;T-reg: 1.2"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;T-cells: 1.2"	"Cell line enriched"	"Detected in some"	22	"HMC-1: 83.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009130	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	"Centriolar satellite"	"HPA009130: AB_2268411"	"unprognostic (1.49e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.72e-3)"	"unprognostic (5.14e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (2.24e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.45e-3)"	9.6	7.0	5.2	2.2	5.3	2.1	11.3	1.9	8.6	17.6	1.2	10.8	2.2	12.3	1.0	2.7	13.0	3.7	6.9	6.6	2.6	6.3	14.0	4.7	4.4	4.6	2.6	21.5	17.9	2.0	8.9	0.6	3.6	22.5	1.4	1.3	15.9	2.7	17.3	14.3	8.4	1.6	2.2	7.0	16.3	2.6	4.2	1.4	17.3	3.4	1.4	10.5	7.6	5.9	0.1	1.0	0.2	0.3	0.8	0.5	0.4	0.8	0.8	0.2	0.2	0.1	0.5	0.6	0.8	0.4	0.4	0.3	0.1	0.0	0.0	1.6	0.9	0.8	1.0	0.3	0.5	0.4	83.7	1.2	0.1	0.3	0.0	1.4	0.1	0.1	0.1	2.3	0.1	1.6	0.2	1.6	0.0	1.2	0.9	2.0	1.3	2.8	0.1	0.3	1.6	0.4	0.1	0.6	0.3	0.2	3.7	1.2	0.6	0.0	0.1	0.4	0.1	0.8	0.2	0.2	1.2	0.8	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.1	0.2	1.0	0.3	0.2	0.0	0.0	0.0	0.1	1.2	0.2	5.2	5.3	1.9	8.6	6.6	2.6	4.6	2.6	3.6	2.2	4.2	5.9	3.0	9.6	5.9	56.2	4.8	1.5	1.1	0.9	2.2	2.5	6.5	8.3	3.9	4.3	2.6	1.8	6.2	0.2	2.1	6.6	0.0	0.7	0.5	1.7	4.8	1.2	17.3	0.8	23.6	0.0	0.3	3.6	12.2	3.8	7.0	1.2	2.5	10.2	2.6	5.0	21.5	9.2	0.0	4.5	1.0	0.6	4.4	1.2	0.0	9.4	1.3	2.5	1.0	11.6	21.0	0.6	7.1	1.9	1.6	2.5	3.8	1.0	1.6	9.6	0.0	2.3	2.1	3.1	4.0	0.9	3.3	0.0	2.3	0.6	2.0	0.7
PPFIA3	"KIAA0654, LPNA3, MGC126567, MGC126569"	ENSG00000177380	"PTPRF interacting protein alpha 3"	O75145	19	49119544-49151026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;pituitary gland: 45.0;skin 1: 42.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 40.8;Horizontal cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 23.1;PC-3: 36.1;SK-BR-3: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043567, HPA050340"	Enhanced		Uncertain	"Nucleoli fibrillar center,Vesicles"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoli fibrillar center, Vesicles"		"HPA043567: AB_2678558, HPA050340: AB_2681096"	"prognostic unfavorable (3.09e-4)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-3)"	"prognostic favorable (8.65e-4)"	"unprognostic (3.46e-1)"	"prognostic favorable (6.46e-7)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.27e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.41e-3)"	"unprognostic (5.21e-3)"	"unprognostic (8.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.32e-1)"	2.0	4.5	16.4	0.8	18.8	0.2	2.7	11.7	28.6	4.6	0.0	6.6	3.0	2.2	0.3	14.1	1.9	0.6	3.1	18.2	11.4	3.1	2.7	2.9	0.8	10.1	8.7	1.3	4.7	2.1	45.0	0.4	9.9	5.6	1.0	3.7	5.3	0.6	1.4	42.3	3.7	0.4	3.5	2.2	2.4	4.2	11.7	2.4	2.8	0.2	1.1	1.4	8.1	16.6	3.3	3.3	3.3	8.0	0.1	0.0	6.0	0.4	0.4	1.5	2.2	2.2	1.3	7.3	4.3	0.4	2.4	1.7	5.0	0.7	0.4	7.9	10.8	4.6	3.5	1.7	0.4	1.9	11.4	0.4	1.8	1.0	0.5	0.7	0.0	12.1	9.0	11.2	0.1	14.2	2.3	3.2	1.4	23.1	36.1	7.6	6.5	3.6	0.5	1.6	7.2	9.5	1.3	29.7	3.3	0.0	16.5	4.4	0.7	1.7	6.1	1.1	0.2	21.0	18.2	5.4	1.7	7.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	18.8	11.7	28.6	18.2	11.4	10.1	8.7	9.9	3.5	11.7	16.6	15.7	0.0	0.6	8.5	0.8	7.1	8.0	3.5	11.4	40.8	10.4	6.1	4.2	8.6	3.0	5.5	14.6	0.5	3.6	19.3	19.6	2.7	1.2	1.3	3.6	15.2	26.5	2.7	19.9	4.4	2.1	3.4	3.6	2.4	0.0	2.7	23.2	8.6	2.5	43.7	21.5	26.3	8.2	2.2	2.4	1.7	5.6	2.7	16.0	2.8	0.0	16.2	0.0	10.6	2.7	1.9	13.7	3.8	1.2	18.2	15.0	4.6	0.9	17.9	0.0	0.6	5.5	2.5	5.9	8.7	11.8	0.5	0.7	13.2	20.4	6.3
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	12	"intestine: 206.4;prostate: 109.0"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 326.1;Enteroendocrine cells: 908.1;Intestinal goblet cells: 717.3;Paneth cells: 328.7;Undifferentiated cells: 624.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	32	"PC-3: 379.0"									HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA047871: AB_2680195"			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.2	0.3	4.4	0.1	106.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	109.0	206.4	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	12.4	12.8	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	379.0	11.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.4	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	110.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	326.1	0.0	0.0	0.7	0.0	0.0	0.4	908.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	717.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	328.7	0.0	0.0	101.9	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.9	0.0	624.3	63.1
PSD4	"EFA6B, TIC"	ENSG00000125637	"Pleckstrin and Sec7 domain containing 4"	Q8NDX1	2	113157325-113209396	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 51.2;Proximal enterocytes: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.8;NB-4: 9.3"	"Low region specificity"	"Detected in single"							"HPA034722, HPA077847"	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA034722: AB_10669730, HPA077847: "	"unprognostic (1.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.56e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.60e-3)"	1.7	13.7	1.4	3.1	1.3	3.7	3.9	0.5	1.2	2.3	0.7	7.0	2.0	0.7	4.0	10.8	1.7	1.3	0.8	1.0	1.0	5.2	21.2	5.8	3.9	1.0	0.8	0.5	11.6	3.0	3.4	0.9	1.1	8.7	1.9	0.5	11.3	1.2	0.6	9.0	17.7	0.4	0.9	23.3	12.4	1.5	1.5	5.9	10.1	0.3	4.0	3.7	4.2	0.9	5.7	1.0	0.3	0.1	0.0	0.0	6.1	0.4	2.2	0.4	0.5	1.5	8.1	9.8	1.2	0.2	1.7	7.4	0.0	2.0	0.1	8.3	0.1	4.1	0.8	2.2	0.1	6.9	6.9	0.1	1.9	0.2	0.5	0.9	0.0	3.8	3.9	4.1	0.0	3.2	7.1	9.3	0.1	1.8	1.1	0.1	0.1	4.3	0.4	1.4	0.5	0.0	0.7	5.1	0.0	0.2	1.6	5.6	0.1	0.3	0.2	0.2	1.6	5.0	4.0	3.0	0.9	3.3	0.1	1.7	0.9	1.7	2.0	0.6	1.7	1.0	1.5	1.8	0.6	1.2	1.7	1.9	3.9	2.4	0.7	1.5	1.1	1.4	1.4	1.3	0.5	1.2	1.0	1.0	1.0	0.8	1.1	0.9	1.5	0.9	0.9	19.2	12.0	7.5	28.6	12.7	10.4	7.6	13.1	0.3	22.5	11.2	1.8	11.5	5.8	33.1	0.0	20.7	41.6	39.1	0.0	21.3	0.3	9.0	1.6	2.1	7.2	13.0	0.9	23.6	11.2	3.0	31.1	20.4	3.8	2.9	2.9	51.2	12.1	3.3	1.7	10.7	4.1	13.8	17.0	0.9	0.9	14.3	1.8	2.8	13.8	10.1	47.4	2.5	0.2	23.1	17.8	0.0	18.3	15.8	50.3	7.1	4.6	0.4	0.0	3.0	1.7	0.2	1.1	17.4	15.8	7.5	28.2	1.7	18.6	11.1
RABEP2	"FLJ23282, FRA"	ENSG00000177548	"Rabaptin, RAB GTPase binding effector protein 2"	Q9H5N1	16	28904421-28936526	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047641	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"HPA047641: AB_2680111"	"unprognostic (4.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.84e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.86e-2)"	"prognostic favorable (1.24e-6)"	"unprognostic (7.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.92e-3)"	7.3	21.5	7.3	25.1	8.8	11.5	9.3	8.2	9.2	11.0	10.7	15.0	16.8	8.4	2.7	18.7	7.0	6.6	16.8	6.5	7.9	19.2	10.6	10.1	46.7	10.7	8.5	6.3	17.9	11.5	16.4	5.3	8.4	28.6	4.6	3.5	17.5	7.0	6.5	23.6	28.3	3.4	7.9	47.9	14.4	6.2	8.2	5.3	13.9	3.2	9.4	12.5	12.3	8.5	13.5	21.1	5.6	10.5	3.3	4.7	10.1	15.5	9.2	10.9	10.7	15.9	12.0	27.7	23.7	6.5	4.4	17.8	2.2	9.9	2.1	9.5	9.9	10.5	17.0	21.7	6.5	7.7	32.1	7.9	8.0	13.5	2.4	6.3	15.5	7.4	4.9	9.7	8.5	31.9	9.5	17.8	7.3	5.4	11.4	33.6	5.1	17.4	7.5	17.5	8.6	11.1	7.6	34.8	7.0	1.2	27.6	15.9	27.5	16.4	8.4	12.1	15.6	15.3	5.0	20.7	17.3	18.2	12.6	0.9	2.8	2.4	3.5	2.9	2.4	12.1	2.5	3.2	3.7	15.0	2.2	2.1	0.7	5.5	3.3	2.2	2.2	2.8	7.3	8.8	8.2	9.2	6.5	7.9	10.7	8.5	8.4	7.9	8.2	8.5	11.5	3.2	10.0	4.9	42.4	5.1	14.7	14.6	17.6	11.1	13.3	11.0	1.9	11.5	12.9	20.2	35.5	26.1	21.0	35.0	17.6	16.0	0.7	9.2	8.2	14.2	17.3	6.5	4.8	20.9	7.1	9.0	23.0	10.0	18.4	12.1	7.9	4.2	12.4	15.2	6.5	33.7	18.3	8.4	11.3	1.3	4.1	10.5	10.6	9.4	11.6	8.6	22.6	5.0	8.4	20.0	44.1	6.4	21.4	15.4	32.3	11.6	8.0	43.4	13.1	7.9	9.6	4.3	6.0	16.6	8.4	22.0	14.5	22.6	26.7	19.0
RAC3		ENSG00000169750	"Rac family small GTPase 3"	P60763	17	82031678-82034204	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 45.0;Extravillous trophoblasts: 152.1;Spermatogonia: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"CACO-2: 230.8;HEK 293: 274.7;NB-4: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047820	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA047820: AB_2680167"	"unprognostic (3.48e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (6.21e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (1.25e-3)"	12.3	5.0	22.8	1.8	20.8	7.7	13.7	26.3	29.5	5.3	9.3	4.8	3.4	2.8	7.3	10.9	3.8	3.0	3.0	19.7	24.5	9.4	20.7	4.0	1.7	23.3	22.3	4.8	4.7	9.3	22.8	5.6	27.0	11.1	1.4	2.8	18.1	4.2	0.8	12.4	3.7	1.3	15.3	1.9	11.8	28.1	26.5	2.2	9.8	0.2	1.5	3.1	7.6	20.6	11.1	15.1	45.6	63.1	9.7	18.2	50.5	7.8	7.2	26.1	22.3	230.8	21.4	5.8	11.5	4.8	1.7	15.6	43.0	17.8	4.1	3.6	274.7	64.6	20.2	16.7	47.0	28.0	12.2	27.5	13.0	3.5	12.0	19.5	60.3	33.8	103.1	30.2	10.8	35.6	7.3	156.4	61.4	39.2	27.6	47.6	4.5	27.7	20.0	5.4	109.8	111.5	4.1	57.2	55.7	16.1	58.6	40.7	21.6	10.8	9.8	5.5	12.1	14.6	9.9	4.4	6.6	17.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	22.8	20.8	26.3	29.5	19.7	24.5	23.3	22.3	27.0	15.3	26.5	20.6	1.6	0.0	0.0	2.3	0.9	8.7	16.3	12.2	19.9	5.3	36.9	45.0	0.2	4.3	3.6	5.5	0.0	30.0	1.8	3.3	21.5	9.8	19.1	5.9	5.4	2.3	3.0	6.9	5.2	3.3	152.1	10.7	8.2	12.6	4.5	17.8	1.4	11.3	9.7	6.7	8.3	5.1	22.4	0.0	2.6	16.6	5.6	0.9	14.2	0.0	2.0	6.0	0.0	3.5	2.0	5.5	2.4	1.9	2.6	16.4	4.2	26.0	2.4	7.3	0.0	0.8	5.3	2.2	58.0	15.8	7.5	14.1	3.1	8.6	5.2	8.4
RASEF	"FLJ31614, RAB45"	ENSG00000165105	"RAS and EF-hand domain containing"	Q8IZ41	9	82979590-83063177	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 41.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 101.7;Gastric mucus-secreting cells: 356.8;Prostatic glandular cells: 106.4;Respiratory ciliated cells: 100.6;Urothelial cells: 107.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 53.2;RT4: 38.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021431, HPA078596"	Approved		Uncertain	Microtubules		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Microtubules		"HPA021431: AB_1856087, HPA078596: "	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	1.1	1.6	16.2	2.8	15.4	3.6	17.6	21.2	21.9	2.9	18.0	15.2	6.3	2.7	10.2	7.1	6.3	12.6	1.1	13.9	9.2	5.3	2.4	8.2	1.5	10.0	6.3	1.5	23.1	5.3	3.9	3.4	9.8	15.2	15.2	5.1	15.3	3.8	1.9	3.8	8.6	1.1	1.0	1.5	41.0	4.0	9.8	3.4	25.9	0.0	3.5	13.8	2.3	24.7	14.0	15.5	1.8	1.5	0.3	0.5	5.6	1.0	0.2	1.6	3.9	8.7	16.9	2.3	13.7	0.4	11.0	16.3	0.3	0.4	1.9	1.4	17.3	1.9	11.9	2.2	0.2	1.7	1.6	0.3	6.7	7.6	0.2	2.1	0.1	2.4	2.5	16.8	0.2	27.2	2.3	1.8	10.5	53.2	6.1	2.5	4.8	6.0	18.0	38.5	5.6	8.3	2.8	26.8	1.1	6.7	22.9	2.0	2.6	2.6	14.6	2.1	1.7	11.3	10.1	1.4	5.8	1.0	3.0	6.5	2.0	1.9	3.7	1.4	3.5	3.9	3.5	2.9	1.1	5.3	3.8	3.3	9.8	3.6	1.6	3.8	2.9	0.7	16.2	15.4	21.2	21.9	13.9	9.2	10.0	6.3	9.8	1.0	9.8	24.7	0.7	76.9	101.7	0.3	1.1	0.8	5.4	7.9	4.0	1.1	61.3	21.1	0.6	42.9	59.7	9.2	4.2	5.5	0.5	61.8	7.9	35.4	0.6	39.7	7.9	4.5	3.6	0.8	1.0	37.4	10.3	5.7	356.8	88.2	22.1	0.4	0.7	1.7	0.8	0.0	0.6	85.7	48.8	0.0	0.4	2.1	0.3	4.2	1.8	4.7	1.6	0.1	0.0	0.0	0.2	46.2	40.0	0.0	1.5	106.4	10.4	8.3	100.6	1.3	0.0	0.7	2.8	0.5	4.8	28.2	0.9	7.5	3.1	1.2	35.7	107.7
REXO5	NEF-sp	ENSG00000005189	"RNA exonuclease 5"	Q96IC2	16	20806429-20849665	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 343.8"	"Cell type enriched"	"Detected in some"	5	"Granulosa cells: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	15	"basophil: 86.7"	"Lineage enriched"	"Detected in many"	39	"granulocytes: 86.7"	"Cell line enhanced"	"Detected in many"		"K-562: 44.7;U-266/70: 42.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040755, HPA040868, HPA066145"	Approved		Approved	"Nuclear membrane,Nucleoli,Endoplasmic reticulum"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear membrane"	"Nucleoli, Endoplasmic reticulum"	"HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: "	"unprognostic (2.39e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.42e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.93e-2)"	2.3	1.8	1.4	1.8	1.4	11.6	3.6	1.6	2.0	1.7	0.4	2.1	2.9	2.2	1.2	2.3	4.2	1.6	3.4	1.4	2.3	1.2	1.8	1.0	2.9	1.7	1.1	1.9	1.7	40.0	0.9	1.5	1.6	5.3	3.0	4.2	1.7	1.3	1.0	2.2	2.1	2.7	0.8	1.0	5.0	343.8	2.2	7.4	0.9	1.3	2.6	2.0	1.6	2.1	11.3	6.5	10.1	4.5	4.2	7.5	3.4	7.6	8.4	8.2	8.9	4.7	10.0	7.0	11.5	6.7	5.7	5.7	7.7	3.4	8.5	6.5	4.9	11.7	10.2	6.7	0.8	17.2	16.4	3.8	1.5	9.7	12.4	3.5	2.8	0.0	44.7	29.8	20.5	15.1	2.8	13.5	5.5	4.6	6.6	14.0	18.8	12.6	2.5	4.0	8.6	9.7	7.3	9.6	2.4	2.9	16.2	14.8	1.4	6.1	5.4	8.2	9.3	42.5	31.1	2.7	12.6	22.3	5.6	86.7	0.4	5.7	0.3	0.1	0.4	0.0	0.4	0.4	0.7	0.0	0.1	0.3	0.4	2.2	0.2	0.2	1.8	0.4	1.4	1.4	1.6	2.0	1.4	2.3	1.7	1.1	1.6	0.8	2.2	2.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.4	0.0	0.0	1.3	0.0	0.0	3.2	0.8	0.0	0.0	1.6	0.0	2.8	1.6	0.6	0.0	0.0	0.0	1.5	2.4	1.5	0.0	1.7	1.3	26.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.6	1.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.5	0.5	4.7	0.0	0.0
RHPN2		ENSG00000131941	"Rhophilin Rho GTPase binding protein 2"	Q8IUC4	19	32978592-33064888	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 61.0;Endometrial ciliated cells: 90.2;Gastric mucus-secreting cells: 94.8;Glandular and luminal cells: 108.8;Muller glia cells: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 52.4;OE19: 50.7;RPTEC TERT1: 52.9;SK-BR-3: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051749	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA051749: AB_2681589"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.32e-1)"	"unprognostic (5.07e-3)"	"unprognostic (3.01e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (1.22e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.40e-2)"	3.0	0.8	5.5	4.4	5.9	0.0	12.7	5.8	6.6	8.4	7.8	23.6	21.7	5.4	2.4	1.2	15.0	13.6	1.5	5.2	5.8	14.5	19.6	4.1	1.3	6.3	6.9	1.7	12.4	16.9	4.8	8.2	6.1	27.1	19.0	20.2	19.4	2.2	0.3	10.5	17.8	1.8	5.1	0.9	35.2	0.7	7.2	1.9	5.4	0.9	2.6	11.5	1.1	6.4	28.6	52.4	4.9	8.6	1.0	0.1	24.5	6.6	5.0	10.0	10.5	45.9	28.6	0.0	41.1	3.7	8.8	13.5	15.9	5.8	12.4	13.2	9.7	3.2	5.9	17.9	6.6	0.0	4.1	1.2	11.5	8.4	4.7	7.6	1.3	1.2	7.2	0.0	3.0	24.4	0.1	2.9	10.5	50.7	8.4	0.0	6.0	5.6	52.9	14.0	11.0	5.8	11.2	54.5	13.4	13.9	15.2	1.4	0.7	0.1	12.7	3.6	11.2	6.3	4.6	2.1	1.6	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.9	5.8	6.6	5.2	5.8	6.3	6.9	6.1	5.1	7.2	6.4	0.3	22.4	1.1	20.2	3.9	1.3	6.3	6.2	7.4	1.9	30.4	15.4	0.9	17.2	14.7	12.9	12.5	18.2	2.1	61.0	3.9	31.0	0.4	90.2	11.1	1.1	4.8	0.0	1.3	13.1	6.8	6.4	94.8	108.8	1.3	0.2	3.3	13.0	1.9	0.0	1.4	22.2	18.3	3.0	0.0	0.3	2.1	1.6	1.8	4.7	0.0	76.8	0.0	9.5	1.6	33.8	52.6	1.2	6.1	23.5	11.7	19.8	51.9	10.1	0.0	0.6	3.7	0.0	1.4	3.8	1.8	3.4	1.1	0.0	23.3	36.1
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062127-137070557	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.1;esophagus: 8.5;skin 1: 6.2"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 10.8;Oligodendrocyte precursor cells: 29.7;Undifferentiated cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 122.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	0.5	0.3	6.9	2.4	5.1	2.0	1.3	4.7	5.4	1.2	1.3	3.7	4.3	0.4	0.0	8.5	0.3	0.2	0.2	5.4	4.5	1.2	0.2	0.5	2.7	7.1	6.8	0.1	0.4	0.0	0.5	0.9	5.7	3.1	1.8	0.1	4.1	0.1	0.1	6.2	4.3	0.4	5.0	2.2	2.4	0.5	6.8	2.3	0.3	0.0	2.5	0.4	2.3	7.0	52.1	27.5	10.7	32.0	0.3	0.7	57.1	8.4	5.7	8.8	4.1	52.5	23.2	53.8	26.5	4.1	8.2	72.3	33.6	9.7	2.0	37.4	38.9	23.6	32.7	59.6	0.2	27.0	39.2	0.1	1.5	3.0	5.8	2.3	14.4	27.1	33.1	23.7	2.6	122.1	7.8	72.7	19.9	119.2	61.9	82.9	40.7	60.1	10.9	14.8	55.2	32.7	32.2	89.1	12.2	2.4	71.9	51.1	9.4	7.9	26.6	24.0	41.9	8.2	25.5	26.3	18.4	31.8	25.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	5.1	4.7	5.4	5.4	4.5	7.1	6.8	5.7	5.0	6.8	7.0	0.5	0.0	0.0	0.7	1.9	4.2	0.7	0.5	0.6	0.2	5.0	5.2	1.3	0.0	1.1	0.0	0.0	2.8	1.6	5.4	1.9	0.3	0.0	1.6	0.8	0.9	0.0	3.6	0.2	0.0	3.5	1.1	6.1	6.0	0.0	3.3	1.4	0.0	3.1	0.0	0.2	10.8	0.0	2.8	1.5	0.1	0.0	2.2	0.0	0.0	1.5	0.5	0.0	29.7	5.6	0.6	4.0	0.0	1.8	2.1	0.5	0.0	0.1	0.6	0.0	0.2	1.0	0.0	1.4	5.8	2.7	0.5	1.3	0.6	12.1	1.1
SCGB1D2	"LIPB, LPHB"	ENSG00000124935	"Secretoglobin family 1D member 2"	O95969	11	62242239-62244812	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"breast: 1227.2;cervix: 4002.8"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3242.1;Glandular and luminal cells: 3417.9"	"Group enriched"	"Detected in many"	6	"breast cancer: 625.1;endometrial cancer: 226.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 10.4"									HPA035318	Approved				"Secreted in other tissues"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"			"HPA035318: AB_10610421"	"unprognostic (8.76e-2)"	"unprognostic (2.14e-1)"		"prognostic favorable (3.46e-6)"	"unprognostic (2.39e-2)"				"unprognostic (5.89e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.43e-2)"	"prognostic favorable (8.03e-6)"		"unprognostic (1.55e-1)"	"unprognostic (1.15e-2)"		12.9	4.9	4.1	0.0	4.0	0.0	1227.2	3.2	5.4	4002.8	13.8	0.3	0.1	89.0	355.8	10.1	110.3	0.1	3.1	3.5	4.4	10.1	0.2	0.1	0.1	4.7	5.7	1.1	4.5	0.5	5.2	0.2	4.2	8.6	0.2	1.8	69.2	2.9	7.2	342.4	0.4	0.0	3.5	0.0	0.3	0.2	4.3	0.4	0.6	6.0	0.0	0.2	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.4	0.1	0.0	1.8	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.0	3.2	5.4	3.5	4.4	4.7	5.7	4.2	3.5	4.3	4.6	2.1	0.0	0.0	0.0	1.6	27.4	4.8	0.0	0.0	0.5	647.8	251.6	10.9	0.0	0.0	7.3	0.0	0.0	5.3	0.0	23.5	0.3	0.0	3242.1	409.9	12.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	3417.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	15.0	823.6	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	46.1	0.0	0.9	0.0	0.2	8.6	0.0	0.0	0.0	7.0	0.1	20.0	0.0	0.0	1.1
SHLD3	"AC008560.1, CTC-534A2.2, FLJ26957, RINN1"	ENSG00000253251	"Shieldin complex subunit 3"	Q6ZNX1	5	65625027-65630928	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 17.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.0;dendritic cells: 5.9;Distal tubular cells: 3.9;Pancreatic endocrine cells: 4.6;Proximal tubular cells: 5.3;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066071, HPA068764"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA066071: AB_2685609, HPA068764: AB_2686028"	"unprognostic (7.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.09e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.17e-4)"	2.3	2.7	2.4	2.7	2.5	17.5	4.2	2.8	3.6	1.8	1.8	2.8	2.8	2.3	3.1	1.5	1.9	2.4	1.8	2.3	2.1	2.9	2.6	2.5	4.8	2.4	2.1	1.5	3.4	2.1	2.5	2.5	2.3	4.3	3.0	3.7	2.0	2.5	1.8	2.9	2.7	1.7	2.4	2.5	2.4	3.2	2.4	3.9	2.4	1.9	3.6	2.5	1.3	3.2	2.6	3.6	5.0	10.8	2.9	3.5	6.3	3.8	3.5	5.8	7.0	5.9	8.0	4.9	4.2	4.6	6.5	3.1	5.1	4.7	8.5	6.7	6.5	4.3	10.3	8.3	2.5	5.0	7.5	2.1	6.8	6.0	6.1	1.6	3.7	7.7	6.4	11.5	4.7	6.9	6.7	7.7	4.0	1.5	2.2	4.4	4.9	7.9	4.9	6.0	6.7	5.5	3.2	3.3	11.0	3.4	3.8	4.6	3.0	5.0	6.8	4.1	6.6	7.2	14.3	10.7	3.7	6.1	4.7	15.9	3.0	6.4	3.8	2.9	4.0	3.9	4.5	4.0	2.8	3.1	6.1	5.6	3.3	4.9	3.1	3.2	6.2	2.1	2.4	2.5	2.8	3.6	2.3	2.1	2.4	2.1	2.3	2.4	2.4	3.2	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	3.6	0.0	0.0	0.0	0.0	0.0	4.0	5.9	0.0	3.9	3.1	0.0	1.9	1.8	0.8	0.0	0.0	0.0	2.9	3.8	0.9	0.0	2.1	0.0	2.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.1	1.8	2.1	0.0	0.0
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 22.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Excitatory neurons: 38.4;granulocytes: 17.8;Inhibitory neurons: 27.8;Intestinal goblet cells: 36.6;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.6;HHSteC: 33.6;OE19: 27.6;U-2197: 67.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031123	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.5	1.1	2.9	1.2	3.2	0.0	2.3	1.0	3.1	1.4	11.7	3.5	5.6	0.6	3.6	4.1	2.0	8.3	0.6	3.4	2.4	3.2	6.8	2.2	0.6	1.6	2.0	0.3	10.0	4.3	2.2	2.7	1.9	2.8	4.2	0.1	11.9	0.6	0.1	1.3	3.6	0.7	1.0	0.3	4.1	2.3	2.0	0.5	22.9	0.0	0.9	2.1	2.2	2.0	14.7	0.0	2.7	0.0	3.3	4.6	6.7	0.8	2.0	0.9	1.7	19.6	6.8	0.0	1.9	5.6	2.8	8.5	0.0	0.0	0.5	0.0	0.0	0.0	7.2	0.0	33.6	0.0	1.0	8.7	8.3	1.9	0.9	16.3	0.0	0.0	0.0	0.6	1.3	3.9	0.0	0.0	9.3	27.6	0.7	0.0	0.2	0.0	6.8	1.3	4.2	0.0	7.0	8.4	0.1	0.9	15.6	0.4	0.2	0.2	1.3	67.9	0.0	0.1	1.9	5.0	3.3	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.2	1.0	3.1	3.4	2.4	1.6	2.0	1.9	1.0	2.0	2.0	0.2	0.0	0.5	7.2	0.1	1.0	1.3	3.3	3.4	0.0	5.6	4.3	1.1	2.8	2.5	23.9	0.0	0.5	0.1	1.6	0.0	3.9	0.3	0.8	1.4	0.3	5.4	0.0	38.4	3.5	6.5	2.1	7.7	2.7	17.8	1.8	0.0	9.4	0.9	0.0	27.8	36.6	0.0	0.0	0.7	0.5	0.0	0.5	0.0	7.5	2.1	0.0	1.0	31.7	2.0	2.9	3.4	0.0	0.2	6.2	2.6	1.5	0.4	0.0	0.0	0.2	0.7	0.6	0.4	4.3	0.3	3.0	0.8	0.1	5.6	1.0
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 9.1"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 4.4;Melanocytes: 5.4;Oligodendrocytes: 4.0;Spermatogonia: 7.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;SiHa: 2.1;T-47d: 1.3;U-2 OS: 1.2;U-266/70: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075017	Approved		Approved	"Intermediate filaments,Focal adhesion sites"		No	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	0.5	0.3	1.1	0.0	3.3	0.2	0.6	0.2	6.0	0.7	0.0	0.3	0.1	0.4	0.0	0.3	0.9	0.1	0.6	0.8	1.1	0.4	0.2	0.3	0.0	4.0	1.4	0.3	0.4	0.0	1.6	0.0	3.6	1.7	0.0	0.1	1.2	0.0	0.5	0.7	0.2	0.0	0.3	0.3	0.4	0.8	2.8	0.0	0.7	0.0	0.0	0.4	0.7	9.1	0.3	0.0	0.1	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.4	0.1	2.1	0.0	0.2	0.1	1.3	0.0	0.0	0.0	1.2	0.0	0.0	4.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.3	0.2	6.0	0.8	1.1	4.0	1.4	3.6	0.3	2.8	9.1	0.6	0.0	0.0	0.7	0.0	1.3	0.5	0.6	0.6	0.1	0.6	0.8	0.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.3	0.1	0.9	0.2	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.4	0.0	1.7	0.7	0.1	1.0	0.0	0.4	0.2	0.0	0.8	1.4	2.5	4.4	0.7	5.4	0.0	0.0	1.4	0.0	0.5	4.0	0.3	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.7	0.0	1.5	2.4	2.1	7.7	0.5	0.9	0.0	0.3	0.6	0.1	0.7
SLC22A17	"BOCT, BOIT, NGALR"	ENSG00000092096	"Solute carrier family 22 member 17"	Q8WUG5	14	23346306-23352912	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 304.0;choroid plexus: 372.6;pituitary gland: 149.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 71.4;Horizontal cells: 201.9;Inhibitory neurons: 111.1;Muller glia cells: 74.2;Oligodendrocyte precursor cells: 120.6"	"Cancer enhanced"	"Detected in all"		"glioma: 51.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.7;AN3-CA: 31.4;ASC diff: 23.2;SH-SY5Y: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002728	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA002728: AB_1079998"	"unprognostic (9.34e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.87e-2)"	7.3	30.1	159.4	3.9	159.6	0.6	11.8	98.0	159.1	25.4	372.6	24.6	4.6	14.8	10.3	4.4	19.1	6.4	22.0	145.5	304.0	16.3	2.5	8.3	3.4	165.6	143.8	17.0	17.2	11.4	149.1	5.0	145.5	39.8	2.4	26.4	25.4	25.7	1.5	7.6	10.2	7.0	125.5	4.2	13.3	8.9	231.8	1.7	19.1	2.7	1.6	15.2	17.9	139.5	0.0	1.9	20.7	31.4	23.2	11.4	3.4	7.5	11.6	2.5	1.9	0.0	1.9	0.0	2.8	11.0	6.6	0.4	0.7	0.5	0.0	0.0	1.4	4.4	0.0	0.2	13.1	0.0	4.4	16.7	1.2	2.6	0.0	11.3	0.8	9.1	0.0	0.2	3.8	3.2	0.1	0.2	11.3	0.0	0.0	0.0	0.7	0.2	0.0	2.0	19.9	41.5	5.8	0.0	0.0	4.0	3.5	0.6	0.0	2.9	8.9	16.6	0.0	0.1	3.2	0.0	1.9	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	159.4	159.6	98.0	159.1	145.5	304.0	165.6	143.8	145.5	125.5	231.8	139.5	7.7	0.0	2.7	46.7	2.3	12.6	18.6	2.6	12.5	53.0	23.4	30.1	10.0	2.8	5.5	20.2	43.8	2.4	1.0	0.0	1.9	0.7	0.2	1.8	10.6	12.0	20.8	1.7	71.4	1.3	4.9	21.7	3.6	0.6	4.5	12.0	16.8	0.9	1.0	201.9	111.1	0.0	0.0	0.6	5.1	2.3	21.1	1.2	7.2	19.7	0.7	74.2	0.0	120.6	49.2	1.5	0.0	42.9	9.2	31.3	0.0	16.9	3.2	69.0	0.0	14.1	18.0	1.1	2.3	3.0	10.9	4.8	2.0	4.5	0.3	6.1
SLC25A16	"D10S105E, GDA, HGT.1, ML7"	ENSG00000122912	"Solute carrier family 25 member 16"	P16260	10	68477998-68527523	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036243, HPA044580"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA036243: AB_2675019, HPA044580: AB_10962723"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.44e-3)"	10.3	3.6	5.1	2.1	5.3	3.7	4.1	7.1	7.9	2.1	0.0	3.2	3.8	3.5	3.2	2.6	2.1	2.3	2.8	5.0	5.6	5.8	11.4	3.1	2.7	2.7	3.5	2.3	5.1	3.5	2.6	2.8	3.4	8.2	2.8	4.7	4.5	2.8	4.9	3.0	3.8	2.6	2.2	2.4	4.5	1.5	7.0	2.0	3.5	2.3	2.0	2.7	2.1	6.1	2.8	1.1	3.2	4.4	4.2	5.0	3.4	3.8	4.2	2.4	2.6	6.6	1.9	3.0	2.7	7.6	1.3	1.6	10.2	1.9	6.1	2.2	6.3	1.6	3.5	2.9	5.1	5.2	3.4	4.3	4.9	4.6	6.4	3.6	2.0	2.6	1.8	4.8	5.2	2.6	2.9	3.7	0.7	0.8	14.8	1.6	2.3	1.0	6.8	9.2	2.2	1.8	5.4	5.2	4.4	2.2	2.9	2.1	8.9	3.6	4.8	6.1	4.5	4.9	2.8	4.9	3.5	4.2	1.6	1.4	0.7	0.7	0.4	0.5	0.4	0.4	0.4	0.3	0.5	0.8	0.4	0.6	1.3	0.6	0.4	0.8	0.4	0.3	5.1	5.3	7.1	7.9	5.0	5.6	2.7	3.5	3.4	2.2	7.0	6.1	9.6	44.8	20.7	23.5	9.9	6.4	6.3	4.9	4.6	19.2	11.0	6.7	10.4	12.8	7.4	12.9	39.6	19.0	12.4	12.9	11.7	8.1	9.9	9.6	9.3	7.8	15.0	9.9	44.0	19.2	32.3	8.8	20.9	14.1	8.2	6.1	13.9	37.7	10.6	20.2	53.7	9.4	8.2	10.3	6.5	13.0	3.1	7.9	1.8	13.1	8.2	9.5	15.5	29.7	48.0	14.4	7.8	7.9	16.4	13.5	17.7	21.4	9.9	31.2	0.0	13.4	11.3	4.5	2.5	10.5	6.8	59.8	9.4	9.4	9.0	10.6
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563450-17590995	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 143.8;choroid plexus: 90.7;liver: 111.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 195.2;Hepatocytes: 72.8"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.8;BEWO: 8.5"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	14.4	1.0	130.1	0.3	132.1	0.1	7.2	116.5	141.1	2.5	90.7	2.9	0.3	2.9	0.2	0.3	3.8	0.9	2.8	119.4	123.3	1.9	111.5	1.2	0.3	121.7	129.2	1.2	1.1	0.2	1.5	0.1	112.5	7.8	0.1	1.9	0.5	0.4	6.2	1.2	1.9	0.5	106.5	4.8	1.5	4.2	143.8	0.3	0.6	4.0	0.1	0.8	1.4	110.7	0.3	0.6	2.2	0.4	3.8	0.0	8.5	0.3	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	2.5	0.7	0.0	0.0	0.0	0.3	1.0	0.3	0.3	0.5	1.5	0.3	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.3	0.0	0.4	0.1	0.5	2.0	0.9	1.4	2.9	0.8	0.0	0.1	0.4	0.8	0.3	0.2	0.4	0.7	1.6	2.5	1.0	0.1	0.1	0.3	0.2	0.3	0.9	1.2	0.0	1.8	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.1	132.1	116.5	141.1	119.4	123.3	121.7	129.2	112.5	106.5	143.8	110.7	1.0	28.9	10.3	195.2	0.3	0.0	0.3	0.1	0.6	0.6	0.3	0.0	1.5	5.7	7.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.6	0.4	0.9	1.7	0.0	10.7	2.0	0.0	0.3	4.7	0.0	0.7	6.3	8.5	3.6	72.8	0.3	0.0	3.0	0.3	0.0	4.1	0.3	0.6	0.9	3.9	0.0	10.3	0.1	2.2	1.0	13.0	11.5	0.0	0.0	2.6	0.1	4.3	0.1	0.8	15.8	3.4	0.0	2.7	2.5	4.8	5.9	0.0	0.1	1.8	2.6	2.6	0.0	0.2
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446207	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Astrocytes: 5.5;Excitatory neurons: 4.1;Gastric mucus-secreting cells: 7.1;Hepatic stellate cells: 5.3;Inhibitory neurons: 3.5;Microglial cells: 6.5;Oligodendrocytes: 4.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"basal ganglia: 10.4"							NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	0.1	0.1	0.3	0.0	0.3	0.0	0.7	2.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.4	0.1	0.4	0.5	0.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.6	0.2	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.2	0.1	0.4	0.4	0.5	0.3	0.4	0.3	0.5	0.3	6.4	2.6	5.5	0.2	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.2	0.5	0.0	0.0	4.1	0.0	0.0	2.2	7.1	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.5	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.0	6.5	0.0	0.3	0.0	2.0	4.2	0.3	0.0	0.0	0.0	0.8	0.0	0.0	2.2	1.2	0.0	0.2	0.1	0.3	0.5	0.0	0.3	0.0	0.6	0.0	0.0	0.6
SLC31A1	"COPT1, CTR1, hCTR1"	ENSG00000136868	"Solute carrier family 31 member 1"	O15431	9	113221544-113264492	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 107.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 20.9;intermediate monocyte: 26.8;myeloid DC: 16.3;neutrophil: 8.2;non-classical monocyte: 31.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 16.3;granulocytes: 8.2;monocytes: 31.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013810	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA013810: AB_1857095"	"unprognostic (1.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.29e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (1.22e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.51e-2)"	11.5	23.9	5.7	11.1	5.8	11.7	12.7	6.6	6.5	20.7	26.3	16.3	45.1	7.2	13.7	12.0	6.5	9.6	7.4	6.9	6.6	28.7	107.6	17.7	6.3	7.2	6.9	4.9	19.1	15.2	5.8	13.5	11.7	21.3	17.0	7.1	66.5	12.8	3.5	18.5	37.4	10.0	6.8	7.6	19.4	6.4	7.0	5.5	10.9	5.8	12.4	14.3	6.5	6.5	22.1	23.4	18.7	41.4	42.0	29.8	68.8	38.3	58.0	26.0	30.1	33.5	18.8	17.2	15.2	33.0	32.9	53.3	35.8	21.8	29.0	15.2	19.9	14.2	18.7	37.6	102.3	26.1	20.6	36.1	48.3	33.6	54.6	17.4	24.0	19.6	32.8	30.9	24.8	23.6	17.9	13.2	30.4	84.2	26.0	18.3	49.1	17.2	23.6	27.2	17.7	23.1	37.0	73.0	101.5	26.2	37.2	22.0	22.3	19.3	11.9	39.1	23.2	18.5	40.5	23.6	31.9	24.2	23.1	3.0	20.9	2.5	2.3	26.8	3.2	1.7	1.6	2.4	16.3	1.5	1.8	1.7	8.2	4.4	31.0	2.3	1.8	7.6	5.7	5.8	6.6	6.5	6.9	6.6	7.2	6.9	11.7	6.8	7.0	6.5	8.0	35.3	33.5	7.5	6.6	15.2	10.6	27.4	10.2	12.6	21.4	14.9	7.4	21.5	50.8	5.5	33.3	16.5	6.9	40.2	9.8	18.3	0.3	16.2	15.6	11.6	9.0	25.4	16.8	27.2	24.1	16.0	15.3	14.5	5.1	11.4	11.4	97.1	43.4	6.7	17.0	18.9	42.7	39.4	19.9	0.9	6.2	40.3	12.4	20.6	21.8	12.2	4.1	16.1	12.3	22.3	11.1	7.2	16.1	28.9	61.7	24.7	30.1	11.2	6.6	8.4	15.2	24.4	30.7	15.1	15.8	22.4	5.5	15.2	19.9	22.6
SLC35E1	FLJ14251	ENSG00000127526	"Solute carrier family 35 member E1"	Q96K37	19	16549831-16572415	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016570, HPA062214"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA016570: AB_2190214, HPA062214: AB_2684713"	"unprognostic (1.76e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.75e-2)"	10.7	9.8	5.9	5.6	4.8	8.0	9.6	3.7	6.6	9.6	6.3	9.2	6.6	8.5	5.9	11.5	7.4	6.1	10.1	5.6	4.7	7.8	11.4	9.1	7.1	4.8	5.9	8.8	22.3	15.2	11.2	7.2	5.0	11.7	6.1	7.4	15.4	10.0	20.5	11.9	7.7	6.8	3.6	6.7	15.3	4.1	9.1	8.5	9.2	14.0	8.1	10.1	8.7	4.5	26.2	10.4	6.9	16.2	25.2	19.8	16.4	17.8	20.3	15.1	18.2	11.8	18.7	13.6	30.2	29.3	14.9	17.6	19.7	21.5	15.2	15.8	29.5	11.9	11.6	14.4	21.1	19.6	14.5	16.5	24.2	17.0	24.5	19.2	14.8	16.0	19.9	17.3	19.4	25.3	15.3	9.3	8.1	24.8	34.6	14.9	10.6	16.6	15.7	16.1	11.9	11.9	12.3	19.6	11.5	8.3	14.7	9.9	15.3	19.5	9.6	26.9	21.2	23.6	26.9	15.1	29.3	21.4	12.6	1.8	1.3	3.2	1.3	0.9	1.8	2.2	1.4	1.3	1.0	0.8	1.0	0.8	1.3	1.8	2.0	1.1	1.8	1.1	5.9	4.8	3.7	6.6	5.6	4.7	4.8	5.9	5.0	3.6	9.1	4.5	21.7	38.5	42.5	6.8	14.9	21.9	15.3	22.1	5.7	28.8	34.1	21.5	16.1	22.8	31.3	29.5	35.5	14.4	43.3	25.2	0.0	20.4	3.6	26.6	20.1	20.2	18.5	13.7	13.9	36.8	29.8	14.8	13.3	50.8	8.2	21.2	22.9	26.9	17.4	30.3	13.9	29.7	8.2	21.1	28.0	4.2	17.1	23.3	8.8	10.3	22.8	19.4	17.5	9.0	6.2	41.7	13.1	21.1	29.3	30.9	22.1	7.0	24.0	29.4	6.6	30.1	14.3	10.2	14.3	13.6	25.9	32.6	29.4	16.2	20.4	28.4
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480525	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"epididymis: 1580.8;intestine: 753.9;kidney: 844.8"	"Group enriched"	"Detected in many"	12	"Proximal enterocytes: 4096.4;Proximal tubular cells: 1884.8"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.7;pancreatic cancer: 37.4;renal cancer: 78.4;stomach cancer: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 154.9;HEL: 74.0;Hep G2: 117.7;MOLT-4: 113.8;OE19: 185.0;REH: 61.5;U-937: 87.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.0	4.2	2.7	5.0	91.3	0.8	4.1	6.8	0.6	5.5	30.4	753.9	0.7	1580.8	0.4	2.8	82.0	0.1	4.7	4.3	844.8	35.8	0.4	1.6	4.3	4.6	0.3	8.0	0.2	3.5	0.1	4.3	1.0	24.5	91.6	0.3	2.3	0.3	1.2	628.2	0.8	4.0	1.2	150.1	2.9	4.6	50.4	0.2	0.1	2.0	0.2	0.2	4.4	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.3	0.0	154.9	0.5	0.2	7.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	74.0	1.0	117.7	0.0	6.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	1.5	0.1	0.1	0.0	113.8	15.8	0.0	185.0	0.3	61.5	0.1	4.3	1.6	0.1	1.4	2.3	0.1	0.1	1.6	0.4	0.0	1.9	0.0	0.0	0.4	1.2	0.1	0.0	0.0	6.5	0.0	87.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.3	0.4	1.0	0.0	5.9	0.0	1.5	1.6	0.8	4.2	5.0	4.1	6.8	4.7	4.3	4.3	4.6	4.3	4.0	4.6	4.4	0.1	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	14.1	0.1	0.8	0.2	188.8	0.0	58.8	27.1	0.0	0.5	35.1	238.7	4.0	5.1	7.7	0.8	0.3	139.0	22.3	0.7	12.4	0.2	0.3	205.4	13.0	1.3	0.2	0.4	36.3	0.1	0.0	0.1	136.6	0.0	0.6	0.0	15.0	0.3	11.6	0.0	0.0	0.7	4.1	0.0	0.0	0.2	12.4	178.9	0.0	1.7	0.3	4096.4	1884.8	0.0	34.9	0.0	0.2	0.3	0.6	0.7	0.0	0.0	0.0	7.4	0.0	141.3	0.2
SS18L2	KIAA-iso	ENSG00000008324	"SS18 like 2"	Q9UHA2	3	42581840-42596934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047377	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA047377: AB_2680020"	"unprognostic (4.09e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.64e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (6.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.24e-3)"	21.0	17.1	27.6	18.5	28.6	33.9	21.9	28.8	37.1	19.8	26.7	17.5	19.0	12.6	17.8	21.2	15.7	10.4	18.7	28.2	28.4	24.5	32.4	19.6	35.4	28.2	27.8	19.1	21.6	13.5	25.1	9.9	28.3	35.9	13.6	13.7	19.1	8.6	16.2	24.9	25.6	7.4	28.4	31.6	22.7	10.1	27.8	23.6	20.4	11.0	30.2	19.4	18.5	31.5	32.3	14.0	29.0	26.4	34.9	27.8	17.3	20.6	22.4	28.7	32.2	27.1	29.1	43.3	18.2	13.6	31.6	17.9	33.9	28.0	30.9	21.7	40.5	46.9	28.9	45.3	25.4	62.5	36.2	22.1	17.7	23.7	21.9	20.6	31.4	39.1	43.2	65.4	23.1	29.3	44.8	76.4	45.9	42.7	34.2	23.6	20.6	61.2	32.3	38.2	16.2	23.0	17.6	27.2	29.8	30.2	35.8	57.4	19.5	18.0	29.0	42.8	38.0	46.5	76.3	73.5	26.3	66.1	17.0	60.4	56.4	84.9	88.4	66.0	121.0	120.3	116.3	106.2	62.1	104.3	99.5	101.1	75.8	83.0	50.9	74.5	139.2	90.4	27.6	28.6	28.8	37.1	28.2	28.4	28.2	27.8	28.3	28.4	27.8	31.5	39.3	12.8	16.7	5.5	96.3	107.1	70.1	101.5	91.0	16.2	78.6	77.8	19.3	42.9	46.1	27.6	8.4	57.1	102.9	39.2	56.7	43.4	4.3	47.0	37.9	37.0	55.1	67.3	13.6	49.2	75.8	39.0	39.8	71.9	45.7	39.6	32.5	61.0	66.8	23.5	11.2	51.1	79.3	38.6	51.2	3.7	34.5	43.0	51.6	6.5	69.3	38.1	88.6	3.0	25.8	50.6	58.9	15.8	72.4	75.6	121.4	85.2	28.2	26.8	13.1	26.4	32.5	19.4	24.7	84.5	138.1	37.4	103.2	34.5	53.7	99.2
STARD10	"CGI-52, NY-CO-28, PCTP2, SDCCAG28"	ENSG00000214530	"StAR related lipid transfer domain containing 10"	Q9Y365	11	72754729-72794047	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 709.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 520.2;Hepatocytes: 660.0;Intestinal goblet cells: 717.9;Late spermatids: 2055.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 21.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 617.7;OE19: 1316.9;SK-BR-3: 427.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026661	Uncertain		Supported	Cytosol		NA	NA		13000	"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA026661: AB_1857538"	"prognostic favorable (6.92e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.24e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.04e-1)"	11.8	178.2	35.1	17.7	37.6	10.3	62.1	39.2	41.8	71.9	40.9	180.6	48.5	27.3	102.9	52.0	26.4	59.5	72.5	33.9	34.1	50.1	709.7	37.7	14.5	38.0	33.0	31.0	212.6	73.2	36.2	40.2	38.2	86.2	188.1	18.7	94.5	30.9	66.7	62.6	66.0	26.7	29.9	20.2	266.9	184.3	34.4	15.6	47.9	157.9	21.8	24.5	41.1	35.7	51.2	15.3	7.7	28.7	9.8	9.6	98.3	5.6	26.2	17.3	17.3	209.8	36.7	4.4	16.7	19.2	42.3	31.8	23.4	46.8	20.2	28.3	9.0	5.9	11.1	217.6	35.2	1.6	10.0	6.6	127.0	19.1	26.7	47.2	17.8	10.0	12.1	21.5	3.9	617.7	4.8	11.1	3.4	1316.9	20.1	4.5	13.3	3.4	23.5	61.4	13.0	10.1	8.6	427.4	73.3	32.8	235.5	6.3	13.6	17.0	11.4	6.0	10.1	22.2	19.8	7.5	4.3	5.6	6.5	12.9	2.6	16.0	1.6	1.1	1.2	4.2	1.5	1.7	1.2	2.4	1.6	1.6	21.7	7.5	0.6	2.6	2.1	1.1	35.1	37.6	39.2	41.8	33.9	34.1	38.0	33.0	38.2	29.9	34.4	35.7	10.6	35.3	74.1	8.1	18.1	31.5	76.3	41.0	25.0	10.5	163.3	125.3	45.3	270.2	76.4	55.2	22.9	212.8	17.1	362.8	123.3	70.7	520.2	26.5	6.8	18.5	302.2	22.9	11.6	94.3	93.1	21.1	372.1	25.3	25.4	10.1	30.0	660.0	26.4	33.7	13.9	717.9	85.5	26.0	34.4	2055.8	26.1	12.3	16.0	5.6	7.7	64.4	7.2	8.0	11.8	93.9	398.9	25.2	13.3	150.9	73.5	58.0	34.5	16.6	6.6	11.3	19.6	101.2	22.7	30.2	55.0	352.2	15.6	7.7	440.7	132.7
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618923-10674318	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.1;stomach 1: 17.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Excitatory neurons: 20.6;Gastric mucus-secreting cells: 15.3;Paneth cells: 12.6;Proximal enterocytes: 10.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.2"	"Immune cell enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.7;HDLM-2: 17.5;HMC-1: 18.3;HUVEC TERT2: 25.5;TIME: 23.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	Nucleoplasm	"HPA040468: AB_2676998, HPA048569: AB_2680446"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.4	0.3	1.2	1.8	3.0	1.1	3.9	0.0	5.2	1.9	0.0	15.9	2.4	0.5	1.2	7.3	2.2	3.5	0.1	3.6	0.0	0.6	0.3	1.3	1.4	0.0	0.0	0.3	0.3	0.0	2.4	0.7	0.0	11.6	17.1	0.9	6.7	0.9	0.1	2.8	11.2	0.6	0.0	0.9	17.5	0.2	0.0	0.2	0.4	0.0	2.5	5.1	3.3	0.3	4.8	0.2	0.0	0.6	0.0	0.0	1.3	7.3	0.7	3.5	3.4	2.6	28.7	0.3	4.7	1.8	4.5	1.4	1.6	8.0	7.4	17.5	0.4	1.0	2.4	0.2	0.0	2.2	18.3	0.4	0.4	5.1	0.3	0.5	25.5	0.2	0.3	0.3	8.1	3.1	0.2	1.3	4.2	11.8	2.0	0.1	2.0	0.3	2.5	14.6	0.9	0.1	4.5	4.9	0.0	6.7	3.5	0.6	23.8	1.0	3.8	0.5	0.8	0.0	1.0	0.2	3.5	0.2	5.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.1	12.5	0.0	0.0	0.0	0.3	1.2	3.0	0.0	5.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	2.2	0.0	0.0	0.3	0.8	3.1	1.2	0.6	3.3	2.0	0.7	1.5	3.3	0.0	0.0	0.1	1.8	19.6	0.0	0.5	0.2	7.3	0.5	0.4	4.2	0.8	20.6	0.2	0.6	0.2	15.3	4.5	1.3	6.3	0.0	0.0	0.0	0.0	1.6	8.9	2.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	6.2	0.0	0.5	5.9	12.6	0.0	0.9	4.7	10.6	0.0	8.8	0.4	0.0	1.2	0.2	0.2	0.8	3.1	1.0	0.3	1.9	0.0	6.9	5.5
SYNE4	"C19orf46, DFNB76, FLJ36445, Nesp4, Nesprin-4"	ENSG00000181392	"Spectrin repeat containing nuclear envelope family member 4"	Q8N205	19	36003307-36008813	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 32.0;Breast myoepithelial cells: 35.9;Cytotrophoblasts: 32.6;Syncytiotrophoblasts: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 32.5;Hep G2: 29.1;MCF7: 34.2;SK-BR-3: 40.1;T-47d: 31.0"	"Region enriched"	"Detected in single"	15	"cerebellum: 6.8"	"Not detected"	"Not detected"			HPA060253	Uncertain					NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"			"HPA060253: AB_2684233"	"unprognostic (8.54e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.36e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (8.64e-9)"	"unprognostic (1.25e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.97e-2)"	0.2	0.2	1.2	0.2	1.0	0.2	5.2	6.7	1.5	2.6	2.5	1.9	3.2	0.7	7.7	1.2	3.9	1.6	0.2	0.7	2.9	8.4	12.0	3.1	0.2	3.7	3.0	0.3	5.4	12.1	12.7	1.6	3.6	10.9	1.4	0.2	9.2	4.0	0.3	1.1	1.3	0.2	1.3	0.3	3.4	0.2	2.5	1.7	8.6	0.0	0.3	0.8	1.3	1.2	0.3	0.3	0.2	0.4	0.1	0.2	4.3	0.0	0.0	0.0	0.1	32.5	3.8	0.3	0.4	0.0	0.2	0.0	0.3	0.4	0.0	1.1	0.5	0.1	0.8	29.1	0.5	0.0	0.2	0.2	0.2	1.1	0.0	0.0	0.2	1.6	0.4	0.4	0.0	34.2	0.5	0.1	0.2	0.3	0.2	0.9	0.0	0.4	2.2	1.0	5.0	0.0	0.0	40.1	0.2	0.2	31.0	0.3	0.0	0.3	0.6	0.5	0.2	0.5	0.7	0.6	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	6.7	1.5	0.7	2.9	3.7	3.0	3.6	1.3	2.5	1.2	0.3	6.4	17.5	0.3	0.7	0.5	14.9	19.9	5.2	0.9	32.0	35.9	0.4	24.3	20.2	29.5	4.2	32.6	0.8	5.4	25.4	21.2	0.0	9.1	1.0	0.8	29.8	0.0	0.6	8.6	24.7	0.7	8.2	10.7	1.3	0.5	0.7	12.5	2.6	0.0	0.9	10.6	26.4	0.6	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.9	11.7	16.9	0.0	0.0	23.9	4.5	24.2	17.3	0.4	0.0	0.3	1.6	0.1	0.4	2.1	0.4	33.9	1.2	0.1	8.8	9.2
SYT13	KIAA1427	ENSG00000019505	"Synaptotagmin 13"	Q7L8C5	11	45240302-45286341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.1;gallbladder: 20.8;pituitary gland: 16.8"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 336.8"	"Group enriched"	"Detected in many"	5	"breast cancer: 13.5;colorectal cancer: 7.4;pancreatic cancer: 19.9;renal cancer: 16.9;stomach cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.1;NTERA-2: 8.8;RPTEC TERT1: 56.8;SCLC-21H: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046224, HPA056602"	Uncertain		Supported	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA046224: AB_10961288, HPA056602: AB_2683185"	"unprognostic (4.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (1.00e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.70e-2)"	"unprognostic (5.13e-2)"	0.1	4.7	7.0	1.5	12.7	0.0	0.2	1.7	30.1	0.0	0.0	12.2	12.5	0.2	0.0	0.0	0.2	20.8	5.2	18.0	11.5	8.9	0.3	0.5	0.0	5.7	1.2	0.0	7.1	0.4	16.8	0.0	5.4	1.8	12.6	11.3	1.9	0.0	0.1	0.2	12.8	0.8	0.0	0.1	11.0	1.7	9.0	0.3	1.6	0.1	0.0	0.0	0.0	5.2	0.0	19.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	1.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	8.8	0.0	0.2	0.0	0.0	0.0	56.8	0.0	15.0	0.7	0.0	0.0	0.1	0.7	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	12.7	1.7	30.1	18.0	11.5	5.7	1.2	5.4	0.0	9.0	5.2	0.0	0.0	0.0	4.6	0.1	0.0	0.2	0.0	0.0	3.3	0.1	0.3	15.3	17.2	0.0	3.7	25.0	0.0	0.0	10.2	5.9	1.2	3.1	0.4	0.2	0.1	336.8	0.0	41.6	0.6	0.0	1.7	3.6	2.0	0.0	2.5	0.0	0.0	0.0	1.7	43.8	37.3	4.1	0.0	0.0	9.7	0.3	0.0	0.0	5.6	0.0	0.7	0.0	1.5	3.5	8.2	14.3	0.0	0.0	2.3	13.9	0.5	0.0	2.7	0.0	0.0	0.2	2.0	0.2	0.0	0.0	0.0	0.0	0.0	32.8	0.2
TDRD5	"FLJ34823, TUDOR3"	ENSG00000162782	"Tudor domain containing 5"	Q8NAT2	1	179591613-179691272	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 6.5;testis: 21.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 36.1;Late spermatids: 12.1;Spermatocytes: 26.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 3.7;SK-BR-3: 5.8;T-47d: 10.3;U-266/70: 14.3;U-266/84: 13.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA029418	Enhanced					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA029418: AB_10603035"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.15e-4)"	"unprognostic (3.96e-1)"	"unprognostic (4.39e-3)"	"unprognostic (4.41e-4)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.31e-1)"	0.2	0.3	0.8	0.1	1.4	0.3	3.6	0.0	0.8	0.1	0.0	0.6	0.5	0.0	6.5	0.5	0.9	0.2	0.0	0.7	0.4	1.8	0.0	0.1	0.0	0.9	0.9	0.0	0.2	0.3	2.3	0.2	1.0	0.6	0.7	0.3	0.8	0.3	0.0	0.3	0.4	0.0	0.6	0.0	0.3	21.9	1.1	0.1	0.8	0.0	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.8	0.0	0.7	10.3	0.2	0.0	0.0	1.5	0.0	0.0	14.3	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.0	0.8	0.7	0.4	0.9	0.9	1.0	0.6	1.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	3.5	1.8	0.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.1	36.1	1.0	0.0	0.1	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.9	0.0	0.0	0.0	12.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	5.7	0.0	0.3	0.0	0.0	0.0	0.3	0.1
TECPR1	"DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358"	ENSG00000205356	"Tectonin beta-propeller repeat containing 1"	Q7Z6L1	7	98214624-98252232	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"pancreas: 84.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3;Rod photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021061	Approved		Supported	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles		"HPA021061: AB_1847687"	"unprognostic (8.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.12e-2)"	8.4	7.0	11.7	10.4	12.3	6.1	8.0	6.5	12.5	6.4	4.7	8.5	9.2	6.8	3.0	9.8	6.9	5.7	9.9	12.7	12.9	7.7	9.2	13.3	11.8	11.8	11.2	5.7	84.9	3.1	16.7	8.6	12.7	11.6	5.0	10.2	18.9	3.8	9.1	5.9	10.8	4.7	8.5	18.6	18.3	4.6	11.5	9.5	9.6	5.0	6.7	6.8	6.6	8.2	4.4	6.1	8.4	18.3	7.2	4.3	6.2	9.1	5.0	7.1	8.7	5.8	5.4	3.6	14.4	10.6	8.8	2.8	5.7	4.2	3.0	8.8	8.0	5.3	9.4	5.3	8.5	6.5	9.9	7.5	3.4	6.9	5.3	6.6	25.2	15.1	3.6	15.0	5.4	7.2	9.4	6.8	3.3	8.6	5.9	7.8	8.5	17.7	5.4	4.8	15.0	16.9	5.4	14.9	8.5	6.1	4.8	9.2	26.0	6.7	11.5	17.4	7.6	17.6	9.8	1.9	14.0	5.6	12.5	2.5	2.9	0.9	2.2	3.2	1.3	1.8	2.9	1.7	1.8	1.6	4.8	4.2	3.5	1.0	4.9	2.4	3.0	2.3	11.7	12.3	6.5	12.5	12.7	12.9	11.8	11.2	12.7	8.5	11.5	8.2	32.2	9.6	18.4	18.3	12.3	2.3	2.2	3.7	1.8	37.1	7.0	5.8	11.2	7.2	7.0	5.5	106.3	6.0	10.9	16.0	1.9	6.4	2.1	6.9	5.5	22.9	29.3	2.1	21.1	13.4	9.8	7.2	35.7	8.1	8.2	11.0	21.0	8.5	13.7	32.0	17.8	22.9	10.2	20.5	4.0	2.2	7.2	14.2	1.8	16.9	19.5	11.4	14.4	10.1	10.1	11.9	10.3	3.4	17.4	4.1	10.8	3.6	7.7	66.7	0.0	7.5	7.4	5.5	4.5	7.1	1.8	3.4	16.0	9.0	10.0	2.9
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.3;Spermatocytes: 56.4;Spermatogonia: 16.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;Karpas-707: 7.9;MCF7: 3.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Vesicles, Plasma membrane"	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.5	0.1	0.6	1.7	0.2	1.1	0.6	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.5	0.4	0.2	0.2	0.1	0.5	0.5	0.3	0.1	0.0	0.2	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.1	27.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.2	0.0	0.1	6.3	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	7.9	0.0	3.3	0.3	0.0	0.4	0.1	0.1	0.3	0.2	1.2	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.1	0.6	0.4	0.5	0.5	0.5	0.5	0.5	0.5	0.8	4.4	0.0	0.0	2.9	5.7	0.9	1.8	0.7	2.8	0.6	4.7	7.2	1.3	5.7	1.5	1.8	0.0	1.6	0.7	0.1	0.0	0.0	23.3	0.4	0.2	1.5	0.0	0.0	2.2	0.0	1.0	0.7	0.5	1.8	1.3	0.2	1.4	0.8	3.7	0.0	2.2	0.5	2.0	0.6	2.3	6.4	0.3	4.6	3.6	2.8	0.0	0.6	1.0	1.0	3.0	0.1	0.0	0.4	4.3	0.7	0.0	0.1	0.2	1.3	0.0	1.2	1.5	56.4	16.2	1.7	0.1	1.1	0.7	0.0	0.0	0.4
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269983-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 75.7;pancreas: 89.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 121.8;Alveolar cells type 2: 136.9;Distal enterocytes: 72.7;Proximal enterocytes: 164.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.8;BEWO: 21.8;CACO-2: 20.6;CAPAN-2: 48.3;OE19: 31.3;SK-BR-3: 41.2;T-47d: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015796			Approved	Midbody,Cytosol		Yes	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favorable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.3	0.7	17.4	3.2	32.2	0.2	11.5	27.6	29.9	16.4	12.8	21.2	35.4	1.6	18.3	10.9	15.5	11.3	0.9	17.0	20.7	16.4	1.1	75.7	0.3	31.5	28.5	1.4	89.6	22.2	31.0	4.4	29.0	22.0	21.0	0.1	31.8	7.1	0.0	12.9	27.5	0.8	22.6	0.3	27.4	1.5	26.8	0.4	44.9	0.0	2.5	2.9	3.4	42.8	26.8	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	20.6	48.3	0.1	1.2	0.0	0.0	11.7	0.0	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	12.1	0.1	0.1	1.1	31.3	0.0	0.0	0.0	0.7	0.4	8.5	12.4	0.1	0.0	41.2	0.0	3.6	33.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	17.4	32.2	27.6	29.9	17.0	20.7	31.5	28.5	29.0	22.6	26.8	42.8	0.2	121.8	136.9	0.0	0.9	0.0	2.3	18.0	0.6	0.0	30.4	15.2	0.5	42.9	56.0	16.5	0.0	33.5	0.1	72.7	17.6	39.1	3.7	20.1	1.4	0.6	21.7	0.0	0.2	38.5	2.2	0.6	45.3	13.1	1.3	4.9	0.0	0.0	2.4	0.0	0.2	63.0	34.6	0.0	0.2	7.9	0.3	0.6	0.0	0.0	0.6	1.7	1.0	0.0	55.3	22.7	40.1	1.2	0.6	12.2	164.2	33.9	43.8	0.0	0.0	0.0	2.3	1.4	0.3	2.1	0.4	7.3	1.0	0.1	38.6	9.1
TMEM178B	DKFZp547G036	ENSG00000261115	"Transmembrane protein 178B"	H3BS89	7	141074064-141480380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.3;parathyroid gland: 11.9;tongue: 12.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 175.0;Excitatory neurons: 584.8;Inhibitory neurons: 566.2;Oligodendrocyte precursor cells: 306.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.0;HDLM-2: 5.7;NTERA-2: 5.1;RPTEC TERT1: 8.2;SCLC-21H: 6.4;WM-115: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048771	Uncertain		Approved	Nucleoli,Vesicles		NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoli	"HPA048771: AB_2680517"	"unprognostic (7.33e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.79e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.10e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.35e-3)"	"unprognostic (8.98e-2)"	0.3	1.4	3.7	0.6	5.4	0.0	0.5	0.2	7.4	0.3	0.0	0.8	0.0	0.8	0.4	0.7	0.3	0.3	11.3	7.0	5.0	1.3	0.0	0.3	1.4	1.5	5.9	0.1	0.9	11.9	4.2	0.0	5.6	2.3	0.3	5.5	1.2	0.5	4.6	0.2	0.4	1.0	0.6	0.7	0.3	0.5	5.2	1.4	8.5	12.2	3.1	0.5	0.2	1.9	0.0	0.1	0.0	0.0	0.5	0.2	1.5	0.1	2.3	0.7	0.8	0.0	0.0	1.9	2.0	0.1	0.5	0.0	6.0	0.0	1.9	5.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	5.1	0.0	0.0	0.4	0.9	2.6	8.2	2.4	6.4	3.9	0.1	0.2	0.9	1.2	0.8	0.0	0.0	0.1	0.9	2.7	0.0	0.0	0.0	0.0	0.4	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.4	0.2	7.4	7.0	5.0	1.5	5.9	5.6	0.6	5.2	1.9	1.3	0.0	0.0	175.0	0.0	0.5	0.7	0.9	0.6	25.5	1.4	0.5	48.7	0.0	1.3	1.8	2.1	0.0	0.0	0.0	1.9	0.1	1.3	0.2	0.1	1.2	0.0	0.0	584.8	0.4	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.1	30.3	566.2	0.0	2.0	0.0	0.0	1.6	0.0	0.1	1.8	24.4	0.0	4.2	0.0	306.1	81.3	0.8	0.0	0.7	0.0	2.2	0.0	3.4	0.2	1.8	0.0	3.9	0.8	1.4	0.7	2.9	0.1	0.3	0.3	0.2	0.1	2.0
TMEM192	FLJ38482	ENSG00000170088	"Transmembrane protein 192"	Q8IY95	4	165070608-165208549	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014717, HPA024110"	Enhanced		Supported	Nucleoplasm,Endosomes,Lysosomes		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"	Nucleoplasm	"HPA014717: AB_1844373, HPA024110: AB_2204898"	"prognostic unfavorable (9.52e-4)"	"unprognostic (5.38e-3)"	"unprognostic (9.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.33e-14)"	"unprognostic (2.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.30e-2)"	12.0	15.2	4.9	7.2	5.9	6.6	13.2	7.5	7.0	9.9	7.1	11.5	9.7	10.5	9.0	8.8	11.2	10.3	12.6	4.8	5.2	48.3	45.2	10.6	8.9	4.7	5.5	24.5	22.3	24.6	5.1	10.8	5.0	22.1	13.3	10.7	14.5	8.4	15.0	5.4	9.3	8.6	4.6	9.1	10.5	9.8	4.8	6.6	26.8	17.0	7.7	8.5	5.4	6.2	13.5	19.9	7.1	18.0	18.1	6.4	16.5	20.1	29.4	20.5	22.8	11.7	21.6	29.5	11.7	13.0	33.4	11.8	26.8	20.6	23.6	19.2	13.8	16.4	14.1	13.4	46.1	41.0	21.2	23.3	42.8	18.4	37.4	17.8	17.0	15.6	28.4	48.1	25.4	29.4	7.1	12.0	14.8	28.1	16.9	16.0	6.2	27.1	16.4	19.6	15.2	15.9	31.4	49.1	31.9	10.4	23.9	18.5	12.6	9.0	11.1	28.6	23.0	46.9	67.0	40.8	21.6	22.2	36.6	2.9	16.6	4.8	12.1	14.9	16.3	26.7	9.4	12.6	15.7	20.2	10.4	12.6	1.7	18.7	8.3	16.3	8.5	10.7	4.9	5.9	7.5	7.0	4.8	5.2	4.7	5.5	5.0	4.6	4.8	6.2	12.3	32.1	36.2	18.9	24.0	9.7	18.4	10.5	10.2	33.0	21.5	15.7	35.0	42.9	19.1	55.2	16.7	31.4	15.4	17.0	11.7	21.0	26.4	11.2	17.0	19.0	21.7	10.1	16.4	25.8	20.5	18.9	7.7	15.5	40.4	26.1	27.8	77.7	38.2	37.0	16.5	18.2	6.1	27.4	17.7	11.1	39.7	22.3	28.4	11.2	21.3	35.8	28.8	14.6	20.9	11.5	14.3	33.4	11.8	33.7	26.3	63.4	10.9	27.1	6.6	30.7	20.7	17.8	18.3	12.0	12.9	33.7	15.9	27.1	24.0	14.2
TRAPPC6A	"HSPC289, MGC2650, TRS33"	ENSG00000007255	"Trafficking protein particle complex 6A"	O75865	19	45162928-45178237	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 246.5;Proximal tubular cells: 303.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 164.5;U-266/70: 135.3"	"Low region specificity"	"Detected in all"							HPA043043	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA043043: AB_10794650"	"unprognostic (2.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.86e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.23e-6)"	"unprognostic (3.85e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.05e-2)"	27.3	32.7	25.4	14.1	28.9	48.7	31.0	27.9	35.1	20.5	19.9	33.1	18.3	21.6	19.5	25.4	29.1	15.9	21.4	24.3	25.5	57.5	59.8	18.6	34.2	30.0	27.2	23.0	28.9	17.1	20.5	12.7	29.2	39.1	11.5	4.6	30.7	16.8	35.2	56.0	28.1	7.0	27.0	42.4	32.2	24.8	26.6	20.6	38.4	15.8	17.4	23.7	24.5	33.2	7.6	42.1	9.4	18.7	15.7	11.3	18.3	2.3	8.2	2.6	5.8	12.6	38.2	76.1	40.0	4.8	22.0	15.8	3.3	6.8	1.1	42.5	30.8	28.0	3.5	14.0	33.0	12.3	28.2	27.8	37.9	2.0	12.8	10.4	8.9	48.8	27.6	57.7	4.1	104.0	30.5	42.0	11.9	164.5	21.0	52.8	10.2	93.9	27.2	26.6	44.2	18.3	16.4	77.9	29.1	16.0	45.1	39.3	3.5	6.3	6.8	4.4	2.7	135.3	43.0	57.0	14.4	25.6	10.5	25.7	59.5	30.5	78.2	60.3	94.8	92.1	105.5	81.8	91.2	93.7	110.4	95.1	4.8	113.6	62.8	87.6	112.7	86.2	25.4	28.9	27.9	35.1	24.3	25.5	30.0	27.2	29.2	27.0	26.6	33.2	28.8	44.8	51.7	5.2	61.6	58.1	64.3	149.3	55.2	13.6	66.6	71.4	17.9	68.6	71.5	58.8	2.1	122.7	63.4	41.7	246.5	53.4	15.1	56.8	26.9	33.7	83.8	23.8	2.7	42.1	43.7	24.8	29.6	65.2	40.6	63.9	42.1	113.7	72.0	13.5	2.3	84.6	148.5	56.6	67.3	94.0	19.3	45.3	108.5	5.6	114.2	54.9	60.8	4.5	10.7	24.4	73.8	10.5	39.9	35.1	61.8	303.6	62.0	13.6	13.1	23.9	34.4	14.2	68.9	43.0	83.5	88.5	72.1	72.7	81.8	71.6
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460259-138589996	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"AF22: 146.5;HMC-1: 196.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic favorable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	7.5	25.7	6.0	6.9	6.8	10.6	9.1	5.8	7.0	6.4	5.2	8.1	10.0	8.8	8.4	9.0	5.7	5.3	10.4	6.0	7.1	8.0	23.1	11.4	8.0	6.8	6.4	30.0	10.8	14.2	3.8	12.3	6.3	11.7	9.2	12.2	8.3	5.2	13.9	8.6	9.7	7.6	6.2	7.2	11.6	27.3	8.2	17.3	9.1	16.4	7.8	7.5	6.1	9.0	15.0	18.1	146.5	42.7	9.6	8.9	11.4	13.7	14.4	10.5	10.2	28.7	13.6	28.7	13.2	13.2	21.5	7.9	71.9	11.4	15.4	22.1	17.7	63.1	13.1	88.9	13.1	49.8	196.8	7.9	11.8	8.8	13.9	7.3	25.0	15.4	72.6	17.1	12.7	29.2	85.2	44.8	56.3	77.6	16.0	66.5	17.3	24.2	23.6	43.9	30.3	68.8	25.5	22.6	7.5	50.6	15.5	32.3	10.7	12.1	9.9	21.4	19.1	15.6	18.2	47.8	20.1	32.1	18.0	0.3	0.6	1.0	0.5	0.6	0.1	0.2	0.4	0.3	0.5	0.3	0.4	0.5	0.9	0.6	0.3	0.3	0.7	0.2	6.0	6.8	5.8	7.0	6.0	7.1	6.8	6.4	6.3	6.2	8.2	9.0	29.0	51.3	46.9	26.1	9.5	13.9	13.4	13.8	10.8	13.6	14.7	14.4	39.7	20.0	18.8	7.3	16.7	28.4	14.9	12.2	5.9	7.1	70.4	16.7	22.9	18.9	10.1	31.3	27.9	12.4	15.2	16.0	20.4	25.2	40.4	85.2	14.3	31.9	10.3	40.4	46.6	10.9	14.2	9.5	14.9	38.7	14.0	13.8	14.2	21.5	12.2	23.3	9.2	64.3	67.1	9.5	9.5	16.1	13.7	12.2	6.8	10.6	14.5	22.4	13.1	21.5	17.6	72.8	14.7	22.2	11.8	22.2	15.8	34.6	19.4	12.8
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.2;Hepatocytes: 81.7;Intestinal goblet cells: 114.8;Paneth cells: 77.1;Undifferentiated cells: 88.9"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 3.3;granulocytes: 2.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"OE19: 32.7;RT4: 60.8;SK-BR-3: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	10.8	6.1	5.8	6.1	5.4	4.6	13.5	8.5	7.0	11.5	4.8	46.1	25.3	9.9	2.5	13.1	9.2	7.4	23.0	5.9	4.5	22.8	15.4	16.0	1.8	6.2	7.4	3.3	10.1	3.7	5.6	5.3	6.9	35.7	12.9	1.3	27.3	6.2	14.0	26.6	22.9	3.4	4.2	5.5	20.6	5.4	6.6	1.0	17.3	5.3	1.9	13.7	14.4	5.1	11.9	9.0	2.1	9.5	7.7	6.6	6.6	10.0	6.0	2.7	3.7	6.1	18.7	0.4	2.7	6.8	3.6	15.7	1.3	3.0	1.0	0.2	3.4	1.9	4.0	3.7	6.6	0.3	11.7	9.3	13.6	5.3	2.6	3.3	4.6	1.0	4.9	2.1	6.9	17.4	0.8	0.9	1.0	32.7	13.3	4.1	2.0	0.6	4.6	60.8	0.8	2.2	4.1	38.6	2.2	0.7	22.6	3.7	11.8	14.4	7.8	7.9	0.2	3.9	4.3	0.4	7.9	7.4	5.3	2.2	4.3	0.7	0.3	2.5	0.2	0.5	0.2	0.2	3.3	0.5	0.3	0.3	2.8	0.5	1.0	3.1	0.2	1.4	5.8	5.4	8.5	7.0	5.9	4.5	6.2	7.4	6.9	4.2	6.6	5.1	12.8	32.1	2.6	9.8	3.5	12.5	15.3	9.9	9.1	2.0	19.0	14.6	16.7	17.2	12.3	14.7	0.0	6.6	0.2	179.2	19.6	7.9	2.9	17.5	8.2	11.7	21.7	0.0	5.4	18.5	6.8	6.0	71.4	36.2	5.7	2.9	11.4	81.7	19.9	0.0	8.5	114.8	14.2	9.8	19.0	3.1	6.8	8.5	39.2	9.4	12.8	6.7	0.0	3.5	0.9	32.9	77.1	7.2	7.6	35.5	55.3	3.8	8.9	2.6	32.9	2.2	8.5	6.1	15.7	8.4	11.5	3.4	1.9	4.1	88.9	33.1
TRPM8		ENSG00000144481	"Transient receptor potential cation channel subfamily M member 8"	Q7Z2W7	2	233917373-234019522	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	57	"liver: 31.5;prostate: 80.2"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 45.2;Prostatic glandular cells: 16.3"	"Cancer enriched"	"Detected in some"	27	"prostate cancer: 72.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.4;Karpas-707: 5.5;RPTEC TERT1: 8.1;SK-MEL-30: 8.9;WM-115: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (4.41e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (7.15e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.88e-3)"	"unprognostic (7.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.36e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.53e-2)"	0.0	0.2	0.2	0.2	0.3	0.1	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	31.5	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.5	0.0	0.3	80.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.4	0.6	8.1	0.0	0.5	0.3	0.0	0.1	8.9	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	1.2	2.0	0.0	0.7	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	5.5	0.1	0.0	0.7	0.2	0.0	1.1	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	2.3	1.2	0.6	0.5	0.0	2.7	0.3	1.7	0.0	0.3	0.0	4.4	0.0	0.1	0.7	45.2	0.3	0.0	0.9	0.0	0.0	0.6	0.8	3.9	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	16.3	0.0	0.0	0.0	0.2	0.0	0.4	0.2	1.3	0.6	0.0	0.1	0.0	0.5	0.0	0.0	4.1
TSPAN8	"CO-029, TM4SF3"	ENSG00000127324	"Tetraspanin 8"	P19075	12	71125085-71441898	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 951.1;stomach 1: 631.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1688.5;Ductal cells: 943.3;Intestinal goblet cells: 886.7;Paneth cells: 2225.8;Proximal enterocytes: 3546.1;Undifferentiated cells: 1583.9"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 283.9;pancreatic cancer: 156.9;stomach cancer: 194.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"OE19: 2160.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA022273, CAB026009, HPA044337"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB026009: , HPA022273: , HPA044337: AB_2678899"	"unprognostic (1.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.66e-5)"	"unprognostic (1.88e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (7.36e-5)"	11.1	9.7	1.9	126.9	5.2	0.0	17.0	6.1	7.1	28.6	1.6	951.1	916.0	12.5	11.7	5.5	13.4	208.2	5.5	1.8	3.4	57.6	53.2	23.0	4.6	12.4	4.9	41.8	60.0	0.4	2.5	2.0	10.5	163.9	862.0	0.3	76.4	10.8	63.7	13.6	848.3	39.2	8.5	0.3	631.0	5.8	4.4	1.1	6.5	12.4	3.8	11.0	4.0	14.6	0.0	0.7	0.0	0.0	5.2	0.8	2.8	0.0	0.0	0.0	0.0	48.8	3.1	0.0	0.2	0.0	0.6	6.5	0.0	0.0	0.0	0.2	0.1	0.0	52.2	3.3	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.3	0.0	0.2	3.0	0.3	2160.7	173.3	0.2	0.0	4.9	34.1	41.0	4.1	7.7	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.3	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.2	6.1	7.1	1.8	3.4	12.4	4.9	10.5	8.5	4.4	14.6	0.8	0.0	2.2	0.0	6.1	20.8	32.5	14.0	0.6	0.3	8.5	1.8	0.3	346.0	76.7	44.1	0.0	1.2	0.0	1688.5	127.2	943.3	34.5	3.7	4.5	3.8	174.1	0.0	0.1	654.9	0.6	37.3	645.3	44.8	4.5	0.0	2.2	26.0	0.2	0.0	0.1	886.7	16.2	2.2	29.1	17.9	44.1	2.6	64.0	0.0	7.8	10.3	0.0	0.5	14.3	325.0	2225.8	32.0	2.2	376.2	3546.1	2.5	30.2	0.6	0.0	7.7	23.6	0.5	1.0	2.7	13.5	1.1	5.8	10.7	1583.9	46.0
TSTD1	KAT	ENSG00000215845	"Thiosulfate sulfurtransferase like domain containing 1"	Q8NFU3	1	161037631-161038977	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 684.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 205.3;OE19: 215.1;SK-BR-3: 284.0;T-47d: 274.9;U-266/70: 315.4;U-266/84: 243.2"	"Region enriched"	"Detected in some"	4	"olfactory bulb: 6.6"	"Low region specificity"	"Detected in all"			"HPA006518, HPA006655"	Approved		Approved	"Cytosol,Cytoplasmic bodies"		NA	NA		57000	"Cluster 37: B-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cytosol, Cytoplasmic bodies"		"HPA006518: AB_2667608, HPA006655: AB_10600919"	"unprognostic (6.10e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.88e-3)"	33.8	72.1	28.3	25.8	31.4	48.3	73.6	19.8	40.3	31.4	34.6	60.3	40.4	10.4	101.5	91.3	69.2	18.9	55.4	28.2	28.0	125.3	74.7	47.4	52.8	21.2	23.4	55.1	93.5	167.2	119.2	13.2	23.2	98.6	40.8	11.4	175.7	43.5	38.7	79.6	50.5	8.5	20.8	39.7	61.3	35.6	27.3	59.5	140.0	18.6	51.2	29.9	46.4	24.9	119.8	1.6	0.3	0.6	0.0	0.0	2.1	0.2	0.0	0.2	0.0	11.1	112.5	25.0	67.9	0.0	0.0	107.2	0.1	46.4	0.0	98.4	84.9	13.3	43.2	0.0	12.2	43.7	0.9	0.6	28.2	0.0	4.8	0.1	15.6	100.8	0.4	130.8	12.8	205.3	118.6	0.6	0.7	215.1	0.3	38.7	0.0	184.8	98.0	32.8	67.5	37.2	0.0	284.0	0.9	54.0	274.9	0.6	0.5	0.0	41.5	0.6	4.8	315.4	243.2	26.3	0.3	0.2	0.4	438.2	24.2	357.7	226.5	72.0	218.8	530.9	296.2	252.0	72.6	506.1	333.3	282.1	337.5	306.5	104.8	203.9	410.8	220.6	28.3	31.4	19.8	40.3	28.2	28.0	21.2	23.4	23.2	20.8	27.3	24.9	6.5	253.2	228.8	1.0	170.3	86.3	307.5	331.1	160.5	16.2	443.9	457.1	68.4	223.1	259.0	367.8	27.1	271.5	101.2	478.1	684.8	169.7	16.3	336.9	29.2	14.0	218.5	29.0	5.8	151.5	112.7	35.8	59.1	201.2	124.7	88.7	10.8	149.3	72.3	3.3	1.9	418.1	402.8	18.7	116.2	25.1	8.4	40.7	151.2	1.9	178.3	73.0	206.0	1.0	0.7	131.5	383.6	9.8	110.5	386.2	426.6	665.8	615.1	31.8	19.7	99.5	37.7	73.3	44.4	199.6	135.8	151.0	149.3	31.7	267.0	384.9
TTC39A	"C1orf34, DEME-6, KIAA0452"	ENSG00000085831	"Tetratricopeptide repeat domain 39A"	Q5SRH9	1	51287258-51345116	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 59.5"	"Group enriched"	"Detected in many"	9	"Early spermatids: 425.0;Late spermatids: 616.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 31.7"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 31.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 70.6;MCF7: 52.4;SK-BR-3: 153.7;T-47d: 111.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028098, HPA043440"	Uncertain		Enhanced	Centrosome		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"HPA028098: AB_10601705, HPA043440: AB_2678483"	"unprognostic (5.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	2.2	8.2	3.5	3.3	3.5	1.7	35.9	3.0	9.6	14.1	0.0	29.5	6.1	1.0	15.9	18.4	7.5	14.9	15.3	1.0	11.4	26.6	2.8	9.1	1.4	7.4	5.3	0.3	13.5	13.5	11.0	0.3	14.0	20.5	35.2	4.6	11.5	4.2	4.1	10.5	8.1	1.6	2.2	0.3	29.4	59.5	7.7	0.5	10.1	1.7	2.0	8.0	9.4	3.7	6.4	3.4	0.7	0.3	0.4	0.7	28.2	0.3	0.2	0.2	0.2	18.2	2.8	0.1	9.6	0.4	0.4	0.2	3.8	0.2	0.1	70.6	9.7	0.5	1.8	3.2	1.1	0.0	0.7	0.1	1.6	0.1	0.0	0.8	1.4	0.2	0.4	0.1	0.2	52.4	0.6	0.2	4.8	33.8	0.6	0.1	0.2	4.3	28.6	9.1	22.1	1.6	0.5	153.7	1.8	2.0	111.7	0.8	0.8	0.4	2.5	0.5	0.5	5.4	7.1	0.2	2.1	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	31.7	0.0	0.3	3.5	3.5	3.0	9.6	1.0	11.4	7.4	5.3	14.0	2.2	7.7	3.7	0.4	3.2	25.2	1.3	1.1	1.5	5.3	1.7	0.0	2.5	30.8	15.1	13.0	5.7	6.4	9.2	0.0	0.5	15.3	29.3	11.7	38.9	425.0	5.4	3.0	1.9	41.4	9.7	9.7	52.7	4.8	0.9	21.9	9.5	3.8	0.5	0.4	0.6	2.0	0.0	10.2	56.0	6.1	0.3	1.3	616.8	2.5	0.9	0.0	1.0	2.6	1.7	0.0	0.0	0.9	30.5	13.7	2.6	0.4	12.0	2.7	24.4	9.3	7.3	6.6	1.8	1.3	22.8	6.5	4.8	6.5	3.4	1.7	0.5	20.7	14.6
TXNDC11	EFP1	ENSG00000153066	"Thioredoxin domain containing 11"	Q6PKC3	16	11679083-11742857	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Plasma cells: 307.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 141.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041174, HPA041390"	Supported		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane, Cytosol"		"HPA041174: AB_10794191, HPA041390: AB_10796670"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (2.12e-5)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.96e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.34e-2)"	15.7	14.2	4.5	22.5	5.6	55.4	16.6	7.7	5.9	20.8	16.6	30.0	38.5	15.1	23.6	13.1	16.2	17.3	13.7	5.0	4.9	25.7	44.3	34.9	25.3	4.8	4.8	16.6	26.5	45.1	12.6	17.0	4.8	24.4	29.8	15.3	34.8	14.9	30.1	12.0	32.0	15.6	4.6	22.4	36.1	8.5	4.9	20.6	34.4	14.9	27.9	25.3	11.8	5.0	26.1	17.7	8.2	11.2	21.6	18.0	14.4	25.3	34.5	22.7	29.1	8.8	40.5	65.2	41.6	32.0	30.9	22.9	10.2	21.4	18.5	29.4	13.5	13.9	19.4	43.8	31.7	20.6	27.1	13.7	23.6	25.4	39.9	17.6	28.9	14.6	21.5	81.8	20.2	23.7	16.1	7.9	10.7	18.6	9.1	20.5	16.5	141.9	26.0	13.7	11.5	10.9	49.6	38.2	27.3	9.1	23.4	28.1	30.1	10.5	12.0	49.8	14.7	110.5	64.8	39.5	22.3	25.7	17.9	3.5	2.4	7.7	1.8	1.7	4.5	3.8	3.3	4.1	2.6	4.6	3.2	2.1	0.7	5.6	2.2	2.0	6.8	2.8	4.5	5.6	7.7	5.9	5.0	4.9	4.8	4.8	4.8	4.6	4.9	5.0	16.2	44.8	46.2	21.9	49.2	14.7	24.8	12.9	23.3	16.2	16.1	18.0	9.1	18.6	24.6	18.4	50.1	21.1	27.2	45.8	15.6	20.4	3.1	19.9	14.6	15.2	24.5	6.5	23.0	39.7	29.8	14.0	45.3	28.5	15.2	13.0	15.7	39.3	30.3	23.5	25.5	44.0	8.2	18.1	26.9	1.4	20.2	29.2	23.2	18.7	21.2	16.4	15.5	22.1	18.6	26.1	21.0	13.2	307.9	28.0	37.1	15.2	15.9	23.4	6.6	13.8	16.2	11.6	13.1	17.5	11.8	25.0	25.2	11.3	27.7	32.1
TXNRD2	"SELZ, TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941820	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 139.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Mitochondria,Cytosol		NA	NA		2800000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	10.5	44.4	11.9	8.9	12.0	14.5	12.3	18.1	19.3	11.7	21.2	14.9	10.3	10.6	6.2	10.2	10.6	6.2	30.0	12.9	11.9	24.8	65.4	13.6	9.1	11.8	12.1	16.5	15.9	13.5	14.4	9.8	11.5	26.8	4.6	4.4	15.4	8.2	23.0	10.9	12.0	5.1	11.3	16.9	26.4	14.6	12.4	4.9	15.2	16.1	6.1	11.8	10.4	11.8	19.4	39.2	3.5	14.9	6.9	9.6	8.8	18.8	21.1	31.8	23.4	36.7	19.4	10.9	43.2	19.0	32.7	33.2	17.8	25.2	12.1	21.6	46.5	18.8	34.4	22.4	12.9	21.1	8.4	9.2	18.5	16.2	13.8	12.9	91.3	2.2	106.4	17.4	24.8	47.1	7.2	30.1	17.7	46.9	27.6	10.5	85.2	10.0	19.3	21.0	19.1	16.4	32.0	39.9	21.8	5.8	33.7	27.6	52.2	23.0	139.5	19.8	38.4	17.6	14.0	6.9	22.4	15.5	30.3	2.7	10.5	5.8	3.5	8.2	2.6	3.9	3.0	3.2	7.8	2.6	3.9	3.2	0.9	3.8	7.9	2.9	2.1	4.6	11.9	12.0	18.1	19.3	12.9	11.9	11.8	12.1	11.5	11.3	12.4	11.8	5.6	16.0	23.6	11.1	10.3	4.2	23.1	15.1	3.4	22.1	11.4	9.1	16.7	15.7	15.7	20.2	10.4	60.7	8.8	14.7	58.7	22.0	26.4	9.8	8.4	14.4	1.2	33.1	9.2	32.0	24.3	12.4	23.4	10.0	1.3	27.6	8.9	49.5	25.9	10.1	8.5	16.9	20.3	22.0	7.8	18.2	15.5	14.6	5.4	10.3	27.2	18.7	10.3	8.5	7.2	22.3	13.9	9.1	12.2	17.8	15.6	52.0	16.6	11.0	6.6	11.3	13.3	10.9	14.0	6.4	5.3	42.0	11.4	36.4	16.4	15.7
UPK3A	UPK3	ENSG00000100373	"Uroplakin 3A"	O75631	22	45284949-45295874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"prostate: 21.3;skeletal muscle: 35.0;urinary bladder: 48.0"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 15.0;monocytes: 22.6;Prostatic glandular cells: 54.1;Proximal enterocytes: 29.8;Urothelial cells: 24.5"	"Group enriched"	"Detected in many"	6	"prostate cancer: 35.3;urothelial cancer: 78.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 86.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 86.6;monocytes: 32.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 29.9;RT4: 48.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018407, HPA018415"	Enhanced		Uncertain	"Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear membrane"	"Nuclear bodies"	"HPA018407: AB_1858641, HPA018415: AB_1858640"	"unprognostic (1.27e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.98e-5)"	"unprognostic (1.69e-2)"	"unprognostic (4.82e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.05e-3)"	0.2	0.1	0.1	0.5	0.1	1.5	0.2	0.1	0.4	0.0	0.3	1.0	0.0	0.1	0.1	0.3	0.3	0.9	0.1	0.1	0.2	0.1	0.0	0.2	0.9	0.2	0.1	0.1	0.2	4.9	0.7	0.0	0.2	21.3	0.7	0.0	2.8	0.2	35.0	0.0	1.3	0.1	0.1	1.1	0.1	0.1	0.1	0.7	2.3	4.5	0.8	48.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	4.6	0.0	0.1	0.0	0.2	0.0	48.9	0.1	0.0	0.2	0.8	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	21.2	0.0	0.0	25.8	0.0	1.2	0.0	0.1	86.6	0.5	0.0	0.0	3.6	0.4	32.0	32.9	0.0	7.4	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.7	1.2	0.1	15.0	0.1	0.0	0.1	4.6	3.6	0.2	2.8	0.1	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.1	3.5	0.0	4.8	8.7	1.7	0.3	6.4	0.0	0.0	22.6	0.8	2.1	0.0	0.0	0.0	9.3	0.0	0.1	54.1	29.8	0.0	0.1	0.0	0.0	1.6	0.5	0.0	0.4	0.0	0.4	0.1	0.2	0.0	4.4	24.5
VIPR1	"HVR1, RDC1, VPAC1, VPAC1R"	ENSG00000114812	"Vasoactive intestinal peptide receptor 1"	P32241	3	42489299-42537573	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 132.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 71.8;Intestinal goblet cells: 48.6;Paneth cells: 96.2;Proximal enterocytes: 58.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	22	"dendritic cells: 2.1;monocytes: 1.8;T-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 60.8;OE19: 36.2;RT4: 44.0;SK-BR-3: 24.7;WM-115: 79.0"	"Group enriched"	"Detected in many"	4	"amygdala: 6.3;basal ganglia: 4.5;cerebral cortex: 9.6;hippocampal formation: 7.7;white matter: 2.5"	"Low region specificity"	"Detected in all"			HPA026777	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA026777: AB_10604003"	"unprognostic (9.02e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.89e-4)"	"unprognostic (4.00e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.05e-2)"	17.5	2.6	10.1	3.4	12.7	2.3	16.9	13.5	15.2	2.9	5.1	28.0	34.5	1.2	6.6	5.3	1.3	6.0	6.5	13.0	5.5	2.7	32.4	132.1	4.6	5.3	4.8	0.6	2.5	4.2	1.9	2.8	6.3	25.0	27.7	4.2	22.7	8.9	1.2	29.8	30.0	1.3	4.4	5.7	6.1	1.4	4.7	1.9	15.1	4.9	2.4	8.7	5.0	12.1	0.1	2.4	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.4	2.2	60.8	0.2	3.1	0.0	0.0	2.4	0.0	1.6	0.1	0.0	5.2	3.8	1.8	0.0	0.3	0.0	0.5	0.0	3.8	0.2	1.2	0.0	0.7	0.6	0.0	0.0	0.0	5.2	0.0	0.3	3.8	36.2	0.2	0.5	0.0	2.8	0.0	44.0	1.3	0.0	0.0	24.7	0.0	7.1	15.2	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	79.0	0.0	1.8	0.0	0.2	1.5	1.0	0.0	2.4	1.0	2.1	0.0	2.7	0.8	0.0	0.0	1.3	0.0	0.4	0.9	10.1	12.7	13.5	15.2	13.0	5.5	5.3	4.8	6.3	4.4	4.7	12.1	16.0	3.2	6.0	3.3	1.3	7.6	4.5	2.2	22.2	0.2	19.2	21.5	2.6	5.7	2.1	1.8	8.4	0.1	0.4	71.8	0.0	0.3	3.0	0.2	0.1	2.8	4.8	0.0	26.9	0.9	1.0	1.0	16.3	0.6	0.0	0.3	19.6	0.4	0.7	0.0	1.5	48.6	0.0	8.7	4.0	0.6	0.0	5.9	0.0	3.7	8.9	1.4	0.0	3.0	1.7	1.2	96.2	0.0	1.5	6.3	58.6	0.1	1.0	5.4	32.9	0.2	20.8	0.1	0.1	4.1	7.7	0.3	2.9	0.1	24.0	3.9
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780610-42797066	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.0;kidney: 37.6;prostate: 11.6"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 160.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 32.6;K-562: 36.8;TIME: 34.1;WM-115: 23.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.3	0.0	0.7	1.1	0.9	0.0	2.8	0.8	3.3	0.6	0.3	9.8	1.9	0.2	0.7	8.9	0.4	0.0	0.1	1.7	1.1	37.6	0.2	0.1	0.1	1.1	0.7	4.3	0.2	0.0	1.2	0.0	0.7	11.6	11.0	0.6	1.8	1.1	0.0	0.5	3.7	0.4	0.6	0.1	3.4	0.2	1.0	0.0	0.0	0.3	0.1	0.2	0.4	1.0	2.1	1.2	0.6	0.0	0.7	0.2	4.8	11.9	4.8	4.5	1.3	0.7	1.0	0.6	6.8	32.6	1.2	0.0	0.2	0.3	8.6	0.6	1.8	0.1	0.0	4.7	7.4	0.3	0.7	3.9	1.4	6.4	2.1	2.1	0.3	0.4	36.8	1.3	0.0	1.0	0.0	1.1	0.3	2.0	8.2	0.6	1.2	0.0	0.0	0.5	0.0	0.2	0.1	0.2	1.7	4.1	2.4	2.7	34.1	0.3	3.1	0.5	0.4	6.2	5.3	1.2	0.0	2.1	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.8	3.3	1.7	1.1	1.1	0.7	0.7	0.6	1.0	1.0	0.2	0.0	0.6	0.0	0.5	0.0	0.2	0.0	0.6	0.2	7.1	4.1	1.0	1.5	0.6	7.3	0.0	0.0	0.3	8.0	160.4	0.0	0.0	5.1	1.1	0.2	13.1	0.0	0.2	0.2	0.2	0.1	3.1	6.7	4.5	0.1	0.7	0.0	0.0	0.0	0.2	40.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.4	0.0	3.6	0.9	1.0	2.9	0.5	0.0	0.2	0.5	0.8	0.8	12.1	0.4	0.0	0.2	0.0	13.1	0.3
ZG16B	"HRPE773, JCLN2, PRO1567"	ENSG00000162078	"Zymogen granule protein 16B"	Q96DA0	16	2830169-2839585	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	717	"salivary gland: 63926.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 194.0;Basal respiratory cells: 181.6;Breast glandular cells: 154.9;Club cells: 343.9;Intestinal goblet cells: 232.2;Prostatic glandular cells: 398.1;Urothelial cells: 357.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 47.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.3;intermediate monocyte: 11.4;non-classical monocyte: 7.4"	"Lineage enriched"	"Detected in many"	7	"monocytes: 11.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 27.1;OE19: 57.5;SK-BR-3: 24.1;T-47d: 22.2"	"Not detected"	"Not detected"							"HPA041125, HPA053549"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		690000	"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"HPA041125: AB_10794264, HPA053549: AB_2682184"	"unprognostic (5.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (3.48e-6)"	"unprognostic (1.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.33e-2)"	2.5	13.2	0.0	3.9	0.0	4.6	33.1	0.0	0.1	33.0	0.0	13.6	11.5	0.6	1.5	25.3	4.4	34.4	9.0	0.0	0.0	2.6	8.2	3.3	0.3	0.0	0.8	10.3	46.6	30.4	6.0	4.8	0.1	89.1	17.8	0.0	63926.2	7.1	6.1	47.7	9.6	0.4	0.0	4.2	33.2	4.4	0.0	0.2	2.9	0.1	5.9	11.2	16.3	0.0	0.0	1.1	0.0	0.0	0.3	1.9	0.2	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.3	0.0	0.2	2.1	0.0	4.4	0.0	0.0	0.0	9.0	2.8	2.4	1.6	0.0	0.0	0.1	0.2	0.0	1.2	0.1	0.0	0.0	0.2	3.6	0.2	27.1	0.0	0.4	0.1	57.5	5.0	0.0	0.0	8.6	0.2	6.3	0.0	0.0	0.1	24.1	0.0	0.1	22.2	0.0	3.1	0.1	0.5	1.9	0.1	0.0	0.5	0.3	0.3	6.5	0.3	1.7	6.3	0.0	0.0	11.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.4	1.2	7.4	0.0	0.5	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	9.1	194.0	181.6	0.0	0.0	154.9	82.5	0.0	70.1	343.9	1.8	0.0	0.1	2.0	107.1	0.0	5.9	7.7	3.5	1.6	2.8	58.2	0.4	0.0	28.1	3.2	1.8	21.9	13.0	5.7	1.7	0.7	0.1	14.6	0.0	0.0	232.2	140.4	4.6	0.5	5.7	0.0	4.4	83.6	0.0	5.6	0.0	0.0	0.0	0.0	46.4	65.3	0.0	0.0	398.1	12.5	0.0	74.7	0.0	0.0	0.0	19.2	1.4	0.6	9.5	24.0	0.3	2.5	21.3	76.7	357.4
ZNF350	"ZBRK1, ZFQR"	ENSG00000256683	"Zinc finger protein 350"	Q9GZX5	19	51964340-51986856	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	4	"prostate cancer: 16.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA001521	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA001521: AB_1080705"	"unprognostic (7.26e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-3)"	"unprognostic (6.64e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.30e-2)"	"prognostic favorable (2.54e-4)"	6.6	4.4	5.8	5.4	7.3	26.2	13.8	8.6	6.7	5.5	4.1	6.6	5.4	6.4	8.2	4.7	5.8	5.2	5.1	6.4	6.5	7.0	5.3	6.3	9.7	6.0	5.7	8.3	4.5	9.2	4.8	9.3	6.1	27.5	9.1	9.7	6.4	6.3	4.5	7.5	6.1	5.8	5.8	9.0	7.3	6.3	6.5	9.0	9.8	5.9	9.1	6.2	5.2	7.2	0.8	4.4	5.6	6.8	7.5	6.7	1.1	4.6	6.5	4.8	9.5	0.0	3.5	2.1	3.6	5.5	8.8	5.8	4.9	6.5	6.6	0.0	10.5	8.6	7.5	3.9	6.3	2.2	10.1	9.5	9.9	6.4	6.6	9.4	5.5	3.5	2.3	0.1	5.8	2.8	8.5	10.2	3.7	0.5	6.8	4.0	8.0	6.9	7.6	11.9	4.7	6.3	0.0	6.0	5.0	7.9	9.8	7.7	5.9	5.2	3.7	3.1	4.7	1.6	2.8	2.7	1.0	0.1	5.6	65.3	11.2	26.9	16.2	12.7	16.4	16.8	15.3	15.6	13.6	17.2	17.7	14.2	30.8	21.5	16.2	8.8	13.4	8.1	5.8	7.3	8.6	6.7	6.4	6.5	6.0	5.7	6.1	5.8	6.5	7.2	9.1	0.0	7.3	4.6	13.1	5.9	11.0	11.1	5.7	9.9	6.0	5.3	6.6	2.8	10.7	9.2	12.5	12.2	12.9	5.1	7.9	6.7	13.0	4.5	4.7	8.0	7.3	2.5	4.2	5.3	9.9	7.1	3.6	6.7	12.0	9.7	6.4	3.1	7.8	6.7	4.1	5.9	16.2	9.5	12.0	3.4	11.1	10.8	12.4	6.5	11.6	7.9	23.7	4.0	9.1	6.0	5.7	6.0	7.5	14.5	7.6	3.9	7.8	13.1	0.0	7.2	8.4	10.2	5.7	3.5	7.0	23.1	15.1	6.8	3.8	13.4
ZNF697	MGC45731	ENSG00000143067	"Zinc finger protein 697"	Q5TEC3	1	119619377-119648266	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.0;Syncytiotrophoblasts: 19.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 14.4"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3;cerebral cortex: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 42.8;WM-115: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049933	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA049933: AB_2680958"	"unprognostic (2.57e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (6.20e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.36e-1)"	4.1	2.9	0.9	1.4	3.3	1.0	3.4	0.0	3.2	1.5	0.0	1.3	1.7	2.2	2.3	0.8	1.4	1.5	4.3	1.5	0.0	7.5	3.1	4.4	0.6	0.0	0.0	2.0	2.8	4.9	2.8	6.9	0.0	4.2	1.4	0.9	5.4	1.0	2.1	1.6	1.5	1.2	0.0	1.4	1.8	3.1	0.2	0.5	3.2	1.9	0.4	2.0	1.0	0.0	2.0	1.0	4.9	1.6	6.4	7.0	6.6	8.8	12.2	5.1	4.6	3.1	0.4	0.0	2.9	4.9	4.0	2.2	3.8	8.7	11.9	0.0	3.8	3.3	2.0	5.9	12.2	2.2	2.2	11.9	2.4	11.4	24.2	5.6	10.1	2.8	3.0	0.4	2.3	1.5	0.0	1.6	26.1	1.8	2.9	0.0	11.8	0.2	2.4	4.5	1.1	6.8	2.0	2.1	42.8	15.4	1.0	3.1	23.4	8.4	10.7	6.0	15.4	1.2	2.0	0.0	11.9	2.3	42.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	3.3	0.0	3.2	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.5	1.3	0.1	2.2	1.5	2.5	0.6	0.8	1.7	0.6	8.8	1.5	1.9	1.8	0.0	7.9	0.0	0.7	3.9	1.8	1.6	1.1	2.6	3.5	2.4	0.0	17.0	0.9	2.3	4.3	1.5	1.8	0.0	5.5	3.3	4.2	2.6	0.0	6.9	2.1	4.1	3.7	12.0	3.6	4.7	3.1	5.4	4.7	2.7	1.1	0.0	8.0	0.6	2.1	3.3	6.4	0.0	3.7	1.8	6.4	0.4	0.9	6.6	0.5	5.4	1.3	1.5	0.4	1.8	19.8	0.1	5.3	1.8	0.9